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ABSTRACT 
Endogenous carmabinoids (endocannabinoids) exert a wide range of 
biological effect . In addition to having their well-known neurobehavioral effects , 
a role for the major endocannabinoid anandamide (N-arachidonoyl ethanolamide; 
AEA), in the cardiovascular system in various pathological conditions has been 
reported. The aim of this thesis is to explore the effects of AEA on contractility, 
Ca2+ signaling, and action potential (AP) characteristics in rat ventricular 
myocytes. A video edge detection system was used to measure myocyte 
shortening. Intracellu lar Ca2 was measured in cells loaded with the fluorescent 
indicator fura-2 AM. AEA (l �M) caused a significant decrease in the amplitude 
of electrical ly-e oked myocyte shortening. The effect of AEA was not altered in 
the presence of pertussis toxin ( PTX), AM251 and S R141716 (CB, arltagonists) or 
AM630 and S R  144528 (CB2 antagonists). AEA also caused a significant decrease 
in the amplitudes of electrically-evoked Ca2+ transients. However, the amplitudes 
of caffeine-evoked Ca2+ transients and the rate of recovery of electrical ly-e oked 
Ca2+ trarlsients fol lowing caffeine application were not altered. In the whole-cel l 
mode of patch-clamp technique, AEA (1 �M) significant ly decreased the duration 
of APs. The inhibition was not altered in the presence of PTX, AM251 and 
AM630. Furthermore, AEA inhibited voltage-activated inward Na+ (INa) and Ca2+ 
(h,ca) currents ;  major ionic currents shaping the APs in ventricular myocytes, in a 
voltage and PTX-independent manner. Cardiac Na+/Ca2+ exchanger (NCX1)­
mediated currents were also suppressed by AEA. The effect of AEA was not 
influenced by the inhibition of fatty acid amide hydrolase ( F  AAH) or in the 
presence of PTX, AM251 and AM630 or fol lowing the inclusion of GDP-�-S in 
pipette solution. The results of this study indicate for the first time that impaired 
VI 
cl+ signaling underlies the negati e inotropic actions of AEA in rat entricular 
myocyte and that the direct interaction of AEA with ion channel(s) shaping APs 
mediate, at least in part, the effects of AEA on myocyte contractility. In addition, 
the results indicate for the first time that, under normal conditions, AEA can 
direct ly inrubit the activity of CX l in ventricular myocytes. In view of the 
massive relea e of various -acylethanolamines (NAEs), including AEA, during 
cardiac ischemia and hypoxic conditions, further understanding of their 
mechanism(s) of action and target proteins is essential in the development of 
better treatment modalities under pathological conditions. 
Keywords: Endo cannabino ids anandamide, myocyte shortening voltage­
activated inward a + current, voltage-activated inward Ca2+ current . 
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1. I NTRODUCTI ON 
1.1. Card iac cel l electrophysio logy 
1.1.] Ca rd iac action poten t ia l  
Ph) iological function of the heal1 results from the periodic execution of a 
enes of coordinated and interdependent mechanical, chemical, and electrical 
proce e v, ithin the cardiac tissue. An important event central to these processes 
is the cardiac action potential CAP) and the mechanism by which this electrical 
excitation initiate cardiac muscle contraction is called excitation-contraction 
coupl ing. 
The AP of a cardiac cell arises from the coordinated opening and closing 
(gating) of ion channels; membrane proteins that control ion passage across cell 
membranes and constitute the molecular foundation for the generation of APs. 
Depending on the cell type, the transmembrane voltage in resting cardiac tissue 
cells ranges from -60 mV to -90 mY, where the intracellular space is negatively 
charged with respect to the extracellular space due to the differences In Ion 
concentration that exist between the intracellular and the extracellular milieu 
(Grant, 2009). This concentration difference not only gives rise to diffusion of 
Ions across the membrane, but also generates a potential difference that 
counteracts the diffusion and determines the electrochemical equilibrium 
according to the Nemst Equation (Kettenmann, et aI ., 1983). It is also important to 
note that due to involvement of multiple ions, the sum of conductances of 
different ion channels determines the final value of the resting membrane 
potential. 
The electrophysiological characteristics of excitable cells are shaped in 
large part by the regulation of voltage-gated ion channels (VGICs). These 
channels are deemed voltage-gated since changes in membrane potential lead to 
alterations in their conformation or gating characteristics. Voltage-gated ion 
channel comprise three main families: Na+, Ca2+ and K+ channels (Bezanilla, 
2005). In general, at any gi en moment, VGICs can be found in one of three 
gating state; closed, open, or inactive (Karmazinova and Lacinova, 20 10). 
Channels in their closed state can be opened by an appropriate change in 
membrane potential. Channels in their open state allow the generation of ionic 
conductance for a particular permeable ion. However. in the inactive state. 
channels at depolarized potentials enter a transient non-conducting refractory 
period in which no changes in membrane potential can re-open them. After this 
refractory period, inactive channels can return to their closed state and become 
a ailable for the generation of the next AP (Bahring and Covarrubias, 2011). 
The AP in a ventricular muscle cell lasts for 200-300 ms and is divided 
into five sequential phases: resting (phase 4), upstroke (phase 0), early 
repolarization (phase I ), plateau (phase 2), and final repolarization (phase 3) 
(figure 1.1) (Am in, et a!.. 20 10). At the resting membrane potential, Na + and Ca
2+ 
channels are mainly in the closed state and the activity of K+ channels. especially 
the inwardly rectifying K+ (KlR) channels determine the resting membrane 
potential. Because the resting state has higher permeability to K+, resting 
membrane potential of most ventricular cardiomyocytes stabilizes near the voltage 
required to oppose the K+ concentration gradient, i.e., the K+ equilibrium potential 
(Chung and Kuyucak, 2002). Upon the arrival of a brief, suprathreshold 
depolarizing stimulus, voltage-gated Na+ channels (VGSCs) in the resting state 
2 
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Fig u re 1. 1  Card iac action potent ia l  and  card iac ion cu rrents :  The cardiac 
action potential is generated by transmembrane inwardly and outwardly directed 
ion currents. The inward (depolarizing) Na + and Ca:!+ currents point downwards. 
The outward (repolarizing) K+ currents are pointed upwards. Adapted from Amin. 
el al., 2010. 
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begin to open allo\\ ing for the rapid influx of + . a Ion into the cell do,", n their 
electrochemical gradient. The influ of positively charged a+ ions further 
depolarize the membrane resulting in the opening of more Na + channels and 
progre ively increasing Na+ influx (phase 0). This fast feed fon ard mechanism 
""ill bring the membrane potential towards Na + equilibrium alue '"' hich is about 
20 mY. It is important to note that this initial depolarizing phase is central to fast 
impulse propagation within the cardiac muscle. During depolarization. NaT 
channels rapidly enter their inactive state in which no amount of stimulus will re-
open them and Na+ current decays within a few milliseconds (Grant. 2009: 
Moreno. et aI., 2012). Following this initial upstroke. a first repolarization phase. 
coined phase 1, is initiated by the opening of a particular K+ channel that 
generates a transient outward current (fLO) and causes a repolarizing notch in the 
AP (Dong, et aI., 2006). Meanwhile, the Ca2+ channels. which exhibit lower 
kinetics than Na + channels, also open in response to depolarization leading to a 
period of prolonged (100-200 ms) depolarization of the membrane potential called 
the plateau phase of the AP (phase 2). This plateau phase results from a delicate 
balance between depolarizing (inward) and repolarizing (outward) currents (Qu 
and Chung. 2012) . During the prolonged depolarization, YGCCs begin to 
inactivate, while delayed rectifier K+ channels begin to activate. Eventually, the 
prevailing repolarizing current carried by K+ channels brings the membrane back 
towards the resting membrane potential (phase 3) (Moreno, et aI., 2012: Grant, 
2009). As mentioned earlier, the resting state of the AP (phase 4) is maintained by 
the KIR . This channel is the primary conductance controlling the resting potentia!. 
and permitting a significant repolarizing current during the terminal stage of the 
AP (Wu, et aI., 2012). 
4 
The characteristic hape of the AP changes significantl across the 
myocardial \-\all from the endocardium, midmyocardium, to epicardium. For 
e ample, epicardial cells have a prominent phase 1 and a shorter duration of AP 
oitychuk. et al. , 2012). On the other hand, AP duration is the longest in the 
midm) ocardial region of ventricular muscle (Antzelevitch. et aI. ,  1991; Grant. 
2009). 
1.1.2 Card iac i nward ion cu rren ts 
1.1.2.1 Voltage-gated Na + chan nels 
Voltage-gated Na + channels (VG Cs) play an essential role in the initiation 
and propagation of APs in neurons and other excitable cells such as cardiac 
myocytes (Catterall. et al.. 2005a). The voltage-gated Na+ channel IS a large 
multimeric complex, consisting of an a. subunit associated with auxiliary � 
subunits (Figure 1.2) (Catterall, 20J 2). The pore forming a. subunit is large 
(molecular weight i about 227 kDa) and is sufficient for functional expression, 
but the kinetics and the voltage dependence of channel gating are modified 
significantly in the presence of the � subunits. In the heart, the Na+ channels 
contain � I through �4 subunits. These auxiliary subunits are involved in channel 
localization and interaction with cell adhesion molecules, extracellular matrix and 
intracellular cytoskeleton (Catterall. et aI., 2005a). 
Analysis of the primary sequence predicts that the a. subunit folds into four 
mam domains (l -IV), that are similar to one another and contain six 
transmembrane a. hel ices (S I -S6). In each of the domains, the voltage sensor is 
located in the S4 segments which contain positively charged amino acid residues 
at every third position. These residues move across the membrane to initiate 
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Figure 1 .2 Structure of voltage-gated Na + channe l :  The a subunit of ... a 
channel is illustrated together with the � l  and �2 subunits. Roman numerals 
indicate the a subunit domains; segments 5 and 6 are the pore-lining segments and 
the S4 helices make up the voltage sensors. Modified from Catterall, 20 1 2. 
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channel activation in respon e to membrane depolarization. The short intracellular 
loop connecting the homologou domains I II  and IV serves as the inactivation 
gate, folding into the channel structure and blocking the pore from the inside 
during ustained depolarization of the membrane. A re-entrant loop bet, een 
helices 5 and 6 i embedded into the transmembrane region of the channel in 
order to fonn the narrow ion-selective filter at the extracellular end of the pore. 
The , ider intracellular end of the pore is formed by the four S6 segments. Small 
extracellular loops connect the transmembrane segments, with the largest ones 
connecting the 5 or S6 segment to the membrane re-entrant loop (Yu and 
Catterall. 2003; Catterall, et al.. 2005a). 
According to the primary sequence of the a subunit. nine subt)pes of a+ 
channels (Navl . I -Na" 1.9) have been functionally characterized (Dib-Hajj, et aI . ,  
2009: Yu  and Catterall, 2003; Catterall, et aI., 2005a). The nine Na+ channel 
isoforms are greater than 50% identical in amino acid sequence in the 
transmembrane and extracellular domains (Catterall, et aI ., 2005a). Generally, 
Nav! '1 and Nav 1 .3  are localized in the soma of the neuron while Nav1.2 subtype 
is expressed mainly in unmyelinated axons. Moreover, Nav ! .1 and Nav 1 .6 
subtypes are highly expressed in peripheral nervous system, and Nav ] .4 and 
Na, 1.5 subtypes are found in skeletal and cardiac myocytes, respectively CRogart, 
et a!. 1989). Cardiac Na + channels (Nav! .5) have a conductance of 19-22 pS 
(Catterall, et aI ., 2005a). The fraction of channels available for opening varies 
from about 100 % at -90 m V to zero at around -40 m V (Y 1I and Catterall, 2003; 
Grant, 2009). 
The cardiac Nav ] .5 channel has consensus sites for phosphorylation by 
protein kinase A (PKA), protein kinase C (PKC) and Ca2+-calmodlllin kinase 
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(Catterall, et al.. 2005a). Moreo er. biochemical studie ha\ e shO\.\n that purified 
a + channel are phosphor lated by the cAMP-dependent PKA and PKC at 
multiple sites In  the intracellular loop between domains I and I I (Cantrell and 
Catterall. 2001). Ithough. in earlier studies, Na+ currents have been sho\\n to be 
m dulated by the cAMP pathway, the results of these experiments are not 
conclu i e: some studies reporting a decrease, \ hereas others reporting an 
increase in the Na + current (Ono, et aI . ,  ) 989; Kirstein. et aI. , 1 996; Frohnwieser. 
et aI. , 1 997) .  However, functional studies have consistently found that 
phosphorylation of the channel by PKC results in a decrease in Isa (Murray, et aI. , 
1 997 ;  Hallaq. et al.. 2012). In a recent study, it was reported that a mutation in 
gl) cerol-3 phosphate dehydrogenase like I kinase wa associated with Brugada 
s) ndrome. and resulted in differential modulation of Na + channel activity. In this 
study, in vitro expression of the channel showed that mutated enzyme action I S  
associated with a decrease in iNa (London, et  aI., 2007). 
Modulation of a + channel currents is undoubtedly important In l'iva, 
although specific deficits that directly affect the function of Na + channel are not 
yet known. ]n  the heart point mutations and deletions in Nav 1.5 cause long QT 
syndrome and idiopathic ventricular fibrillation due to a slow and an incomplete 
inactivation of the cardiac Na + current resulting in prolongation of the AP 
(Keating and Sanguinetti, 2001). It has also been shown that mutations that subtly 
alter Na + channel function, can lead to human diseases of hyperexcitability (Yu 
and Catterall, 2003). 
Besides genetic modification, various pharmacological agents also modify 
the function of Na + channels. For example, Na + channels are activated by a 
number of compounds such as veratridine, batrachotoxin and aconitine, and 
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blocked by tetrodoto i n  (ITX).  ax i tox i n ,  I cal anesthetic and antiarrhythmic 
drug ( Yu and Cattera l l .  2003 ) .  In th i s  context, i t  i s  important to note that a l though 
neuronal a + channe ls  ha e h igh sens i t iv ity to TT ( in nanomolar concentrat ion). 
card iac a+ channels are on ly  affected at m icromolar concentrat ion and therefore. 
are cal led TTX -resi tant a + channels (Z immer. 20 1 0). 
1.1.2.2 Voltage- gated Ca2+ chan nel  
2 + Vol tage-gated Ca channe ls  ( VGCC ) are key transducers of membrane 
potent ia l  changes i nto i ntrace l l u lar Ca2+ tran ients that i n i t iate various 
phys io logical e ents, rang ing from neurotransm i tter re lease to muscle contract ion 
(Cattera l l ,  et aI . ,  2005b) . Vol tage-gated Ca2+ channels consist of five subun its 
cal led a i ,  a2, "(, �. and () of which al const i tute the pore form ing subun i t  
( F igure 1 .3 ) .  The assoc iated subun its ha e se  era l  functions inc lud ing regu lation 
of channel traffick ing and modulat ion of current k inet ics ( Bod i ,  et a I . ,  2005) .  The 
channel prote in form ing the a l subun i t  consists of more than 2000 amino ac ids 
( mo lecular weight � 1 70 kOa) and conta ins  four homologous domains  ( l - I V ). Each 
domain conta i ns s ix  transmembrane segments (S 1 -S6) and a membrane associated 
loop between S5 and S6 segments. The S4 segment of each homologous doma in  
serves as  the  voltage sensor for acti vat ion ;  mov ing outward and rotat i ng  under the 
i nfluence of the e lectric field and in i t i at i ng  a conformational change that leads to 
the open ing of the pore . The S5 and S6 segments and the membrane-assoc iated 
pore loop between them form the pore l i n ing of the VGCC (Cattera l l ,  20 1 1 ;  Grant, 
2009). Each of the four  pore- l i n ing loops ( P - l  through P- I V )  of each domain  
contributes a gl utamate res idue ( E) to the pore structure. These conserved res idues 
( EEEE) in the pore have been shown to be cr i t ica l  for Ca
2+ se lect iv ity of the 
channel ( Sather and McC leskey, 2003) .  Express ion of the al subun i t  i s  suffic ient 
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F igure 1 .3 Structu re of  voltage gated Ca2+ channe l :  The a subunit of Ca2+ 
channel is illustrated together with the �, 'Y and a18 subunits. Roman numerals 
indicate the domains of a subunit; segments 5 and 6 are the pore-lining segments 
and the S4 helices make up the voltage sensors. Adapted from Catterall, 20 1 1 .  
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to produce a functional Ca2+ channe l ,  but it d i sp lays low expression leve l .  
abnormal  k inet ics and vol tage dependence ( Perez-Reyes, e t  a I . ,  1 989). tudies 
ha e shown that co-e press ion of a28 subun i t  and � subun i t  enhances the level of 
express ion and confers more phys iological  gat ing propert ies ( Lacerda. et a I . ,  
1 99 1 ; i nger, et a l . ,  1 99 1 ) . 
To date, ten subtypes of VGCCs have been descr ibed i n  mammals (Table 
I ) . These subtypes serve d ist i nct ro les in  s ignal transduction and other cel lu lar 
functions (Cattera l l , 20 1 1 ) . The L-type subfam i ly (or Cav l )  of VGCCs i n i t iate 
contract ion,  secret ion, regu lat ion of gene e press ion and integrat ion of synapt ic 
i nput i n  neurons ( M i nor. Jr .  and F indeisen,  20 1 0) .  The neuronal Cav2 subfami ly  
wh ich inc ludes the N-type (Cav2 . 1 ), P/Q-type (Cav2 .2) .  and R-type (Cav2 .3 )  
channels  i s  respons ib le for i n i t iat ion of synapt ic  transm ission a t  fast synapses 
(Cattera l l ,  et a \ . ,  2005b) .  The T-type channels (or Cav3 )  are important for 
repet i t i  e fir ing of act ion potent ia l s  i n  rhythmica l ly  fir ing cel l s  such as card iac 
ce l l s  ( M i nor J r .  and F i nde i sen, 20 1 0; Cattera l l .  20 J I ) . 
I n  card iac musc l e the two types of  VGCCs, the L -type ( long last ing) Ca2+ 
channe ls  and the T-type (transient) Ca2+ channels p lay an important ro le i n  muscle 
contract ion and automat i c i ty, respect ive ly (Grant, 2009) .  There are four  a l  subun i t  
variants of the  L-type Ca2+ channe ls :  Cav 1 . )  (a l s) ,  1 .2 (a lc) .  1 .3 ( a I D) and 1 .4 
( a I F) of  which Cav ) .2 (a l C )  subun i t  i s  the card iac spec ific  L-type Ca
2+ channel 
subun i t  (Table 1 . 1 )  ( M i nor, J r. and F i ndeisen, 20 J 0). 
In the presence of Ca2+, the currents are rap id ly  i nactivated via a 
Ca2+/ca lmodu l i n -dependent mechanism ( Ferre i ra et a I . ,  1 997) .  This process IS 
cruc ia l  for l i m i t i ng Ca2+ entry dur ing long card iac A Ps .  Moreover. reuptake of 
Ca2+ by the sarcoplasm ic ret i cu lum (SR)  dur ing prolonged depolarization can 
) )  
CaZ+ a l  Con d ucta n ce, Act i at ion I nactivat ion Locat ion and  Reference 
cu rrcn t u bu n i t p t hre hold rate Fu nct ions 
type 
L Cay 1 . 1  25  H igh S low Excitat ion Bod i .  et a ! . .  
Cav l .2 contract ion 2005; 
Cav l .3 coup l ing in Cattera l l .  et 
Ca 1 .4 musc le, card iac a l . . 2005b: 
pacemak ing,  Cens, et  
endocri ne a ! . .  2006. 
secret ion and 
neurona l Ca2+ 
transients 
N Ca 2 . 1 20 H igh Moderate Neurons on ly; Cattera lL  et 
neu rotransm i tter a l . .  2005b; 
release M inor, J r. 
and 
F i ndeisen, 
20 1 0 . 
P/Q Cav2 .2 1 0-20 H igh Fast Neurons on ly: Cattera l l .  et 
neurotransmitter a l . , 2005b: 
re lease M inor. J r. 
and 
F inde isen, 
20 1 0 . 
R Cav2 .3  - H i gh - Neurons on ly; Cattera l l .  et 
neurotransm i tter a l . . 2005b: 
re lease M inor, J r. 
and 
F indeisen, 
20 1 0 . 
T Cav3 . l 5 - 1 0  Low Fast Card iac Cattera l l ,  et 
Cav3 .2  s i noatr ial node, a l . .  2005b; 
Cav3 . 3  neurons; M inor, Jr. 
repet i t ive and 
spik i ng and F indeisen, 
spike act iv ity 20 1 0 ' 
Cattera l l ,  
20 1 1 .  
Table 1 . 1  S u b u n it composi t ion and  fu n ct ion  of  Ca2+ chan ne l  types 
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re U l l  i n  the recovery from a2+-dependent inact ivation, and enable econdary 
depo larizat ion (Grant, 2009). The carboxy l  term in i  of L-type Ca2+ channels have 
mu l t i p le  Ca2+ b ind ing s i tes and Ca2+/calmodu l i n-dependent k i nase acti v i t . 
B i nd ing of ca lmod u l i n  to these domains has been sho'W l1 to cause Ca2+-dependent 
i nact i \ at ion of L -type Ca2+ channels ( Bod i ,  et a l . .  200 - :  Cens, et a I . ,  2006). 
Impor1ant ly . us ing Ba2+ as a charge carrier removes the Ca2+- i nduced inacti at ion. 
In other words, act i vat ion of L-type Ca2+ channels in  the presence of Ba2+ resu l ts 
in im ard BaH currents that act i vate rap id ly ,  but inacti vate s lowly ( Ferre i ra,  et a I . ,  
1 997) .  
In  compar ison to L-type Ca2+ channels .  there are three al  ubuni t  variants 
of T-type Ca2+ channe ls :  Cav3 . ] (a I G), 3 . 2  (a l I I )  and  3 . 3 (a l l ) (Zhang. et a I . ,  20 1 3) .  
These channe ls  are act ivated at  much more negative membrane potent ia ls  
(ac t ivat ion starts at -60 mY) ,  i nactivated rap id ly ,  have a sma l l  s ingle channel 
conductance « l O p  ) ,  and are insens i t ive to the convent ional L-type Ca2+ channel  
antagon ists d ihydropyr id i nes, pheny la lky lam ines and benzoth iazepines ( Bod i ,  et 
aL 2005 ' Zhang, et a l .  20 1 3 ) .  W h i le L-type Ca2+ channel are important in  
ma intain i ng  the  p lateau phase of A P  i n  ventr icu lar cel l s, both L-type and T-type 
Ca2� channels p lay a ro le i n  generat i ng  the AP in cel l s  that are involved in  
rhy1hm ic e lectrica l  behav ior; s inoatria l  node and atrioventricu lar node (Cattera l l ,  
e t  a l . .  2005b; Bod i ,  e t  a I . ,  2005 ;  Zhang, e t  a I . ,  20 1 3 ) . 
1 . 1 .3 Myocard ia l  Ca2+ h a n d l ing  
The importance of Ca2+ s igna l ing 1 11 the  heart has  been apprec iated for 
decades. W ith each heartbeat, Ca2+ concentrat ion i n  the Cy1oso l of card iac 
myocy1es is e levated approx imate ly  1 0-fo ld  from a rest ing level of about ] 00 nM 
to - I  IJ.M ( Bod i et a I . ,  2005) .  The levels of cy1oso l i c  Ca2+ control the  act ivat ion of 
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contract i le prote in . I n  other \\ ords, the on et. the durat ion and the inten it) of 
m ocard ia l  contract i n are tr ict l )  contro l led by intrace l l u lar [Ca2+] , .  The 
e lectr ical act i  at ion with the spread ing of the A P  throughout the heart i n i t iates 
contraction by caus ing a transient i ncrease i n  cytoso l ic Ca2+ concentrat ion, lead ing 
to a brief (-400 m ) Ca2+ transient ( Bers, 2002). 
The AP generate the c)'toso l ic Ca2+ trans ient via a process cal led Ca2+_ 
induced Ca2+ re lea e ( Fabiato. 1 983 ; E isner, et a I . ,  20 1 3 ) ( F igure 1 .4) .  During th is  
process. the i nflux of a sma l l  amount of Ca2+ v ia  vol tage-gated L-type Ca2+ 
channels located i n  the T-tubu les. i nduces Ca1 re lease from the SR by act ivat i ng 
ryanod ine receptor 2 ( RyR2). Th is  leads to a considerable ampl i fication of the 
i n i t ia l  Ca2+ i n flux to a leve l  requ i red for the opt ima l  b ind ing of Ca2+ to the 
myofi lament prote i n  tropon in  C in  the tropon in  complex on the th in  fi lament. 
which in turn sw itche on the contract i le mach i nery ( Bodi ,  et a I . ,  2005) .  The 
tropon in  complex i s  composed of tropon in  C (TnC or the Ca2+ b ind ing subun i t) ,  
tropon i n  I (Tn l ,  i nvo l  ed i n  inh ib i t ion of act in -myo i n  interact ion in  the absence 
of Ca2+) ,  and t ropon in  T (TnT which b inds the tropon in  complex to tropomyosin,  
another fi lament prote in)  in  a sto ich iometric rat io of I :  1 :  I (Gomes, et a I . ,  2002) .  
The th in  (act i n )  and  th ick (myos in )  fi laments s l i de a long each other driven by 
ATP hydro lys i s  resu l t i ng in m usc le shorten ing and force product ion.  Relaxation 
occurs after 1 00-200 ms when Ca2+ gradua l l y  decays back to d iasto l i c  leve ls .  I n  
th i s  case tropomyosin  i s  pos i t ioned such that act i n  and myos in  cannot interact 
lead i ng to the re l axat ion of card iac musc le ce l l  ( H uke and Knol lmann, 20 1 0). 
Calc ium homeostas is  is  part icu lar ly important in card iac musc le cel ls .  The 
dec l ine in cytoso l i c  Ca2+ concentrat ion is due to tenll i nat ion of Ca2+ re lease from 
the S R  ( inacti vat ion of RyR2) and rapid removal of Ca2+ from the cytosol .  Two 
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F ig u re 1 .4 Ca2+- i nduced Ca2+ release a n d  Ca2+ cyc l i ng  i n  a card iac cel l :  Ca2+ 
entry v i a  the L-type Ca2+ channel causes the re lease of Ca2+ from the SR v ia RyR 
resu l t ing i n  Ca2+ trans ient and muscle contract ion . Relaxat ion occurs by the Ca2+ 
be ing taken back in to the S R  by SE RCA and pumped out of the ce l l  by NCX.  The 
inset shows the ampl i tude of the Ca2+ transient as a function of SR Ca2+ content. 
Mod ified from E isner, el  al. , 20 1 3 . 
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major route are re ponsib le for Ca:!+ removal from the cytoso l :  the R Ca2+_ 
ATPase ( ERCA2a) that use A TP to pump Ca2+ back into the SR and the 
od ium-ca lc ium e changer (NCX ) (Otto l ia, et a I . ,  20 1 3 ) ( F igure 1 .4 ) .  Under 
physio logic cond i t ions. CX remo es approx imate ly the same amount of Ca2+ 
that entered the cel l through L -type Ca2+ channel in order to maintain the cel l u lar 
Ca2+ balance (Bridge, et a I . ,  1 990). Sarcolemmal Ca2+-ATPase and the 
m i tochondria l  Ca2+ un iport are considered m i nor p layers in  Ca2+ homeostasis, 
a l though there is accumu lat ing e idence that they can a lso influence the levels of 
Ca2+ in cel l u lar Ca2+ stores and mod i fy exc i tat ion-contraction coup l ing ( Dedkova 
and B l atter. 20 1 3  � Otto l i a .  et a I . ,  20 1 3) .  
As mentioned ear l ier. t he  ampl itude of the Ca2+ transient determ ines the 
l evel of myofi lament act ivat ion. and therefore the magn itude of contract ion .  The 
two main factors that determ ine the amount of Ca2+ re leased from the SR and the 
ampl itude of the Ca2+ transient are :  the ampl itude of the L-type Ca +2+ current 
(Trafford. et a I . ,  200 1 ) , and the Ca2+ concentrat ion in the SR (Shannon, et a I . ,  
2000). The S R  Ca2+ concentrat ion can be increased by  the  st imu lat ion of 
SERCA2a act iv i ty and pro longation of the duration of the A P, and decreased by 
the st imu lat ion ofNCX working in the forward mode (Otto l i a, et a l . .  20 1 3) .  
In  genera l ,  any a l ternat ion i n  Ca2+ flux resul ts in  an overal l change JI1 
contrac t i l i ty (Otto l i a  et a I . ,  20 1 3) .  For example, a pers istent reduction i n  cel l u lar 
Ca2+ efflux,  not matched by a decrease in Ca2+ influx, resu l ts in  an increased 
cel l u lar Ca2+ which w i l l  accumulate in the SR rather than the cytoplasm. The 
i ncreased amount of Ca2+ in SR typica l l y  resu lts in  larger Ca2+ transients and 
therefore contract i l i ty ( Bassan i ,  et a I . ,  1 995 ;  Shannon, et a I . ,  2000). Converse ly .  
an i ncrease in  Ca2+ efflux w i l l  deplete S R  stores and depress contract i l i ty. 
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nder in vivo cond i t ions, the ma in  modu lator of Ca2+ transient ampl i tude is  
p-adrenergic st imu lat ion that  is  med iated by cAMP/PKA which has three main 
act ions on Ca2+ s igna l ing (Cattera l l ,  20 1 1 ) . F i rst, i t  st imu lates the L-type YGCCs 
to increase the amount of Ca2+ that enters during each AP. Second. i t  
phosphor) lates the prote in  phospholamban (PLB)  to reduce i ts inh ib itory effect on 
ERCA2a pump which is  then able to increase the lumina l  Ca2+ concentrat ion so 
that more Ca2+ is re leased from the SR .  Th i rd ,  cAMP/PKA phosphorylates the 
RyR2.  thereby enhanc ing its abi l i ty to re lease Ca2+ ( Frank,  et a I . ,  2003) .  Therefore. 
the act ivat ion of both L -type Ca2+ channel and S ERCA2a leads to a substant ia l  
i ncrease in  the ampl i tude of Ca2+ transients.  
1 . 1  A Role of the Na  +/Ca2+ exchanger in ca lc ium homeostas is 
The NCX is a p lasma membrane transport prote i n  and is cons idered as the 
ma in  extrus ion path\ ay for Ca2+ from entr icu lar myocytes. I t  i s  d i rect l y  invol ved 
i n  the regu lat ion of excitat ion-contract ion coup l i ng  by means of modu lat ing Ca2+ 
ry+ 2+ efflux.  S R  Ca� load ( Bers, et a I . ,  ] 989; Bers and Weber, 2002), SR Ca re lease 
( L i twin ,  et a I . ,  1 998) and Ca2+ spark frequency (Goldhaber et a I . ,  J 999). Th is  i s  
I i ke ly  to  contribute. a longs ide other prote ins  such as  SR Ca2+ -A TPase and 
ca lmodu l i n, as an effect ive buffer ing mechan ism to mainta i n  steady-state Ca2+ 
fl ux dur ing short term Ca2+ trans ients. 
2+ h b 
. 
The NCX can extrude i ntracel l u l ar Ca across t e ce l l  mem rane agamst 
i ts  chem ical  grad ient by us ing the downh i l l  grad ient of Na+ .  I t  is wide ly  accepted 
that the sto ich iometry of th i s  ion exchange occurs such that whi le one pos i t ive 
charge (Ca2+ )  go out ,  three pos i t ive  charges ( 3  Na +) are taken up by the cel l ( Bers. 
2002; Bers and Weber, 2002) .  Therefore, NCX act iv i ty is e lectrogen ic .  Under 
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rest ing cond i t ions, C functions i n  forward mode. However, C I S 
b id i rect ional and can a lso med iate Ca2+ entr and outv. ard movement of a+. This 
i referred to as the reverse mode. The d i rect ion and amp l i tude of the NCX current 
is go erned b Na + and Ca2+ gradients across the cel l membrane, as wel l  as, the 
membrane potent i a l .  The most recogn ized action of CX is  its Ca2+ removal in  the 
forward mode at membrane vol tages less than the equ i l i br ium potent ia l ,  which 
under phy io logical  cond i t ions i s  about -50 mY to -60 mY ( Reuter, et a I . ,  2005 ;  
Otto l ia ,  e t  a I . ,  20 1 3 ) .  
Recent ly ,  t he  molecular structure of NCX prote in  has been e luc idated 
( F i gure 1 . 5 )  (Morad, et a I . ,  20 1 1 ) . I t  has been shov. n that mammal ian NCX forms 
a mu l t igene fam i l y  of homologous prote ins  compr is ing three isoforms.  Sod ium­
calc ium exchanger I (NCX 1 )  \ as the first NCX c loned and i s  h igh ly  expressed in  
card iac musc le  and bra i n  and to  a lesser extent in many other t i ssues ( H i lgemann, 
et aL, 20 1 3 ; Lytton ,  2007). Sod ium-calc ium exchanger 2 (NCX2)  i s  expressed 
primari l y  i n  the bra i n  (Can itano, et a I . , 2002). whi le sod ium-ca lc ium exchanger 3 
(NCX3)  i s  expressed i n  the bra i n .  as we l l  as, skeletal t i ssue (Can i tano, et a I . ,  2002; 
Lytton ,  2007). 
The card i ac N C X  1 consists of 970 amino acids with a molecu lar  weight of 
about 1 1 0 kDa. A l though recent crysta l structure of NCX I strongly supports the 
presence of 1 0  transmembrane segments ( Ren and Ph i l i pson, 20 1 3 ), biochemical 
analysis has ind icated the presence of n i ne transmembrane segments, and a large 
hydroph i l i c  group wi th conserved regions between transmembrane segments five 
and s ix .  The N- and C-term i n i  are located on the externa l  and internal s ides, 
respect ive ly (Sh igekawa and Iwamoto, 200 1 ; Ren and Ph i l ipson, 20 1 3 ) .  
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Figure 1 .5 Hypothetica l funct iona l  organ izat ion of Na +/Ca2+ exchanger: The 
cr i t ica l  res idues T73 1 ,  1723, and S722 are important for cA MP-dependent 
regulat ion. Deta i led structures have on l y  been determ ined for the Ca2+-binding 
domains PI  and P2 . The detai led arrangement and funct ion of a l l  other 
components, inc lud ing the a-hel ices of the transmembrane-spanning ( top) and a­
caten in- l i ke (aCat) domains and the unstructured l i nker sequences ( S  I .  S2, NB­
CDEXF)  remain to be ascerta i ned. Adapted from Morad, e/ aI. , 20 1 1 .  
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im i lar to Ca2+ channel , X i a lso regu lated a l losterica l l y  by [Ca2+] ,  
(Otto l ia ,  e t  a ! . ,  20 1 3 ) .  I n  add it ion, the  act iv ity of CX is  regulated by  the 
s igna l ing l i p id  pho phat idy l i nosito l -4,5-b isphosphate ( P I P2 ) ( H i l gemann and Bal l ,  
1 996), free rad icals ,  pH and temperature, a s  'Ii e l l  as, PKA ( chu lze, et a ! . .  2003 : 
Wei ,  et aL 2003) and PKC ( B lauste i n  and Lederer, 1 999; Iwamoto, et a ! . ,  1 996). 
However, the phys iological s ign i ficance of these factors as in vivo regulators of 
C remain to be e tab l i shed. 
1 .2 .  The en doca n n a binoid system 
1 .2 . 1  I n t rod uct ion 
The psychoact ive propel1 ies of the p lant Cannabis salim have been known 
to man for thousands of years. The popular i ty of marijuana, one of the mo t 
commonly u ed drugs of abuse, reflects i ts powerfu l  effects on sensor 
percept ion. learning and anx iety. Non-psychoact ive uses of marij uana inc lude 
pa i n  re l ief, m usc le re l axat ion,  attenuation of nausea and vom it ing and treatment of 
m U lt ip le  sclerosis ( Pertwee, 200 1 ; Howlett, 2002 ' Sm ith,  2004) .  Despite its use for 
centuries, i t  i s  on ly  dur ing the last few decades that the bio logical bas is  of the 
effects of marij uana and its bioact ive ingred ients. col lect ive ly ca l led cannabinoids, 
has begun to unfo ld ( Kunos, et aI . ,  2000) .  I n  the 1 960s, �9 -tetrahydrocannabinol  
(THC) was d i scovered as the pr imary psychoact ive component of Cannabis saliva 
( Mechoulam and Gaon i ,  J 965; Mechoulam, et a l . .  1 995) .  However, it i s  important 
to note that Cannabis conta ins  over 60 chem ical s w i th c lose ly re lated structures. 
Among them, THC, cannabinol  and cannabid io l  are the most common ly stud ied 
cannabinoids ( D i  Marzo, V,  2006). 
The i so lat ion of THC paved the way for the development of THC-based 
l i gands and led to the d i scovery of cannabinoid receptors. The first cannabinoid 
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b ind ing ite In  rat bra in  \ a ident i fied i n  1 988 ( De ane, et a I . ,  1 988). and the 
receptor \ a c loned later in  1 990 (Matsuda, et a l . .  1 990). This receptor \� as 
named cannabinoid receptor 1 (CB I ) . The second receptor, cannabino id receptor 2 
(CB2), \Va d i  covered hort l  after (Munro,  et a J . .  1 993) .  
I n  earl ier tudies, the presence of opiate receptors i n  the mammal ian brain 
( Pert and nyder, 1 973)  has led to the d i scovery of endogenous opioid pept ides. 
Therefore, several groups have searched for endogenous l i gands that m im ic  the 
act ion of Cannabis. Only in the early n i neties, s im i lar to the opioid system, 
cannabinoid receptors were found to have endogenously produced l igands 
( Devane, et a l . .  1 992) .  These are now cal led the endocannabinoids.  
The endocannabino id system ( ECS)  i s  a comple and ubiqu itously 
expressed s igna l i ng  s stem which inc ludes several neuromodu latory l i pids 
(endocannabinoids), the i r  receptors and a set of  enzymes that synthesize and 
degrade endocannabinoids .  The ECS has been ident i fi ed in most human organs 
and t i ssues, and has important regu latory ro les in a wide range of normal and 
pathologica l  processes, such as pain ,  energy homeostas i s, fert i l ity, Immune 
response and behav ior (Rodriguez de, et a ! . ,  2005 ; De and D i ,  Y, 2009a) . 
1 . 2 . 2  E nd oca n nab inoids 
Endocannabinoids be long to a fam i l y  of  polyunsaturated fatty ac id-based 
compounds synthesized from the l i p id  precursors in the plasma membranes of 
v i rtua l l y  a l l  types of ce l l s rang ing from neurons and endocr ine ce l ls to ske letal 
musc le fibers and card iomyocytes ( Pac her, et a ! . ,  2006) .  They are impl icated in  a 
wide variety of physiological  processes inc lud ing memory, immun ity s leep, pai n  
sensat ion,  percept ion ,  reproduction ( Mart in ,  e t  a I . ,  1 999) and card iovascu lar 
funct ions (C lapper, et a I . ,  2006; Steri n-Borda, et a I . ,  2005; Randal l  and Kendal l ,  
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1 997) .  To date, the t\ 0 mo t exten ively studied endocannabinoids are 
arach idono lethanolam ine ( EA). a l so known as anandam ide ( from the Sanskrit 
' ananda' for happiness, joy or enjoyment), and i ts g lycerol ester analogue 2-
arach idonoy Jg lycerol (2-AG) .  Anandamide was first descr ibed in  1 992 ( Devane. 
et a l . .  \ 992) .  However. 2 -AG was d i scovered as the second endocanabinoid a fe\ 
years later ( Mechou lam. et a l . .  1 995 ;  Sugiura, et a l . .  1 995)  (F igure 1 .6) .  
In add it ion to AEA and 2-AG, other endocannabinoids with s im i lar fatty 
acid-based chemical  structures were a lso ident i fied dur ing the last decade, 
i nc lud ing. 2-arach idony lg lycerol ether ( nolad i n  ether) ( Hanus. et a l . .  200 1 ). 
arach idono) I -dopamine (NA DA)  ( B i sogno, et a l . .  2000) .  and i rodham ine ( PoI1er. 
et a I . ,  2002) ( F i gure 1 .6 ) .  V i rodham ine has a very s im i lar structure to AEA.  but 
opposite orientat ion around the arach idonic acid (AA)-ethanolam ine bond ( P0I1er, 
et a l . .  2002). L i kewise, nolad i n  ether and 2- AG are structura l l y  s im i lar (F igure 
1 .6) .  However, phannacological characterizat ion of these chem icals has not been 
\\ e l l  establ i shed. 
Anandamide be longs to a group of chem icals tenned -acylethanolam ines 
(NA Es). Other N A Es are not usua l l y  considered as endocannabinoids but are 
produced by the same enzymes that synthesize AEA .  1 n recent years. severa l 
stud ies have shown that these chem ica l s  p lay a ro le i n  vascu lar control ( Ho. et a l . .  
2008), food intake, energy ba lance ( Borre l l i  and  l zzo, 2009) and neuroprotect ion 
( Hansen, et a I . ,  2000; Hansen 20 1 0). Two of these NAEs, oleoylethano lam ide 
(OEA) and pa lm itoylethanolam ide ( PEA) have been extens ively invest igated as 
they are present at h i gher concentrat ion than the endocannabinoids i n  many 
mammal ian t issues ( A lexander and Kenda l l ,  2007; Lambert and Mucc io l i ,  2007) 
(F igure 1 .7 ) .  
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Fig u re 1 .6 Chem ical  structu res of the proposed endoca n nab inoids. Adapted 
from Di Marzo, 2009 
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Fig u re 1 . 7 Chem ical  s tructu res of a n a ndamide  and  rela ted N -
acylethano lamines. 
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1 .2 .3 E ndoca n nab i noid receptors 
s mentioned earl ier. to date, at least two endocannabinoid receptors ha e 
been ident i fied and c loned based on the i r  pharmaco logical propert ie and gene 
structure .  The C B ]  receptors are pri nc ipa l ly located in the central nervous system, 
\\ here they are h igh l  abundant and appear to part i c ipate i n  negat ive retrograde 
s igna l i ng  (Matsuda. et a l . .  1 990; Mackie,  2008) .  In add it ion,  they are found in  
se  eral peripheral t i ssues i nc l ud ing the  heart and the  vascu lature ( I shac, e t  a l . .  
1 996: Bonz, e t  a I . ,  2003 ; L i u ,  e t  a I . ,  2000) .  The CB2 receptors, on the other hand, 
are expressed pr imari l y  in the immune system (Munro,  et a l . .  1 993)  and 
hematopoiet ic  ce l l s  (Va lk  and Delwel ,  1 998), but recent ly the ir  presence in  the 
bra in  (Van.  et a I . ,  2005) ,  l i ver (Mal lat and Lotersztajn .  2008: Mack ie, 2008). 
myocard ium ( Montecucco, et a I . ,  2009; Defer. et a I . ,  2009). vascu lar endothe l ia l  
and smooth musc le ce l l s  ( Rajesh, e t  a I . ,  2007), ha e a lso been demonstrated. Both 
receptors are G prote i n -coupled receptors (GPCRs) \\ i th seven transmembrane 
pann ing domains ( Howlett, et a l . .  1 990). Most of the G prote ins l i nked to the 
cannabino id receptors are i nh ib i tory prote ins  (G Ila) .  They are sens i t ive to pertussis 
tox i n  ( PTX) and i nh ib i t  adeny ly l  cyc lase (AC)  act i v i ty and thus, inh ib i t  the 
formation of cAMP ( Pertwee, 2006). However, coupl ing of cannabinoid receptors 
to PTX- i nsens i t ive Gq prote i n  has a lso been reported i n  recent stud ies ( Stra iker et 
aL, 2002 '  M c lntosh, et a l . ,  2007). 
The C B )  receptor can be act ivated by both AEA and 2-AG,  although 2-AG 
i s  more potent, and A EA i s  often considered to be a part ia l  agon ist ( H i l l ard . 
2000). S i m i l ar ly, both endocannabinoids are agon i sts of CB2 receptor, a l though 
agai n  2-AG is more potent. Both AEA (Ko  val ues for C B )  and CB2 receptors are 
6 1 -543 nM and 279- 1 940 nM,  respect i ve ly)  and 2-AG (Ko values for C B )  and 
25  
B2 receptor are 58 -4 72 nM and 1 45 - 1 400 nM ,  respect i  el ) ha e greater 
atTi n i t ie  for C B I  receptor than C B2 receptor (Munro, e t  a l . ,  1 993;  Pertwee. 2006: 
Pertwee, et aL, 20 I 0). It appears that the se lect iv ity of endocannabinoids varies 
s ign i ficant l . For example, the endocannabinoid nolad in  ether is  a se lect ive CB I 
receptor agonist ,  \ h i le i rodham ine is a part ia l  C B2 agon ist and a C B I  receptor 
antagonist .  On the other hand, NADA appears to be a se lec t ive agon ist for CB I 
receptor ( Peliwee, et a I . ,  20 1 0 ; Pertwee and Ross, 2002) .  
J .2 ,4  Syn thesis and meta bol ism of a n a ndamide 
Endocannabinoid are synthesized predominant ly v ia the c leavage of 
membrane phosphoglyceride precursors ( B i sogno, 2008). As the endocannab inoid 
precursors are physio logica l  chemica l  const i tuents of ce l l  membranes. it i s  the 
anatom ical  locat ion of endocannabinoid synthes iz ing enzymes and receptors that 
d i ctate the i r  act iv i ty and therefore, the i r  phys io logical  ro les in cel l u lar 
env i ronments (D i ,  Marzo, et a I . ,  2007) .  Endocannab inoids are often referred to as 
s ignal i ng  molecules � h ich  are synthes ized "on demand" and i n  neurons, at least, 
endocannabinoids are synthesized and re leased very rap id ly  (wi th in  tens of 
m i l l i seconds) upon sti m u lat ion (A lger and K im ,  20 1 I ) . 
As ment ioned ear l ier, the b iosynthet i c  pathway for AEA is thought to 
i nvo lve the breakdown of pre-formed arach idonoyl phosphol i p ids in the ce l l  
membrane ( F igure 1 . 8) .  ] t  was shown that the  pri mary route for AEA biosynthesis 
is the format ion of N-arach idonoyl phosphat idy lethano lam ine (NAPE) ( H i Jey, 
2009) wh ich is produced by the transfer of AA from phospho l ip ids to the n i trogen 
atom of phosphat i dy lethanolam ine .  Subsequent ly  it is transformed into A EA via 
mu l t i ple pathways, the most d i rect of  wh ich i s  cata lyzed by Ca
2+ -sensit ive NAPE-
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Fig u re 1 .8 Mechan isms of a n a n da m ide  formation and  deactivation : The 
format ion of AEA is thought to i nc lude the synthesis of the AEA precursor N-
arach idonoyl phosphat idy lethanolam i ne (NA PE)  catalyzed by the enzyme 
acy l t ransferase and then the c leavage of NAPE to y ie ld  AEA, catalyzed by 
phosphol i pase D ( upper panel ) . A EA can be i nternal ized by ce l l s through a h igh 
affi n i ty transport mechan ism;  the endocannabinoid transporter. Once ins ide the 
ce lL  it can be hydrolyzed by FAAH to y ie ld  arach idonic ac id  and ethanolamine 
( lower panel ) . Modi fied from P iomel l i , 2003 . 
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e lect i \ e  pho pho l i pase 0 PE-PLD) ( De Petroce l l i s  and Di  Marzo, 2009a) .  
Thi  enzyme atalyze the h dro lys is  of the bond between phosphate and 
ethanolam ine resu l t ing in the formation of AEA and phosphat id ic  ac id .  
Endocannab inoid igna l ing is tenn inated by a rapid  c learance from the 
extra e l l u lar m i l ieu ( ha l f- l i fe is  seconds to m inutes) ( De Petrocel ls, et a I . ,  2004). 
tudie ugge t that fo l lovv ing cannab ino id receptor act i vat ion, AEA i s  taken up 
by cel l s  v ia  a fac i l i tated transport mechanism med iated by a putat ive anandam ide 
membrane tra porter ( M T) ( Bari ,  et a I . ,  2006; P iome l l i ,  2003) fo l lowed by 
intrace l l u l ar degradat ion.  A l though data from several biochem ical and 
pharmacological  stud ie support the ex istence of an AMT, th is  is  a contro ers ia l  
top ic .  and the structure of AMT prote i n  remains to be ident ified at  the mo lecu lar 
Ie e l  ( De Petrocel l i s, et a I . ,  2004) .  Current ly ,  i t  i s  wel l  establ i shed that AEA i s  
predom inant ly degraded i n  the cytosol under the act ion of FAAH to  ethanolam ine 
and AA ( H i ley, 2009; Deutsch and Ch in ,  1 993;  Cravatt, et a I . ,  1 996). On the other 
hand. 2 -AG is  predominant ly  broken down by a spec ific  monoacylg lycerol l i pase 
(MAGL)  (Vandevoorde and Lambert, 2005) .  In vitro experiments ind icate that 
endocannabinoids are a lso substrates for ox idat i ve metabo l i sm v Ia  
cyc looxygenase ( Fowler, 2007) and l i poxygenase ( Kozak, e t  a l .  2002) pathways. 
Fatty acid amide hydro lase was ident ified in 1 996 (Cravatt, et aL 1 996). I t  
has mu l t ip le substrates, but exh ib i ts spec i fic i ty for the  long-cha in  am ides of 
ethanolam ine ( Schmid ,  et a I . ,  1 985) .  There are two i soforms  of F AAH,  FAAH - l  
and FAAH-2,  which share approximate ly 20 % DNA sequence homology, 
although, the cata lyt i c  s i te is rel at i ve ly  wel l  conserved ( Wei ,  et a I . ,  2006a).  The 
two i sofonns are d i fferent ia l l y  expressed across t i ssues. I n  human k idney, l i ver, 
l ung and prostate both isoforms are expressed . However, on ly F AAH - J levels are 
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h i gh i n  human bra in ,  mal l i n test ine and test is .  FAAH-2 is predominant l}  
expres ed i n  the heal1 ( Wei .  et a I . ,  2006a). I t  i s  important to note that the two 
i oforms have d i fferent substrate spec i fi c i ty with FAAH - J  hav ing s ign i ficant ly 
greater hydro lyt ic  act i v ity on AEA than F AA H-2 ( rates of hydrol s is  in  
nmo l/m in .mg are 1 7± 1 and 0.46±0.04, respect ively) (We i ,  e t  a l . .  2006a). Due to 
the pharmacological  imp l icat ion of modu lat ing endocannabinoid levels. in recent 
ears. several i nh ibi tors have been synthes ized ( Fowler. et a I . ,  200 I ) . For 
example.  U RB597,  J P 1 04,  OL-92 and OL- 1 35 are potent inh ib i tors of FAAH 
( M ichaux,  et  a I . , 2006;  M in ,  et  a I . ,  20 1 1 ) . However. these i nh ibi tors d i ffer in  their 
select i v i ty .  W h i le J P I 04 i s  a potent i nh ib i tor of  both FAAH - l and FAAH-2 (Wei ,  
e t  a I . ,  2006b), U R B597 i s  more potent a t  FAA H-2 ( P iomel l i ,  e t  a I . ,  2006) .  
FAA H i s  a membrane bound enzyme (McK inney and CravatL 2005) and is  
thought to form homod i mers ( Bracey. et a I . ,  2002) .  The locat ion and structure of 
F AAH ma) a l l ow the hydro l  s i s  of  AEA with in the c lose i c in ity of p lasma 
membrane (McK inney and Cravatt, 2005) .  I ndeed, the rate of AEA hydrolys is  in  
t i ssues from F AAH knockout m ice is  50- 1 00 fo ld reduced, and AEA 
concentrat ions i n  the  bra in  (Cravatt, et a I . ,  200 1 ; L ichtman, e t  a I . ,  2002) and l i ver 
(Tourino, et a I . ,  20 1 0) are e levated s ign i ficant ly .  
]n  recent years, F AAH has emerged as a target for modulat ing 
endocannabinoid s igna l i ng  (Ahn ,  et aI . ,  2008) w ith a therapeut ic potent ia l  in 
anx iety, pa in and various i nflammatory d isorders (Cravatt, et aI . ,  200 ] ; Cravatt, et 
aI . ,  2004). In the heart,  FAAH plays a key ro le in  contro l l ing endocannabino id­
induced myocard ia l  t i ssue i nj u ry i n  pathological  cond i t ions assoc iated with acute 
ox idat ive stress ( M ukhopadhyay et a I . ,  20 1 1 ) .  I t  was found that A EA induced 
enhanced cel l death in human card iomyocytes that were pretreated with F AAH 
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i nh ib i tor, and enhanced sens i t i  i ty LO reacti e oxygen species ( RO ) generat ion i n  
i n flammatory ce l l s  of FAAH knockouts, a l l  of \ h ich suggest a ro le for F A H  in  
contro l l ing t i  ue  inj ury (Mukhopadhyay, e t  a l .  20 1 1 ) . 
1 .2 .5  Cel l u la r  and  molecu lar  m echa n ism of endocan nab inoid actions 
1 .2.5. 1 Signa l  tra n  d u ct ion mechan isms 
ignal transduction through C B I  and C B2 receptors i s  med iated by G­
prote i n  (Gl/o) which couples negat ive ly  to AC and thus, inh ib i ts cAM P generat ion. 
Modulation of  intrace l l u lar cAMP concentrat ion regulates PKA phosphorylat ion,  
and thereby re u l t  i n  major changes i n  cAMP-dependent s ignal  transduct ion 
pathway ( Demuth and Mol leman. 2006). In fact, the first characterized CB I 
receptor s ignal transduction response v as the inh ib i t ion of AC by m icromolar 
concentrat ion of  THC in neuroblastoma ce l l s  ( Howlett and F leming, 1 984) .  
ubsequent stud ies demonstrat ing the blockade of th is  response by PTX treatment 
suggested that Gllo type G-prote ins  are involved ( Howlett. et a l . .  1 986) .  T) pical 
Gllo -med iated i ntrace l l u l ar events coupled to C B I  act i vation are the inh ib i t ion of 
VGCCs of most types, i nc lud ing P/Q (Twitche l l ,  et a I . ,  1 997), N ( W i l son, et a I . ,  
200 1 )  and L-type (Gebremedh in ,  e t  a I . ,  1 999; Stra iker. e t  a I . ,  1 999) channels and 
the st imu lat ion of potassi um channels such as K IR channels (McA l l i ster, et a l . .  
J 999) and m i togen-act i vated prote i n  k i nase (MA PK)  ( Derk i nderen, e t  a I . ,  200 I ) . 
I n  the central nervous system, the ro le of endocannabinoids in  retrograde 
s igna l i ng  has been we l l  establ ished. It has been shown that the act ivat ion of 
presynaptic C B  I receptors contro ls  the re lease of several neurotransm i tters, such 
as g lutamate and GABA ( Lov inger, 2008; Foldy, et a I . ,  2006). Synthes is  of 
endocannabinoids occurs fol lowing the re lease of  exci tatory neurotrasm itters and 
the i r  d i ffus ion outside the synapt ic  region.  The act ion of g lutamate on its receptor 
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I n  the p t ynapt ic  mem brane leads to the re l ease of intrace l l u lar Ca2+ and the 
open ing of VG . An  e le ated Ie e l  of Ca2+ act i vate the enzymes responsible 
for endocannabinoid synthes i s  from l i p id precursors. Anandam ide and/ or 2-AG 
are re lea ed and fol lowing retrograde d i ffusion i n  the synaptic c left .  presynapt ic  
BI  receptor are act ivated . Th i s  act i vation resu l ts in  the inh ibi t ion of VGCCs or 
act i  at i on of K+ channe l s  resu l t i ng i n  decreased intrace l l u lar Ca2+ concentrat ion. 
prevent i ng further neurotransm itter re lease from the presynapt ic term ina l  
(Vaughan and Chr ist ie, 2005) .  
Recent stud i es ind icate that the i nteract ion of cannabinoids with G prote ins 
I S not l i m i ted to G1,o subtype. Ev idence suggests that CB I receptors can a lso 
i nteract v. i th Gs prote i n  under condi t ion of PTX treatment that prevents the 
receptor 's  i nteract ion w i th Gl/o protein ( Howlett, et a I . ,  1 986) .  CB2 receptors. in 
contrast. do not seem to couple to Gs ubtype. suggest ing further d i fferences 
betv" een C B I  and C B2 receptor s ignal ing (G lass and Felder. 1 997) .  For example. 
t imu l at ion of  cAM P accumu lat ion by H U -2 1 0 (the synthet ic analogue of THC) 
and CP 55 .940 (a h i gh ly potent cannabinoid agon ist) was observed after PTX 
treatment of Ch inese hamster ovary (CHO) cel l s  express ing the human C B I  but 
not C B2 receptors (Ca landra, et a I . ,  1 999; G lass and Felder. 1 997) .  In add i t ion to 
the dual coupl ing of cannab ino id receptors to Gs and GJ/o prote ins. the presence of 
d ist i nct isoforms of AC in d i fferent cel l u lar preparations has a lso been shown to 
contribute to the d ivers ity of cannabinoid act ions. To date, n i ne isoforms of AC 
have been i dent ified (AC- l ,  AC- l l , AC- I l l  AC- I V ,  AC-V, AC- V l ,  AC- V l l ,  AC­
V I I l  and A C- I X )  ( Demuth and Mol leman, 2006) . The isoform AC- I i s  found 
ma in ly  in the bra in  wh i l e the isoforms AC- V and AC-V I  are h igh ly  expressed i n  
bra in  and heart .  When monkey k idney (COS-7) cel l s  express ing exogenous CB I 
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receptor were transfected with each AC isofonn in  turn and t imu lated 'W i th the 
cannabinoid agon i ts H -2 1 0  and W I  5 5,2 1 2-2,  the isoforms AC- l ,  AC-V, AC­
VI and AC-Y J J J  were hovv n to be inh ib ited , whereas, AC- l l , AC- 1V and AC-V J l  
\vere st imu lated b B J  receptor act ivation ( Rhee, et a l . .  1 998) .  Col lecti e ly, a l l  
these resu l ts  uggest that C B J  receptor may be dua l l y  coupled to both Gs and G1.,o 
prote ins  i n  some systems .  It is l i ke l)  that the contrast ing effects of cannabinoids 
on A act i v ity could be attri buted to the spec i fic isofonn present i n  d i fferent 
ce l l u lar preparat ions. How ever, physio logical s ign i ficance of these d iverse 
coup l i ng  mechan isms of cannabinoid receptors to various G-prote ins needs further 
In e t igat ion .  
Another effect descr ibed for both C B J  and CB2 receptors i s  the modulation 
of intrace l l u lar Ca2+ concentrat ion.  C B J  receptor agonists, inc lud ing AEA and 2-
AG. \ ere shown to d i rect ly st i mu late the hydrolys is of P I P2 by phosphol ipase C 
( P LC-�) \v i th subsequent re lea e of J P3 fo l lowed by Ca2+ mobi l ization from the 
endopl asm ic ret i cu lum v ia  e i ther Gq-med iated or Gl/o-mediated mechan isms 
(Sug iu ra, et a I . ,  1 996; Ho,  et a I . ,  1 999; Lauckner, et a I . ,  2005) .  In NG 1 08- 1 5  ce l l s  
(Sug iura, e t  a I . ,  1 996) and in  cu l tured cerebe l lar granu le  c e l l s  (Netzeband, et a I . ,  
1 999), cannabinoid receptor agon i sts have been shown to i ncrease in t race l l u lar 
Ca2+ concentrat ion by re l easing Ca2+ from l P3-sens i t ive stores. It appears that these 
effects of cannabinoids are sens i t ive to C B  J antagonism and PTX treatment 
(Sug iura, et a I . ,  1 996; Netzeband, et a I . ,  1 999) .  
Act i vation of C B2 receptors has a lso been shown to increase intrace l l u lar 
Ca2+ l eve ls, a lthough, C B2 receptor-med iated Ca
2+ responses are less pronounced 
than the potent C B J  receptor-mediated effects ( Fe lder, et a i . ,  1 995 ;  Zoratt i ,  et aI . ,  
2003) .  I n  ca lf  pu lmonary endothe l i a l  cel ls ,  Zoratt i e t  aI. , observed C B2-dependent 
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i ncrea e in  C) to o l ic a2+ v i a  act ivat ion of  PL and a ubsequent re lea e of Ca�+ 
fr m l P,-sens i t ive stores (Zoratt i ,  et a I . ,  2003) .  
1 10\ ever, In some other experiments, cannabino id- i nduced Ca2+ release 
ha been ho\\ n to be assoc iated with the re lease of n i tric oxide (NO). For 
example,  in  cu l tured human arteria l  endothe l ia l  ce l l s ,  AEA evoked an i ncrease in 
i ntrace l l u lar Ca2+ concentrat ion in an SR  1 4 1 7 1 6A-sensi t ive manner. Th is  increase 
\\ a hown to be coupled to NO re lease ( F i m ian i ,  et a I . ,  1 999). I n  human umbi l ical 
endothe l ia l  ce l l s, intrace l l u lar Ca2+ i ncrease was i nsensi t ive to PTX and on ly  
marg ina l ly  blocked by  S R 1 4 1 7 1 6A .  Anandam ide a l so s ign i ficant ly i ncreased 0 
) nthase acti i ty ( Mombou l i ,  et a l . .  1 999). Col lect ively,  these resul ts suggest that 
C B I  receptor-dependent and independent increase in  i ntracel lu lar Ca2+ and 
subsequent NO production may account for some of the vasod i lator actions of 
E . However. the increase in  i ntrace l l u lar Ca:!+ concentrat ion seems at odds 
part icu larl) wi th cannabino id i nh ib i t ion of neurona l excitab i l i ty wh ich is  thought 
to be caused by VGCCs i nh ib it ion . In add i t ion to NO synthase act i vat ion 
mechan ism. i t  i s  possib le  that subce l l u lar local ization of s igna l ing pathways cou ld  
exp la in  th i s  paradox.  For example,  i t  may be env isaged that Ca2+ release from 
i ntrace l lu lar stores in exc i tab le ce l l s  can be i nh ib itory through act ivat ion of Ca
2+_ 
dependent K+ channels ,  lead ing to hyperpo larizat ion.  Th is  wou ld  then prevent the 
act i vation of VGCCs and large Ca2+ i nflux ( Demuth and Mol leman, 2006). 
I n  add i t ion to the second-messenger pathways descr ibed above, funct ional 
modulat ion of various ion channels and receptors by endocannabinoids has a lso 
been demonstrated . One of these ion channels is the transient  receptor potent ia l  
(TRP) channel which const i tutes a large and a funct iona l l y  versat i le fam i l y  of  
cat ion-permeable transmembrane prote ins .  To date, van i l lo id  receptors (TRPV l )  
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are the best characterized TRP channels .  The are pri mari ly heat receptors 
e pressed in ensory neurons and the ir  act i at ion leads to Ca2+ entry and 
neurotransm itter re lease ( Demuth and Mol leman, 2006) .  
The rea l izat ion that AEA i s  chem ical l y  s im i lar t o  capsa ic in  an  agon ist of 
TRPV 1 channel ( Di Marzo, et a I . ,  1 998)  lead to the d i scovery that AEA can serve 
as an agonist not on ly  on cannabinoid receptors but a lso on TRPV l channels .  For 
example, the TRP V I receptor-med iated vasod i l atory effect of A EA in rat and 
guinea p ig  al1eries ha been shown to be blocked by the TRPV I antagonist 
cap azepi ne (Zygmunt, et a I . ,  1 999) . S im i l arly, appl ication of AEA ( 1 0  JlM)  
causes activat ion of  TRPV 1 receptors i n  cu l tured cel ls  transfected w i th  rat or 
human TRPV 1 receptors or in neurons of neonatal rat dorsal root gangl ia  
(Zygmunt .  et  a I . ,  1 999; Smart ,  et  a I . ,  2000; Ross, et aI . ,  200 1 ). Fu rthermore,  the 
abi l i ty of A EA to st imu late TRPV I receptors appears to be regu lated by the state 
of act ivat ion of prote in  k inase A and prote i n  k i nase C ( Premkumar and Ahem, 
2000; Di Marzo, et a I . ,  2002) .  In this context, i t  i s  important to note that co­
loca l i zat ion of cannab ino id receptors and TRPV 1 channels have made the 
i nterpretat ion of some experiments d i fficu l t ( Hermann, et a I . ,  2003 ; D i  Marzo and 
Cr ist i no, 2008) .  
In recent years, i t  has been shown that endocannabinoids are l igands for 
perox i some pro l i ferator-act ivated receptors ( PPA Rs) (O'Su l l i van, et a I . ,  2005 ;  
Lenman and Fowler, 2007) .  PPARs are nuclear transcr ipt ion factors that are 
h igh ly  expressed i n  metabo l ica l ly  act ive t issues such as l iver, ad ipose, skeletal 
musc l e  and heart (St ienstra, et a I . ,  2007) .  These receptors play key ro les i n  
regulat i ng cel l u lar d i fferent iat ion, l i p id  metabo l i sm and inflammat ion (G lass and 
Ogawa, 2006). I n  the heart, these receptors can modu late myocard ia l  l ip id 
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metabol i sm,  a wel l  a , gl ucose and energy homeostasis ( Lee, et a I . ,  20 J I ) . 
Cannabinoid-re lated agon ists ident i fied to date for PPARs inc lude AEA, 2 -AG. 
OEA. THC, A DA and cannab id io l  ( Fu ,  et aI . ,  2005 ; O'Su l l ivan, et aI . ,  2009a: 
0' u l l i  an. et a I . , 2009b; O'Su l l i van, et a I . ,  2005 ; Rockwe l l ,  et a I . ,  2006). I n  some 
tudie . i t  has been sho n that the ant i - inflammatory effects of AEA and 2- G 
are sens i t i  e to PPA Rs antagon i sm ( Rockwe l l  and Kami nsk i ,  2004 ; Rockwe l l .  et 
a l . .  2006). I n  add i t ion ,  a study carried by O 'Su l l ivan el af. has shown that the 
endocannabinoid A EA, acti vates PPARs in rat aorta, lead ing to NO-dependent 
re laxat ion (0' u l l i  an. et a l . .  2009a) . Act i vat ion of P PA Rs in the heart by some 
endocannabinoids may represent a no e l  mechanism for endocannabinoid 
regulat ion of the card iovascu lar system (O'Su l l ivan . et aI . ,  2009a).  
Further to these we l l -recognized endocannabinoid targets, emergl llg 
e idence demonstrates that, beyond the i r  receptor-med iated effect , AEA and 
other cannabino id-receptor l igands are able to a l ter the functional propert ies of 
l igand-gated ion channe l s  in a cannab i no id receptor- i ndependent manner (Oz. 
2006). D i rect effects of endocannabino ids i nc lude modu lation of the funct ion of 
seroton in  type 3 ( 5 - HT-3) receptors (Oz, et a I . ,  2002) ,  n icot in ic  acetylcho l i ne 
receptors ( Jackson, et a ! . ,  2008;  Oz et a I . ,  2004a; Butt, et a ! . ,  2008), muscari n ic  
acetylcho l ine  receptors (Chri stopoulos and W i lson. 200 1 )  and g lyc ine receptors 
(Hejaz i .  et a I . ,  2006; X iong, et a I . ,  20 1 2 ) .  
I n  addi t ion to  l igand-gated ion  channels, endocannabinoids have been 
shown to interact wi th several c l asses of vol tage-gated ion channels 1 11 a 
cannabino id  receptor-dependent and independent manner (Oz, 2006). Evidences 
for both mechan isms are d i scussed in the fol lowing sect ion .  
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J .2 .5.2 Receptor-dependent  and  i ndependent  effect of endoca n nab inoids on 
ol tage-ga ted ion chan nels 
1 . 2 .5.2 . ] Effect 0 11 Na + cha n n els 
Endocannabinoid have been shown to inh ib it d i rect ly  the functions of 
o l tage-gated a+ channels (VG Cs) in neuronal structures. In an earl ier study, 
ichol  on el aI. , have demonstrated the ab i l i ty of AEA and W I  55 , 2 1 2 -2 to 
i nh i b it VGSCs (act ivated by veratrid ine)  in mouse synaptosomes (N icholson, et 
a I . ,  2003) .  The cannab inoids a l so blocked the veratrid ine- i nduced re lease of 
neurotransm i tters from synaptosomes inc l ud ing GABA and g lutamate . The C B I  
antagon i st AM25 1 d i d  not attenuate a + channel i nh ib it ion (N icholson. et a l . .  
2003 ) .  I n  add i t ion, AEA and  W IN 55 ,  2 1 2-2 were able to  d i splace the b ind ing of 
eH]batrachotox i n i n  A 20-a-benzoate ( e H J BTX-B)  to VGSCs (N icholson, et a l . ,  
2003) .  Together, t he  data suggest that cannabinoids can d i rect ly modulate the 
act i  i ty  of VGSCs, depress ing synapt ic transmission in the bra in ,  and in tum, 
reduce both excitatory and i nh ib itory neurotransm itter re lease. 
I n  rat dorsal root gangl ion neurons. AEA inh ib i ted both tetrodotox i n  
(TTX) -sens i t ive and TTX-resistant Na + currents in  a concentrat ion-dependent 
manner. Th i s  i nh ib it ion was not reversed by the C B I  antagon ist AM25 1 ,  the CB2 
antagoni st AM630 and the van i l lo id  receptor antagon i st capsazepine. suggest ing a 
d i rect act ion of AEA on a + channels ( K im,  et a l . .  2005 ) .  In a study carried out by 
Duan et at. , 2-AG and NADA were found to mod i fy the b ind ing of e H J BTX-B to 
VGSCs of mouse bra in  and i nh ib i t  their  function in vitro ( Duan, et a l . ,  2008) .  
These effects were not i nfl uenced by the appl icat ion of the C B I  receptor 
antagon ist AM25 1 .  I t  was concluded that 2-AG and NADA d i rect ly  inh ib i t  Na 
+ 
channel funct ion, which contributes to the suppression of neuronal exc i tat ion and 
i nh ib i t ion of neurotransmi tter release in the presynapt ic  membranes ( Duan, et a l . ,  
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2008). A recent study ha shown that A EA blocks sensory neuronal a + channel 
i o� ml av 1 .7 in  tabl transfected human embryon ic k idney ( H EK) 293 ce l l s 
(The i le and ummins, 20 1 I ) . However, i nh ib it ion of VGSCs is not l im ited to 
endocannabinoid . Other members of NAEs fam i l  have a lso been shown to act 
on a + channels .  In mou e bra in  synaptosomes, OEA inh ib i ted the b inding of 
eH J BTX-B .  In add it ion. OEA at a concentration of  1 0  11M decreased peak a + 
currents in  cu l tured N 1 E- I 1 5  neuroblastoma ce l l s  i n  a vol tage-dependent manner, 
and cau ed a hyperpo lar iz ing sh i ft in the inact ivat ion curve of the channel .  I n  th is  
re peel. the effect of  OEA reflects the actions of loca l  anesthetic drugs used as 
ant iarrhythmic  agents. Therefore, OEA is l ike ly to regu late card iac cel l 
e 'c itab i l it) ( icholson. et a I . ,  200 I). I ndeed , a recent study in  neonatal 
card iomyocytes show ed that the nvo N AEs, SEA and OEA, i n fluenced the 
vol tage-dependence of act i vat ion, i nact i vat ion, and the k i net ics of Na + currents 
( Voitychuk, et a I . ,  20 1 2) .  These effects may in part be responsib le for the decrease 
in card iom) ocytes' excitab i l i ty by these l ip ids under normal as wel l  as 
pathological  cond i t ions. I nterest ing ly, the e ffects of endocannabinoids such as 
A EA and 2-AG on card iac Na + channels have not been reported. 
1 . 2 .5 .2 .2  Effects on Ca2+ chan nels 
In earl ier stud ies i t  has been shown that AEA, W IN 55 ,  2 1 3 -2,  and CP 55 ,  
940 act v i a  CB I  receptors t o  decrease Ca2+ i nflux i n  NG 1 08- 1 5  cel ls  (Mack ie  and 
H i l l e, 1 992 ; Mack ie ,  et a I . ,  1 993) .  Th i s  effect was b locked by pretreatment w ith 
PTX, demonstrat i ng its mediat ion by Guo protein, and was i ndependent of cAMP 
pathway. as  the  response was not  reversed by the  add i t ion of 8-Bromo-cAM P  
(Mackie and H i l le, 1 992; Mackie, e t  a I . ,  1 993) .  S im i larly, i n  rat superior cerv ical  
gangl ion neurons transfected with C B I  receptors, W IN55 ,2 1 2-2 and CP55 ,940 
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i nh ibited -type Ca2+ current In a PTX-sens i t i  e manner ( Pan. et a I . ,  1 996). 
nother study in rat triatal neurons ind icated that W IN5 5.2 1 2-2 inh ib i ted 
cort icostriatal gl utamaterg ic synaptic transm ission in an R 1 4 l 7 l 6A-and a PTX ­
sens i t ive manner. The i nh ib i t ion of  N-type Ca2+ channels \\ as thought to med iate 
th i s  effect as co-conotox i n  abo l i shed the W ]  55 ,2 1 2-2-med iated synapt ic  
i nh ib it ion ( H uang, et a I . ,  200 I ) . On the other hand,  another study has reported the 
d i rect effect of AEA ( 1 - J 0 I-lM)  on N-type VGCCs in superior cerv ical gangl ion 
neurons that do not express endogenous cannabinoid receptors. The effect 
persi sted in the presence of e i ther SR 1 4 1 7 1 6A or PTX . However, 2 -AG ( 1 0  f.JM)  
d i d  not have s im i lar effects (Guo and I keda, 2004) .  
]n cu l tured rat h ippocampal neurons, A EA,  W IN5 5,2 1 2-2 and CP55 ,940 
i nh ib i ted N- and P/Q type Ca�+ currents in an SR 1 4 l 7 1 6A- and PTX -sensit ive 
manner (Twitchel l ,  et a I . ,  1 997 :  Shen and Thayer, J 998). I n  the presence of 
R l � 1 7 J 6, W in55 ,2 1 2-2 (nanomolar concentrat ions) i nh ibited N-Type VGCCs 
b)- on ly 2 % ( Shen and Thayer, 1 998) .  I nterest i ng ly, at concentrations h igher than 
I I-l M ,  W in5 5,2 1 2-2 inh ib i ted N-Type VGCCs in  a manner independent of 
SR  1 4 1 7 1 6A .  T n  add it ion, the i nact ive stereoisomer W rN55,2 1 2 -3 (micromolar 
concentrat ions) a l so i nh ib i ted Ca2+ currents i n  an SR 1 4 1 7 1 6A- i nsens i t ive manner. 
Col lect ive ly, these find ings i nd icate that at m icromolar concentrat ions, the effects 
of W lN 5 5,2 1 2-2 are not med iated by C B I  receptors, suggest ing a d i rect effect of 
cannabino ids on N-type VGCCs. 
] n  addit ion to neuronal Ca2+ channels ,  modulation of T-type Ca
2+ channels 
by endocannabinoids has a lso been demonstrated in several stud ies. Prev iously. 
d i rect i nh ib i tory effect of A EA on T-type VGCCs has been reported (Chem in ,  et 
a 1 . ,  200 I ) . T -type VGCCs are known to contribute to pacemaker act iv i ty in the 
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centra l  ner Oll sy tem and in  the heart. A l l  three c loned T-type YGCCs (a I H ,  a l l 
and a l G) � h ich were transfected in  H EK 293 and CHO cel ls  and endogenously 
e pressed in G 1 08- 1 5  cel ls ,  were inh ib i ted by A EA in  the concentrat ion range 
of 0.0 1 - 1 0 11 M ( hem in ,  et a I . ,  200 I ) . Thi i nh ib i tory effect as not m im i cked by 
ynthet i c  cannab inoids inc lud ing W ]  55 ,2 1 2 -2,  CP55  940 and H U-2 1 0, and was 
not blocked by S R 1 4 1 7 1 6A (Chem i n. et a l .  200 1 ) . Notably ,  A EA cont inued to 
inh ib i t  T-type VGCCs in exc ised ins ide-out patches of H E K -293 cel l s  (Chem in ,  et 
a I . ,  200 1 )  suggest ing that the effect of A EA is membrane del im i ted , and is not 
mediated by second messenger pathway. Furthermore, the effect of AEA was 
m i m icked b) methanandam ide ( metAEA) ,  the metabo l ical ly stab le analogue of 
A EA (Abadj i ,  et a I . ,  1 994),  ind icat ing that the metabo l ic products of AEA 
hydro lys is, such as AA and ethanolam ine. are not involved in  the inh ib i t ion of T­
t pe Ca2+ currents (Chem in ,  et a I . ,  200 I ) . From these observat ions i t  was 
suggested that AEA d i rectl y  inh ib i ts  T-type YGCCs by act ing on the ce l l  
membrane. A more recent study support ing these find ing 'V as carr ied out by Ross 
el af. ( Ross, et a I . ,  2009) .  Human recombinant T-type VGCCs expressed in HEK 
293 cel l s  and nat ive mouse T-type VGCCs were used to test the effect of the 
endocannabinoid ADA. The results of th is  study have shown that NADA 
robust l y  i nh ib its both human recombinant and nat ive mouse T-type VGCCs (The 
rank order of  potency was (PECso) of CaY3 .3  (6 .45)  � CaY3 . 1  (6.29) > CaV3 .2  
(5 .95))  ( Ross, e t  a ! . , 2009). These resu l ts were broad ly  s im i lar to  those previously 
reported for A EA (Chemin .  et a! . ,  200 1 ; Chem in ,  et a ! . ,  2007).  
Besides N -type and T-type Ca2+ channels,  L-type Ca
2+ channe ls  have a lso 
been shown as target prote ins for endocannabinoids. I n  cat cerebra l arterial 
smooth musc le cel l s, i t  was found that act i vat ion of CB I receptors inh ib its L-type 
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VG , re u l t i ng In cerebral asod i lat ion (Gebremedh in .  et a l . .  1 999). 
W 55 .2 1 2-2-and EA induced concentrat ion-dependent inh ib i t ion of peak L­
t pe Ca2+ current .  The i nh ib i tory effects of both l igands were abo l i shed by PTX 
pretreatment and by the C B ,  antagon i st SR 1 4 1 7 1 6A .  In add i t ion.  both 
W I  5 5,2 1 2 -_ and AEA produced concentrat ion -dependent re laxat ion of pre­
constricted cerebra l arteri a l  segments that was abo l i shed by SR I 4 1 7 1 6A 
(Gebremedh in ,  et a \ . ,  1 999) .  These find ings suggest that C B ,  receptor and i ts 
endogenous l i gand may play an important ro le in the regu lat ion of cerebra l arterial 
tone by modu la t ing the i n flux of Ca2+ through L-type VGCCs (Gebremedh in ,  et 
a l . .  1 999). Furthermore, in i so lated rat ventricu lar  myocytes. A EA ( L  1 0  and 1 00 
n 1 )  caused a concentrat ion-dependent i nh ib i t ion of L-type Ca2+ current and 
sh i fted the current-vol tage re lat ionsh ip curve of the Ca2+ current. Anandamide 
( l 00 n M )  sh i fted the steady-state i nact i vat ion curve to the left and the recovery 
curve to the r ight ( L i ,  et a I . ,  2009). B lockade of C B ,  receptors with AM25 1 ,  but 
not C B2 receptors with AM630, e l im inated the effect of A EA on L -type VGCCs. 
These data suggest that AEA suppresses L-type VGCCs in card iac myocytes 
through the act i vat ion of C B ,  receptors e L i  et a I . ,  2009). 
The above ment ioned studies have ind icated that cannabinoids inh ib i t L­
type Ca2+ channe ls  by the act ivat ion of C B ,  receptors. However, the C B ,  receptor­
i ndependent modu lat ion of L-type Ca2+ channels by cannabinoids ha a lso been 
reported. I n  1 988,  Jan i s  ef 01. , i so lated a l i p id fract ion from bov ine bra in  and 
showed that A EA inh i bi ts the spec i fic eH]  n i trend ip ine b ind ing to L-type Ca2+ 
channe ls  i n  rat card iac membranes, and it blocks Ca2+ currents in  GH3  p i tu i tary 
ce l ls  (Jan i s  et a I . ,  1 988) .  Further stud ies i n  cort ical membranes have al so 
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ident i fied A EA a an endogenous modu lator of L -type ci+ channel s  (Johnson, et 
a l . , 1 993) .  
T -tubu le of the  skelela l  musc les are known to  be  the  richest source of  L­
type VGCCs.  I n  T-lubule membrane ves ic les from rabbit ske leta l musc le fibers, 
AE i nh ib ited the b ind ing of d i hydropyrid i ne ( D H P) ( e H ] PN 200- 1 1 0), 
phen l a l ky lamine ( eH]D888), and 1 .5-benzoth iazapine ( e H ]d i l t i azem) c l ass of 
Ca2+ channel antagonists with IC50 val ues of 4 �M, 8 �M and 29 IJM,  respect ively 
( h imasue, et a I . ,  1 996) .  I n  add i t ion, functional stud ies in  T-tubule membranes 
i nd icated that A EA ( 1 - 1  0 �M)  and metAEA can i nh ib i t  the depolarizat ion­
induced �5Ca2+ fluxes med iated b the act ivat ion of L -type Ca2+ channel s  in a 
manner that \ as i nsensi t ive to SR 1 4 1 7 1 6A or PTX (Oz, et a I . ,  2000). Further 
stud ies on T-tubu le  membranes showed that not on ly  AEA,  but a lso 2-AG ( 1 - 1 0  
pM), i nh ib i ted .J5Ca2+ nuxes and d isplaced the spec i fic b ind ing of D H P  ( Oz, et a I . ,  
2004a). Hm e er, d i rect effects of these endocannabinoids on L-type Ca2+ 
channels were not m i m icked by the major psychoact i ve cannabinoid compound of 
marij uana, THC,  and synthet ic C B 1  receptor agon ists C P55 ,940 and W IN 5 5,2 1 2-
2 .  
I n  adu l t  rat ventricu lar  myocytes, the effect of AA, the metabo l ic product 
of AEA hydro lysis,  on L -type Ca2+ channels was a lso stud ied (L i u ,  2007). It was 
found that the exposure to AA d i rect l y  a l ters the vol tage dependence of gat ing 
propert ies of L-type Ca2+ channels,  and thereby, reduces L-type Ca2+ current, 
wh ich accounts for AA inh ib i t ion of contract ion and Ca2+ transient in  rat 
ventricu lar myocytes ( L i u ,  2007). I n  a more recent study, it was found that the 
synthet i c  cannabinoid A-955840 inh ib i ts  the function of L-type ci+ channels i n  
4 1  
rabbit heart in  a manner that is not sens i t i  e to C B t  and CB2 antagon ists ( u ,  et 
a I . ,  20 I I ). 
1.2.6 Role of endoca n nab inoids i n  the ca rd iovascu lar  system 
The card io  ascu lar effects of cannabinoid compounds have been 
recognized for se era l  decades ( Randal l , et a I . ,  2002 ; Pacher, et a I . ,  2005a). I n  
humans, the acute effect o f  smoking Cannabis usua l l y  man i fests a s  a n  increase i n  
heart rate "" i th no s ign i ficant change in  b lood pressure ( Kanak is, e t  a ! . .  1 976). 
1 -I 00\ e er, chron ic use of marij uana in  man, as we l l  as, both acute and prolonged 
adm in i strat ion of THC to experimental an imals, have been shown to cause long 
la t i ng decrea e in b lood pressure and heart rate ( Benowi tz and Jones, 1 975 ) .  
Because of the  we l l -knov n effects of cannabinoids on the centra l  nervous system, 
ear l )  re earch on the ir  card iovascu lar effects concentrated on the abi l i ty of these 
compounds to i nh ib i t  sympathet ic tone as the ir  mechan ism of act ion (Vo l lmer. et 
a l . .  1 974) .  
S ince the d i scovery of the endocannab inoid system, regu lat ion of various 
card iovascu lar funct ions by these molecules has been stud ied extens ive ly ( Pacher, 
et a l . .  2005a; Pacher and Kunos, 20 1 3) .  I n  both in vitro and in vivo stud ies, 
endocannabi noids have been shown to exert complex card iovascu lar  effects, both 
med iated by receptor-dependent and independent mechan isms. I n  experimenta l 
an ima ls  and humans (depend ing on the route of adm in i st rat ion, durat ion and 
dose). the card iovascu lar effects of endocannabinoids may inc lude C B t -med iated 
bradycard ia/tachycard i a, hypotension, and depressed card iac contract i l i ty 
( Ma l i nowska, et a I . ,  20 1 2) .  Mechan isms of these effects i nvolve modu lat ion of 
autonom ic outflow through s ites of act ion at presynapt ic  autonomic nerve 
term ina ls  and in the centra l  nervous system, as wel l  as d i rect effects on 
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m) ocard ium and the ascu lature ( Pacher. et a l . .  2005a) .  Despite e idences on the 
presence of CB2 receptors in the myocard ium (Mukhopadhyay. et a \ . .  2007; 
Bouchard. et a 1 . .  2003 ; MontecLlcco, et a I . ,  2009) and a few recent studies 
imp l icat i ng th i s  receptor in  myocard i a l  protect ion ( Bouchard ,  et a 1 . ,  2003; 
Montecucco. et a1 . ,  2009), i ts  ro le in  card iomyocytes remains elusive.  A l though 
the endocannabinoid system appears to play a l im ited ro le in card iovascu lar 
regu lat ion under normal  physiological  cond i t ions, it may become overact ivated 
and p lay i m portant protect ive and/or detrimental ro les in various d i sease 
cond i t ions ( M ukhopadhyay, et a 1 . ,  2008) .  The various card iovascu lar effects of the 
endocannabinoid system are descr ibed in the fol lowing sect ions. 
1 .2 .6 . 1 Ca rd iovascu lar  effects of endoca n nab inoids in vivo 
Systemic  adm in istrat ion of cannabinoids i n  anesthet ized rats and m ice 
causes hypotension and bradycard ia  by peripheral i nh ib i t ion of sympathetic 
outflow and increased vaga l act iv i ty ,  respect ive ly  ( Pacher. et a I . ,  2005a). 
Anandam ide was found to e l i c i t  a tr iphasic b lood pressure response with 
bradycard i a  ( F igure 1 .9)  ( Varga, et a 1 . ,  1 995 ;  Varga, et a 1 . ,  1 996; Lake, et a I . ,  
1 997a; M a l inowska, e t  a I . ,  20 1 2) s im i lar to  that reported earl ier for THe 
( S ique i ra, et a 1 . ,  1 979). The i n i t i a l  phase of the response consisted of bradycard ia 
(with brief secondary hypotension) that l asted for a few seconds on ly, and was 
be l ieved to be vaga l l y  med iated as it was abo l i shed by atropine treatment and 
vagotomy.  Th i s  vagal component was fol lowed by a brief pressor response which 
persi sted in the presence of a-adrenergic blockade, and a lso in  rats in which 
sympathet i c  tone was abo l i shed by p i th ing, and was thus not sympathet ica l l y  
mediated ( Varga, e t  a I . ,  1 995) .  
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Fig u re 1 .9 Typica l traces show i n g  the i n fl uence of AEA on card iovascu lar  
parameters i n  anaesthet ized rat .  Adapted from Ma l inowska el  01. , 20 1 2 . 
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The pressor component, which consti tutes the second pha e. was a lso 
unaffected by C B I  receptor antagon ists and it pers i ted in  C B I  knockout m ice 
(Jara i ,  et a I . ,  1 999; Pac her, et a I . ,  2004), ind icat ing the lack of in vol  ement or C B I  
rec ptor . The exact mechan i  m o f  th is  vasoconstr ict ive response i s  not wel l  
understood, howe er. d i rect act ion on the ascu lar smooth musc le has been 
proposed (Jara i ,  et a I . ,  J 999). A l though the centra l  invol vement in the pressor 
response \ as ru led out, central l y  adm in i strated cannabinoids can i ncrease the 
act iv i ty of sympathoexc itatory neurons in the card iovascular regu latory centers 
iederhoffer and Szabo, ] 999) .  Therefore, the potent ia l  ex i sts that cannabinoids 
may increase blood pressure via act ions on the central nervous system. Current ly 
known mechan isms of cannabinoid receptor s igna l ing wou ld  suggest that they 
pri nc ipa l l  act v ia i nh i b i t ion of neurotransm itter re lease, suggest ing that the 
central sympathoexc i tatory effects of cannabinoids may be med iated by 
d i s i nh ibi t ion of inh ib i tory neurons. 
The th i rd phase of AEA effect was hypotension assoc iated w ith moderate 
bradycard ia that lasted for 2- 1 0  m inutes ( Varga, et a I . ,  1 995 : Varga, et a I . ,  1 996; 
Lake, et a I . ,  1 997a) .  I nterest ing ly, the th i rd phase was absent in  consc ious 
normotensive rats ( Ste in,  et aI. , ] 996; Lake, et a l . .  1 997a) but present and more 
prolonged in consc ious, spontaneously hypertensive rats ( Lake, et a I . ,  1 997b; 
Batka i ,  et a I . , 2004b). S i nce sympathet ic  tone i s  known to be low in consc ious 
und i sturbed normotensive rats (Carruba, et a I . ,  1 987),  these observat ions appear to 
be compat ib le  with a sympatho- i nh ib itory mechan i sm , underly ing AEA- induced 
hypotension and bradycard ia. The reduction of the sympathet ic tone by AEA is  
a l so compat ib le  with early find i ngs with THe. where experimental man ipulat ions 
to decrease sympathetic tone resu l ted in a para l l e l  decrease in the depressor 
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respon e to TH ( V  l lmer, et a l . .  1 974).  L ikewise. EA \ as unable to reduce 
blood pre sure in anesthetized rats a fter cerv ica l  transect ion of the spinal cord or 
after blockade f a-adrenoreceptor (Varga, et a l . ,  1 995) .  The fi nding that metAEA 
cause i m i lar but more prolonged hypotension and bradycard ia, e l im inates the 
poss ib i l i ty that the effects of A EA are med iated ind i rect l y  by a metabol ite ( Kunos, 
et a l . . 2000). 
evera l  l i nes of  ev idence imp l icate C B I  receptors in  AEA- induced 
h) potension and bradycard ia .  For example, these effects are effect ive ly inh ib i ted 
b the se lect ive  C B I  receptor antagon i st SR l 4 1 7 1 6A ( Lake, et a l . ,  1 997a; Varga. 
et a ! . .  1 995) .  Th is  fi nd ing was upported by the tota l absence of cannabinoid­
i nduced hy potension and bradycard ia in  C B I  receptor-knockout m ice ( Ledent, et 
a ! . .  1 999). I n terest i ngly .  in a study carried out by Jerai el af. it was found that 
AEA- induced mesenteric vasod i lat ion persi sted in m ice deficient in CB I receptors 
or in both C B I  and CB2 receptors, suggest ing a vasod i l atory effect through a s i te 
d ist i nct from C B  I or C B2 receptors ( Jara i .  et a I . ,  1 999). Further ev idence for the 
in o l vement of C B I  receptors is that the rank order of the hypotensive and 
bradycard i ac potency of a series of cannab ino id analogs, inc lud ing AEA, is 
i dent ical  to the rank order of potency of the same substances for b ind ing to the 
C B I  receptors in rat bra in  ( Lake. et a l . .  1 997a) .  
Stud ies have shown that st imu lat ion of presynapt ic CB I receptors inh ib i ts 
norepineph rine re lease on per iphera l  sympathetic nerves, both in vitro ( Ishac, et 
a I . ,  1 996; V iz i .  et a I . ,  200 1 )  and in vivo ( Varga, et a I . ,  1 996; Ma l inowska, et a l . ,  
1 997) .  which has a major impact on b lood pressure regulat ion.  A recent study 
showed that the use of A M 3506 (a F AAH inh ib i tor) in rodents revealed that the 
ant ihypertensive effects of endogenously e levated AEA levels are med iated v ia  
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act i  at ion f B I receptor In  the centra l  ner ou S) stem. and a reduction in  
ympathet ic  tone (God lewsk i .  e t  a I . ,  20 1 0). Wagner ef  al. . showed that 
cannabinoids are potent coronary and cerebral vasod i lator agents in  the rats in vivo 
(Wagner. et a l . .  200 I b) .  I n  the same tudy, the ynthet ic  cannabinoid H U -2 1  0 (as 
a fu l l  agon ist for C B I  receptors ) and AEA (as a part ia l  agonist for C B I  receptors). 
d i ffered in the i r  effects on card iac output and system ic vascu lar res istance 
(Wagner. et a I . ,  200 I b). Prev ious stud ies have a lso demonstrated that A EA caused 
R 1 4 1 7 1 6A -sens i t ive coronary vasore laxat ion in isolated perfused rat hearts 
( Randa l l  and Kenda l l ,  1 997;  Fu lton and Qu i l ley, 1 998). imp l icat ing the 
involvement of cannabino id receptors . 
An  in vivo study by E l l i s  ef al. demonstrated that AEA causes 
cerebro ascu lar re laxat ion I n the rat that was sens i t ive to indomethac in  
appl icat ion .  ind icat ing that the  effect was l i kely med iated by st imu lat ing the 
release and metabo l ism of endogenous AA (E l l i s ,  et a I . ,  1 995) .  
1 .2 .6 .2 Card iovascu lar effects of endoca n nab inoids in vitro 
The vasore laxant effects of AEA are complex and appear to involve 
mu l tip le  ce l l u lar and molecu l ar mechan isms.  Anandam ide has been shown to act 
v i a  the release of endothe l i um-derived N O  in a range of human blood vesse ls  and 
the r ight atri um ( B i l fi nger, et a I . ,  1 998) .  Vasore laxant effects were a lso seen in the 
rat i so lated mesenteric ( Randa l l .  et a l . ,  1 996; Randa l l ,  et a l . ,  1 997;  P lane, et a I . ,  
1 997) and coronary vascu l ature ( Randa l l  and Kenda l l ,  1 997) .  However, in  both 
preparat ions A EA- induced re l axat ion was i nsens i t ive to cyc looxygenase 
i nh ib i tors endothe l ia l  denudat ion and i nh ib i t ion of NO synthesis .  , 
Further studies on the mechan ism of AEA- induced vasore laxant effect 
suggest that K+ channels  are a lso involved in their act ions. For example, the 
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end the l i um- independent re laxat ions by A EA i n  the mesentery (Randal l ,  et a I . ,  
1 996; Wh ite and H i ley.  1 997) were blocked b ra is ing extrace l l u lar K+ . 
suggest ing that AEA- induced responses are med iated by the act ivation of K+ 
channels  (Randa l l .  et a ! . ,  1 996; P lane, et a ! . ,  1 997;  Wh ite and H i ley, 1 997; White 
and H i Je , 1 998) .  Furthermore, re la ation to AEA was a lso sens i t ive to K+ 
channel b lockade with tetraethylammon ium (TEA) ( Randa l l .  et a ! .  1 997) .  I n  l i ne 
with these find i ngs. AEA was found to inh ib i t  delayed rect i fier K+ channels i n  rat 
aort ic  and hepat ic  arteri a l  myocytes (Zygmunt, et a I . ,  1 997 :  Van, I and Vanhee l ,  
2000). The effect of  endocannabinoids on Ca2+ -act i vated K+ channe ls  has been 
equ ivocal .  Whereas several stud ies in rat me enteric arteries suggested a role for 
the large conductance Ca2+-act i vated K+ (BKCa) channe ls  ( P lane. et aI . ,  1 997; 
I sh ioka and Bukosk i ,  1 999), others did not (Wh ite and H i ley, 1 997; Ish ioka and 
Bukosk i ,  1 999; Fu lton and Qu i l l ey, 1 998) .  In add i t ion to K+ channe ls ,  Ca2+ 
channels  have a l so been sho\\ n to be modu lated by endocannabinoids .  For 
example .  A EA- induced re laxat ion has been attri buted to the inh ibi t ion of L-type 
VGCCs in cat cerebral al1erio les (Gebremedh in ,  et a I . ,  1 999). However. another 
study has suggested that i nh ib i t ion of Ca2+ mobi l i zation mediates AEA effect in  
rat hepat ic  arteries (Zygmunt. e t  a l . .  1 997) .  
I nterest i ngly.  the re l axant effect of AEA shows a s ign ificant t i ssue 
se lec t iv i ty as it does not re lax certa in  blood vesse l s  such as rat carotid arteries 
( Ho l land, et a I . ,  1 999) and the rat aorta ( Herradon, et a I . ,  2007) .  However, AEA 
does re l ax rat hepat ic and gu i nea p ig bas i lar arteries (Zygmunt, et a l .  1 999) and 
the bov ine coronary artery. Therefore, i t  i s  poss ib le  that there are regional and 
species d i fferences in the act ions of  endocannabinoids.  
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I n  se eral tud ie in  rat coronary, me enteric, renal and rabbit mesenteric 
arteries. the asore la ant effect of A EA were antagon ized by R 1 4 1 7 1 6A. 
suggest i ng the invol  ement of C B )  receptors ( Randa l l ,  e t  a l . .  1 996; Deutsch.  et  a I . ,  
1 997;  Wh ite. et  a l . .  200 I ;  Fu lton and Qu i l ley, 1 998 :  Chaytor. et  a! . ,  1 999). In  
contrast. the re l axant effect of AEA in other stud ies in  rat mesenteric and bov ine 
coronary arteries was insens i t ive to SR 1 4 1 7 1 6A (P lane, et a ! . .  1 997; Pratt, et a \ . ,  
1 998; Zygmunt, e t  a \ . ,  1 999). I n  a study done i n  rat mesenteric and hepat ic 
arteries. and in gu inea pig bas i lary artery, i t  was reported that AEA - induced 
re l axat ion was unrelated to e i ther endothe l i um or cannabinoid receptor, but 
attributable to act i vat ion of TRPY 1 receptors located on the peri ascu lar sensory 
nerve cau i ng  the re lease of the vasod i latory pept ide calc iton in  gene -rel ated 
pept ide (CG R P) (Zygm unt, et a J . ,  1 999). i m i larly, i nvolvement of TRPY I 
receptors in  the mesenteric vasod i lator act ion of metAEA has a lso been suggested 
( Ralev ic .  et a \ . ,  2000). I n  th i s  study. CGRP receptor antagon i  t and capsazepine 
i nh ib i ted the response to metAEA support ing the invol ement of TRPY I channels 
in the asore laxant act ion of AEA ( Ralev ic ,  et a \ . ,  2000). 
]n contrast to the i ncreas ing knowledge on the vascular effects of 
endocannabinoids ,  l i t t le is known about the effects of endocannabinoids on 
card i ac muscle .  I n  earl ier  studies, the card iodepresssant effects of H U-2 1 0 and 
AEA,  have been shown in isolated e lectrica l ly  st imu lated human artria l  
appendages ( Bonz, et a J . ,  2003 ) and i n  i so lated Langendorff rat hearts ( Ford e t  a\ . , 
2002). These in vitro studies are i n  agreement with earl ier in vivo studies. 
i nd i cat ing that AEA reduces both card iac contract i l i ty and total periphera l  
res i stance ( Batka i ,  et a \ . ,  2004b). I n  i so lated sect ion of human r ight  atr ium (atr ia l  
appendage), A EA, metAEA and H U -2 1 0  dose-dependent ly decreased the 
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contract i le performance. The negat ive inotropic effect was blocked by AM25 1 but 
not M630 .  I ndomethac i n  d id  not prevent the depress ion of contract i l ity by AEA, 
and metAE d i splayed the same effects a AEA (Bonz, et  aI . ,  2003 ) .  
Furthermore.  A EA cont inued to  decrease the  contract i le performance in  the 
pre ence of l- A M E. an i nh ibitor of n i tric oxide synthase (NOS) (Bonz. et a I . ,  
2003) .  The e find ings suggest that the effects of AEA on contract i le function are 
not med iated by C B2 receptor act i at ion, NO, or prostanoid re lease. Consistent 
wi th  these find ings. H U -2 1 0  decreased le ft ventricu lar pressure in i solated 
perfused rat heart ( Maslo . et a 1 . .  2004 ; Krylatov, et a I . ,  2005), and decreased 
m) ocard ia l  contrac t i l i ty \ i thout a major effect on the total periphera l  res istance 
( Pacher, et a l . .  2005a) .  
In an e lectrophys iological  study i n  rat card iac pap i l lary musc le. AEA. at 
low concentrat ions (0 . 1 - 1  � M ). decreased the AP  durat ion i n  a concentrat ion­
dependent manner and suppressed the ampl itudes of card iac APs ( L i ,  et a l . .  2009). 
Furthermore, A EA inh ib i ted l-type Ca2� currents in ventr icu lar myocytes. 
B lockade of CB 1 receptors with AM25 1 ,  but not CB2 receptors with AM630, 
e l im i nated the effect of AEA suggest ing that the effects of A EA are med iated 
through C B 1  receptors ( l i ,  et a l . .  2009). I n  another study in rat heart ,  Ford et al. , 
showed that AEA i nduces negat ive inotropic responses i n  i so lated langendorff 
heart (Ford, et a l . .  2002) .  In terest i ngly ,  the cannabino id anatagon ists SR 1 4 l 7 1 6A, 
A M2 8 1  and S R 1 44528 s ign i ficant ly  blocked the negat ive inotropic responses to 
A EA that were not s ign i ficant ly affected by AM25 1 ,  AM630 and capsazepine, 
which led the authors to propose a no el s i te d ist inct from the c l assic CB 1 and CB2 
receptors ( Ford, et a I . ,  2002) .  
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I n  add it ion to cannab inoid receptor-dependent effects i n  the heart. 
endocannabinoid can a lso interact d i rect ly with several c lasses of card iac 
o l tage-gated ion channels in  a cannabino id receptor- i ndependent manner. For 
e. ample .  EA is  a potent  b locker of potassium channel Kv l .5  which is  h igh ly 
expressed in  human atr ia ,  and contributes to A P  repolar ization of  human atria l  
m yocytes ( Barana, et  a I . ,  20 1 0 : Amoros et aL,  20 I 0 ;  Moreno-Gal i ndo. et  aJ . .  
20 I 0) .  ConcUITent w i th these resul ts AEA has been a lso shown to  block card iac 
K v4 . 3  potass ium channel i n  a receptor-i ndependent manner CAmoros et a I . ,  20 I 0) .  
0\ eral  I .  these earl ier stud ies suggest that cannabinoids have negat ive inotropic 
act ion on card i ac muscle.  However, the ro le of  cannabinoid receptors in  mediating 
thi effect i s  current l y  not c lear. 
1 .2 .6.3 E ndoca n nab i noid system in ca rd iovascu lar  d isease 
Despite the presence of cannabino id receptors, endocannab inoids and the ir  
metabol iz ing enzymes, the molecu lar mechan i sms and physio logical s ign i ficance 
of the endocannabi no id system in the card iovascular system under normal and 
pathological  cond i t ions are not fu l ly understood. I t  has been w ide ly accepted that 
the endocannabinoid system plays a l i m i ted ro le in card iovascu lar regulat ion 
under nom1al physiological  cond i t ions, wh ich is supported by the norma l b lood 
pressure ,  myocard ia l  contract i l i ty and baroreflex sens i t iv ity of cannab inoid 
receptor. or F AAH knockout m ice (Pacher, et a l .  2005b; Pacher, et a I . ,  2006). 
Base l i ne  card iovascu lar parameters, systo l ic  and d iasto l i c  functions, and 
baroreflex sens i t iv ity were found to be s im i l ar in FAAH
+ and FAAH+1+ m ice. 
This suggests that, under normal  physio logical  cond i t ions, the absence of F AAH 
does not  lead to  the  appearance of an endocannabinergic tone on the 
card iovascu lar system ( Pacher, et aL, 2005b). I n  add i t ion, in  normotensive m ice, i t  
5 1  
wa found that base l ine blood pressure is s im i lar in  C B I -knockout m ice and their 
w i ld-t. pe l i ttermate ( Ledent, et aI . ,  1 999). However, in  many patho logical 
cond i t ions such as heart fa i l ure, the endocannabinoid ystem may become 
overact i  ated and may contribute to hypotension/card iodepress ion through 
card io  ascu lar cannabino id receptors (Man i t i u, 20 1 3 ) .  
The Ie e l s  of  AEA,  but not 2-AG, are e levated in  the hearts of F AA R/-
m Ice ( Pacher, et a I . ,  2005b).  In terest ing ly, these m ice also show decreased 
deteriorat ion of card i ac function w ith age relat ive to their F AAH+1+ l i ttermates 
( Batka i .  et a I . ,  2007), which may be due to the enhancement of the effects of 
endogenous AEA.  The find ing of measurable l evels of AEA in mouse heart 
contrast v. ith an earl ier report that AEA was undetectable in l ip id  extracts of 
norma l  rat heal1, a l though 2-AG was present (Schmid,  et a I . ,  2000). Neverthe less, 
it seems that both synthet ic and metabo l i c  pathways for endocannabinoids are 
present i n  the mamma l ian heart . However, the capac ity for produc ing NAPE 
precursor appears to be low i n  several spec ies, i nc lud ing humans (Moesgaard, et 
a 1 . .  2002), and wi th the except ion of m ice, the ev idence for AEA synthes is  and 
act i v ity is genera l l y  c i rcumstant ia l . On the other hand. a l terat ions i n  
endocannabinoid system tone has been suggested t o  be assoc iated wi th varIOUS 
pathological  states as a resu l t  of the a l tered expression of cannabinoid receptors, 
endocannabino id metabol iz ing enzymes and synthet ic  pathways, in a t i ssue 
spec ific  and t ime-dependent manner ( Pacher and Kunos, 20 1 3) .  
Ear l ier stud ies in  card i ac musc le  have shown that a considerable elevation 
111 AEs content can occur under hypoxic cond i t ions when extens ive membrane 
degradat ion occurs dur ing myocard ia l  i nfarct ion (Schmid,  et a I . ,  1 996: Epps, et 
a I . ,  ] 979; Epps, et a I . ,  1 982) .  I n  fact, accumu lat ion of N A Es during pathological 
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cond i t ion v as fi r t ob er ed i n  experimental myocard ia l  i nfarct ion induced by 
l igat ion of coronary arteries i n  can ine heart ( Epps, et a ! . .  1 982:  Epps, et a I . ,  1 979) .  
In cu l tured human coronary artery endothe l ia l  cel l s  ( Rajesh, et  a l . .  20 1 0) 
and card iom) ocyte ( M ukhopadhyay. et a I . ,  20 1 0) C B 1  act i vation has been sho\\ n 
to promote stress i gna l i ng, ce l l  death, and decreased contracti l i ty ( Pacher, et a l . .  
2008 :  Montecucco and D i  Marzo, 20 1 2) .  Furthermore,  i n  several pathological 
cond i t ions (e.g. shock, heart fa i l ure ,  card iomyopath ies and advanced l iver 
c i rrhosi ) .  the endocannabino id system may become acti vated to promote 
hypoten ion and card iodepress ion through card iovascular C B 1  receptors ( Pacher, 
et a l . .  2006: Pacher, et a I . ,  2008) .  I n  rat mode ls of acute and chron ic myocard ial  
i nfarct ion,  stud ie wi th C B 1  agon i sts/antagon ists y ie lded con fl ict ing results .  For 
example .  the find ings by Wagner et 01. i nd icated that the act ivation of C B 1  
receptors contributes to se ere hypotension after experimenta l myocard ial  
i n farct ion i n  rat . In  this stud , the select ive CB I antagon ist R J.+ 1 7 1 6A 
prevented post-myocard ia l  i nfarct ion hypotension, but aggravated early 
endothe l ia l  dysfunct ion and worsened morta l i ty (Wagner, et a I . ,  200 I a) .  In a 
subsequent study, the authors reported a deleterious effect of C B 1  antagon ism with 
AM25 1 on card iac funct ion in  a chronic myocard ia l  i nfarction mode l .  On the 
other hand, treatment with the syntheti c  agon ist H U -2 1  0 prevented hypotension 
and endothe l ia l  dysfunct ion in aort ic  r ings i so lated from treated rats ( Wagner, et 
a ! . .  2003) .  A poss ib le  explanat ion of the confl ict ing resu lts in  these two studies 
m ight be the invo lvement of non-CB I receptor med iated effects. 
More recent ev idence suggested a card ioprotect ive ro le of CB I 
antagon ism.  The ro le of  the endocannabinoid system was explored i n  a model of 
doxorubi c i n  ( DOX)- induced heart fa i l ure ( Mukhopadhyay, et aI . ,  20 1 0) .  
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Fol lo\ ing 0 adm in istrat ion. the t i s  ue AEA content, but not CB l/CB2 receptor 
express ion. was elevated in the myocard i um and a lso in card iom ocytes exposed 
to DOX in vitro, suggest ing act i ation of the endocannabi noid system. 
Pretreatment of  m ice w i th B I antagon ists, SR 1 4 1 7 1 6A and AM28 1 . not on ly 
i mpro ed DOX- induced card iac dysfunct ion, but  a lso attenuated the DOX­
i nduced ce l l  death in vivo and in vitro. These observat ions suggest that the 
cytoprotect i  e ro l e  of  C B I  antagon ists in  card iac pathologies may extend beyond 
the hemodynam ic effects. 
Other stud ies have a lso supported the ro le of the endocannabinoid system 
in ce l l u l ar metabo l i sm and iab i l i ty. For example. AEA w as shown to l im i t  the 
damage induced by i schemia-reperfusion in rat i o lated hearts ( Underdown, et a I . ,  
2005 :  Lepic ier, e t  a I . ,  2007) .  im i larly, AEA has been shown to protect the heart 
from adrena l i ne- i nduced arrhythm ias ( Ugdyzhekova, et a l . .  200 1 )  and arrhythm ias 
induced by i schem ia-reperfusion through the st imu lat ion of CB2 receptors 
( K ry latov, et a l . .  2002) .  Furthermore. us ing potent C B2 receptor agon ists and 
knockout m ice, i t  has been demonstrated that CB2 receptor act ivation has a 
protect ive effect agai nst myocard ia l  i schem ic-reperfusion injury ( Haj rasou l iha, et 
a I . ,  2008) .  Another study in  iso lated rat heart prov ided d i rect ev idence of the 
potent ia l  card ioprotecti ve  ro le of endocannabinoids and AEA-related mediator 
s igna l i ng in ischem ia-reperfusion injury was invest igated ( Lepic ier, et a l . .  2003) .  
I nterest ing ly ,  i t  was shown that perfusion w ith PEA and 2-AG, but not AEA, 
decreased myocard ia l  damage in i so lated rat hearts. I n  addi t ion, i nfarct s ize was 
l i m i ted by e i ther a se lect ive C B I  agon ist (arach idonoyl-2ch loroethylam ide; 
ACEA) or a se lect ive CB2 agon ist ( J W H O I 5) .  However, PEA is s
upposedly 
i nact i ve at CB I and C B2 receptors, a fact supported by the find ing that PEA was 
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devoid of  a t i \  i t}  w hen adm in i tered to rat isolated heart ( Ford , et a I . ,  2002) .  I n  
contra t .  A cau e negati e i notropy and  coronary vasod i latat ion in  rat isolated 
hearts ( Ford ,  et a l . .  2002) .  It i therefore interest ing that A EA fa i led to reduce 
myocard ial  i n farct ion inj ury wh i le  PEA and 2 -AG were effect ive .  In a subsequent 
tud) in i so lated rat heart ,  however. A EA perfusion reduced the infarct s ize, 
which 'v'v as blocked by e i ther C B I  or C B2 antagon ism . us ing SR 1 4 1 7 1 6A or 
SR 1 44528 ,  respect i e ly .  However, us ing Arach idonoyl cyclopropylam ide 
(ACPA : C B I  agon i st )  and J W H - 1 33 (CB2 agon ist) cou ld  not m i m ic the effect of 
EA. sugge t i ng the in o lvement of a novel cannab inoid s i te of act ion 
( Underdov. n. et a I . ,  2005 ) .  
Ac t i  at ion of CB2 receptors In i nflammatory cel l s  and endothel i um has 
been suggested to atten uate TN F-a- i nduced endothe l ia l  i nflammatory response, 
chemotaxis ,  and adhes ion of i n flammatory cel l s  to the act i vated endothe l i um. 
ubsequent re l ease of various pro in flammatory med iators ( key processes involved 
i n  the in i t iat ion and progress ion of atherosc lerosis, restenos i s  and reperfusion 
i nju r� ) (Mach.  et a I . ,  2008; Pacher and H asko 2008),  and smooth musc le 
pro l i ferat ion have a lso been proposed to be decreased after the act ivat ion of CB2 
receptors ( Raje h .  et a I . ,  2007) .  However, the ro le of myocard ia l  CB2 receptors 
dur i ng i schemia-reperfusion and other card iovascu lar pathologies is current ly not 
wel l  establ i shed. 
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The main objectives of the current study are :  
I .  To te t the effects of AEA on contract i l i ty and Ca2+ s igna l i ng In rat 
entricu lar myocytes. 
2. To test the effects of AEA on the character ist ics of card iac action 
potent i a l .  
3 .  To  study the  effects of A EA on  card iac vol tage-act i vated inward Na + ( INa) 
and Ca2+ (h,ca) currents, which are the major i nward currents shaping the 
act ion potent ia l  in ventricu lar myocyte . 
4 .  To study the e ffects of A EA on  card i ac sod ium-ca lc ium exchanger (NCX) .  
56  
2. MAT E R I AL S  AN D METHODS 
2 . 1  Experimenta l  a n i m a ls 
The \ ork was performed w ith approval of the An imal Research Ethics 
omm i ttee of  the Co l lege of Med ic ine and Health Sc iences (A I  A in ,  U AE).  The 
or ig ina l  stock of W istar rats were purchased from Harlan Laboratories (Oxon, 
England) .  An ima ls  were bred at our own An imal  Fac i l i ty from the original stock. 
The an ima ls  were housed i n  polypropylene cages (43  x 22 .5 x 20 .5  cm;  s ix  rats/ 
cage) i n  c l imate and access contro l led rooms (22 -24 °C : 50 % humid ity). The day/ 
n i ght cyc le was 1 2  hl l 2h .  Food and water were prov ided ad libitum. The food \\ as 
standard maintenance d iet for rats purchased from Emi rates Feed Factory (Abu 
Dhabi , U AE) .  
2.2 Ven tricu lar  myocyte isolat ion 
Ventr icu lar myocytes were iso lated from adu l t  male Wistar rats (264 ± 1 9  
g) accord i ng to prev ious ly descr ibed techn ique (Howarth .  et a l . ,  2002).  The 
an i ma ls  were euthan ized us ing a gui l lot ine and hearts were removed rapid ly  and 
immersed in cold perfusate to l im i t  any ischem ic i njury dur ing the period between 
excis ion and the restorat ion of vascu lar perfus ion.  Having c leared extraneous 
t i ssue, the aorta was carefu l l y  eased over the tip of the cannu la  and mounted for 
retrograde perfusion accord ing to Langendorff method. The Langendorff 
apparatus (F igure 2 . 1 )  employed a ro l ler (perista l t ic)  pump (M in ipuls3,  G i lson, 
France) which was set to del i ver i so lat ion so lut ion at a constant flow rate ( 8  
m llm i nute/g weight of t i ssue) and at 36-37 ·C with a solut ion conta in ing (mM) :  
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Fig u re 2 . 1  Langendorff a ppa ratus :  Arrangement of the system (upper pane l ), 
heat exchanger and heart warm ing jacket ( lower left panel )  and cannu lated heart 
( lower right pane l ) .  
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1 30 aC I ,  5 . 4  K I .  1 .4 MgCI2 • 0 .75 CaCb. 0 .4 aH2P04• 5 HEPE , 1 0  gl ucose. 
20 taur ine ,  and 1 0  creat ine set to pH 7 .3  with aOH .  
Once the heart contract ion had stabi l ized. perfus ion was cont inued for 4 
m inutes wi th  Ca2+ -free i so lation olut ion conta i n ing O. I m M  EGTA, and then for 
6 m inutes with ce l l  isolat ion so lut ion conta i n i ng 0 .05 m M  Ca2+, 0 .75 mg/m l 
col l agenase ( type 1 ;  Worth i ngton B iochem ical  Corp, U SA)  and 0.075 mglm l 
protease (type X I V ;  S igma. Gennany). Ventr ic les were then excised from the 
heart, m i nced and gent ly shaken in  a col lagenase-conta in ing isolat ion so lut ion 
supplemented w ith 1 % BSA for 4 m inutes at 36-37 0c.  The suspension was then 
fi l tered through a nylon mesh ( pores of 300 11m). Tissue remain i ng in  the nylon 
mesh \ as re-suspended in col lagenase-conta in ing i so lat ion so lut ion supplemented 
with 1 % B SA and shaken for 4 m inutes at 36-37 0c.  The fi ltrate suspension of 
cel l s  was centr i fuged at 400 rpm for I minute. ubsequent ly. the supernatant was 
removed and the ce l l  pe l l et v. as re-suspended in iso l at ion so l ut ion conta in ing 0 .75 
m M  Ca2+ . Th i s  process was repeated four t imes. Ventricu lar myocytes were 
col lected from second. th i rd and fou rth shakes and stored at 4 0c . Experiments 
were perfonned in ventr icu lar myocytes that d isplayed rod-shaped morphology 
and regular striat ions ( F i gure 2 .2) .  
2 .3 Measu rement  of ven tricu la r  myocyte shorten i ng  
Shorten ing of myocytes was recorded us ing a v ideo edge detection system 
(YED- l 1 4, Crystal B iotech .  U SA)  ( F i gure 2 .3 ' for the arrangement of the 
recording  system used for v ideo edge detect ion experiments) . This system is used 
for measuring  the length or width of ce l l s  or sma l l  t i ssues in rea l -t ime.  The v ideo 
edge detect ion system was composed of a h igh-speed v ideo camera ( Myotrac, 
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ry tal B iotech.  T. ), an analog dual -edge detector ( VED- 1 1 4. Crysta l 
B iotech.  ). a data logging de ice (CED- 1 40 I +. Cambridge E lectronic Design. 
ambridge. Cambridge. U K ), a PC and a mon i tor. The s stem is  able to record up 
to 240 length mea urements per second .  
Figu re 2 .2 M icrographs of ventr icu lar  cel ls :  The upper panel  shows a co l l ection 
of v iable ( rod-shaped) and nonviable ( round-shaped) ventr icu lar myocytes. The 
lower panel shows a s ingle fresh ly  i so lated ventricu lar myocyte. Myocytes were 
typica l ly  80- 1 20 )lm in length.  
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Fig u re 2 .3 The  record ing  system used for v ideo edge detection and  Ca2+ 
imagin g  experi ments :  The system inc ludes an ant i -v ibrat ion table (A) ,  a Faraday 
cage ( 8), an inverted m ic roscope (C), a ce l l  superfusion system (D) with a 
temperature contro l system ( E ), a v i deo edge motion detector ( F), a 
m icrofluorescence photometry system (G)  and an e lectrica l  st imu lator ( H ) . 
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Ventri u lar myocytes were fi rst a l lowed to sett le  on the glass bottom of a 
Per pex chamber mounted on the stage of an i nverted microscope (Ax iovert 35 .  
Zeiss. German ) .  Cel l s  were then e lectrica l l y  st imu lated at I Hz to  produce 
contract ion b means of t\ 0 plat i num electrodes pos i t ioned around the 
c i rcumference of the chamber and connected to an electrical st imu lator (SD-5 .  
Grass l nstruments. U A) .  Us ing a m icroscope equipped wi th  a h igh-speed 
camera. the ce l l  is pos it ioned so that the ax is  of contract ion runs from left to right 
on the ideo screen .  The cursors were pos i t ioned over the edges of the ce l l  (F igure 
2 .4 ) .  The raster l i ne was adjusted to move the cursors upwards or downwards. The 
edge detector triggers on the fi rst large wh ite/black or black/whi te transit ion 
wi th i n  the left cursor and the last wh i te/black or black/whi te transi t ion i th i n  the 
r ight cursor. \ i tches set the des ired transi t ion type (b lack/wh ite or wh ite/b lack) 
and the threshold for each cursor. Under these condit ions, s l ight ly defocusing the 
cel l image can enhance the edge contrast. A wh ite dot w ith in  each cursor shows 
the edge as detected by the system . An analog voltage output proport ional to the 
d i stance between the two edges is conveyed to the data logging dev ice 
(CE D 1 40 I +, Cambridge E lectron ic Design,  Cambridge, UK),  and to the 
computer. Data were acqu i red and analyzed w ith S ignal Averager software v 6 .37  
(Cambridge E lectron ic Design,  U K) .  
M yocytes were superfused (3-5 m l/m i n )  w ith normal Tyrode (NT) 
conta i n i ng  ( i n  m M ) :  1 40 NaC I ,  5 KCI ,  1 MgCb, l O  g l ucose, 5 H EPES and 1 . 8 
CaC b  (pH 7 .4) .  I n flow of superfusate to the chamber was contro l led by two 
m icropumps ( P07002-39/P07002-33 ,  Cole-Parmer, USA) .  Outflow and the level 
of flu id  in the chamber was contro l led by a glass tube d ipping i nto the chamber 
and connected to a waste bott le  wh ich in tum was connected to a serv ice vacuum 
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F ig u re 2.4 Video edge motion  detect ion : The upper panel shows the ideo edge 
motion detector. The lower panel shows a ventricu lar myocyte with v ideo edge 
cur ors pos i t ioned across the edges of the cel l .  
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l i ne. The temperature of the chamber so lut ion was regu lated b a temperature 
control ler (TC-20, P I ,  Germany). \ h ich comprised a heat ing co i l  wound around 
the i n flow l i ne, a therm istor located in the chamber and the contro l  system.  
Re t i ng ce l l  length (R  L ), t ime to  peak (TPK)  shorten ing. t ime from peak to  ha l f  
re l axat ion (TH \LF) and ampl itude o f  shorten ing (expressed as a % o f  rest ing ce l l  
length)  were mea ured under these cond i t ions. 
2.4 Western i m m u noblot assay 
Ventr ic le ", ere obta i ned from normal W i star rats as described earl ier in  
ect ion 2 .2 .  I n  the  first step. t i ssue samples were flash-frozen in  l iqu id n i trogen 
and tored at -80 °C for later use. After thawing, t i ssue extracts were prepared by 
homogen izat ion on ice with R l PA buffer (P i erce B iotechnology, I L, USA) 
supplemented with protease i nh ibi tors ( Roche, GmbH, IN ,  U SA).  Later, the 
extracts were c lar i fi ed to remove the cel l u lar debri s b centr i fugation at 1 3000 
r.p .m .  for I S  m inutes at 4 0c . Protein content in the extracts was determ i ned us ing 
the Lowry assay (B ioRad).  A measure of 50 /lg prote in  was resolved in  1 2  % 
DS-PAGE and was transferred onto n i trocel l u lose membranes (GE Heal thcare, 
U K) .  B lock ing  was performed for 2 hours at room temperature w ith 5 % non-fat 
sk immed m i l k  powder prepared i n  phosphate buffer so l ut ion ( PBS)  conta in ing 0. ] 
% Tween 20 ( igma, CA, U SA) .  After wash ing w ith phosphate-buffered sa l i ne 
0. ] % Tween 20 ( PBST), the membranes were probed wi th e i ther rabbit 
polyc lonal  C B I  (Cayman Chem icals,  I :  1 000 d i lut ion) or with an ant ibody ra ised 
aga inst the last I S  res idues of rat C B I  or CB2 ant ibody (Cayman Chemicals, 1 :  
1 000 d i l ut ion)  overn i ght at 4 0c . A fter subsequent wash ing w ith PBST, the 
secondary anti body (goat ant i - rabbit) coupled w ith H RP (horserad i sh perox idase) 
(G£ B iosc iences, U K )  was added and the blots were incubated at room 
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temperature for I hour. Later. the membranes ere de e loped uSing a 
chem i l um ine cence detect ion k i t  ( uper igna l -West P ico ubstrate, P ierce). To 
confinn un i fonn load ing, the membranes were stri pped and re-probed w i th �-act i n  
(Chem icon. CA,  USA) .  
2.5 Measu remen t of i n t racel l u l ar  Ca2+ con cen tration 
In order to measure i ntrace l l u lar Ca2+ concentrat ion,  ventr icular myocytes 
ere loaded \ i th  the fluorescent ind icator fura-2 AM (F - I 22 I ,  Oregon, Molecu lar 
Probes, U A) (Howarth, et a I . ,  2002) .  Fura-2, a polyam ino carboxyl ic acid. i s  an 
u l tra v io let l ight-exc itable rat iometTic Ca2+ ind icator. In i ts salt fonn, fura-2 can be 
i ntroduced i n to the cel l by m icro inject ion.  As an acetox meth I (AM) ester. it can 
pa s ive ly  d i ffuse across ce l l  membranes. Once i ns ide the ce l l ,  the esters are 
c leaved by i ntrace l l u l ar esterases to y ie ld cel l - impermeable fluorescent i nd icators. 
Upon b ind ing to Ca2+, fura-2 AM exh ib i ts an absorpt ion sh ift that can be observed 
by scann i ng the exc i tat ion spectrum at wavelengths between 300 nm and 400 nm, 
v .  h i le mon i tor ing the fl uorescence emission at wavelength � 5 1 0  nm. 
The fluorescence photometry system was used to generate exc itat ion l ight 
and col l ect em i ss ions (Ca i rn Research, Kent, UK) .  A monochromator, compri s ing 
the l ight source (75 W Xenon arc l amp), rapid galvanometer d i ffract ion grating 
and automated ex i t  s l it generated exc i tat ion l ight of requ i red wavelength ,  
bandwidth and i ntensi ty. I n  the  case of fura-2 AM,  the  exc i tat ion l ight a l ternated 
rapid ly  between 340 and 3 80 n m .  The l ight was transm itted from the source v ia a 
l iqu id  l ight guide and various m i rrors and a FLUAR 40xJ 1 .30 (u l trav io let 
transmit t i ng) o i l - immersed object ive to the fura-2 AM loaded cel l .  A 400 nm long 
pass d ich ro ic  fi lter reflected l ight < 400 nm to the cel l .  L ight em i tted from the ce l l  
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was d i rected through the bjective and through a 600 nm long pass d ichroic fi l ter 
\ h ich  transm itted red bright fie ld l ight > 600 nm to a h igh-speed v ideo camera 
( Myotrac, Crystal B iotech.  UT U A) so that the ce l l  cou ld be v isual ized on a 
mon i tor. F i nal ly  fl uorescence l ight < 600 nm was d i rected v ia  a 480 nm long-
pa emiss ion fi lter to a b i -a lka l i  photomu l t ip l ier tube (C I 5 1 ,  Cairn Research, 
Kent U K )  and thence. as a h igh voltage s ignal ,  to the contro l  system (C208, Cairn 
Research.  Kent.  UK) .  The contro l  system co l lected 340 and 380 nm signals and 
generated a rat io  (340/380 nm)  s igna l .  These s ignals were conveyed via a data 
logging dev ice (CED- 1 40 1  +. Cambridge E lectron ic Des ign. Cambridge, UK)  to 
the computer for process ing and for d isplay on the computer mon itor. The 
340/3 80 fura-:2 AM rat io prov ided the i ndex of i ntrace l l u l ar Ca2+. 
I n  our experi ments, 6 .25  II I of a J mM stock solut ion of fura-2 AM 
(d i sso lved in DM SO) \: as added to 2 .5  m l  of cel l s  to give a final  fura-2 AM 
concentrat ion of  2 . 5  11 M .  Myocytes were shaken gent ly for 1 0  m i nutes a t  room 
temperature .  A fter load i ng, myocytes were centr ifuged, washed wi th normal 
Tyrode to remove extrace l l u lar fura-2 AM and then le ft for 30 m inutes to ensure 
comp lete hydrolys is  of the i ntrace l l u lar ester. I n  order to measure i ntrace l l u lar 
Ca2+ concentrat ion .  myocytes were a l ternate ly i l l um inated by 340 nm and 380 nm 
l ight us ing a monochromator (as ment ioned earl ier) which changed the exc itat ion 
l ight every 2 m i l l i seconds. The resu l t i ng fluorescence em it ted at 5 ]  0 nm was 
recorded by the photomu l t ip l ier tube and the rat io of the em i tted fluorescence at 
the two exc i tat ion wavelengths (340/380 rat io) was ca lcu lated to provide an i ndex 
2+ . of i ntrace l l u lar Ca concentrat IOn .  
Data were acqu i red and analyzed with S ignal Averager software v 6 .37 
. K C 2+ . (Cambridge E lectron ic  Design, UK) .  Rest ing fura-2 rat io TP a tranS ient ,  
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TI lAlF deca) of  the ' -'-a- tran ient. and the ampl itude of the 
measured in e lectrica l l  st imu lated ( I  Hz) myocytes. 
2.6 Measu remen t of a rcopla m ic ret icu l u m  Ca2+ con ten t 
a2+ tran ient were 
arcopla m ic  ret icu lum (SR)  Ca2+ re lease was a sessed us ing prev iously 
de cr ibed techn ique ( Howarth,  et aI . ,  2002 ; Bassan i .  et a l . .  1 995) .  fter 
e tabl i sh i ng stead tate Ca2+ transients in electrica l l y st imu lated ( I  Hz) myocytes 
maintai ned at 3 5-36 ·C and loaded wi th  fura-2 ,  st imu lation was paused for a 
period of 5 seconds.  Caffe i ne (20 m M )  was then appl ied for 1 0  seconds using a 
solut ion switch ing device custom ized for rap id so l ut ion exchange. E lectrical 
st imu lat ion was resumed and the Ca:!+ trans ients were a l lowed to recover to steady 
tate Ie el . SR-re leasable Ca2+ was assessed by measuring the area under the 
curve of the caffe i ne-evoked Ca2+ transient .  Fract ional re lease of R Ca2+ was 
as e sed by compari ng the ampl itude of the e lectrica l ly e oked steady state Ca2+ 
trans ients i th  that of the caffe i ne-evoked Ca2+ transient and refi l l i ng of R was 
assessed by measuri ng the rate of recovery of e lectrica l l y  evoked Ca2+ transients 
fo l lowing app l icat ion of caffe i ne .  
2 .7  A sessment  of myofi lament  sens i t iv ity to Ca2+
 
In some ce l l s  shorten ing  and fura-2 rat io were recorded s imu ltaneou ly.  
Myofi lament sens i t iv ity to Ca2+ was assessed from phase-plane d i agrams of fura-2 
rat io vs. cel l length by measuring the grad ient of the fura-2-cel l length trajectory 
dur ing late re laxat ion of the twitch contract ion (Spurgeon, et a l . .  1 992).  The 
posi t ion of the trajectory reflects the re lat ive myofilament response to Ca
2+ and 
hence, can be used as a measure of myofi lament sens i t iv i ty to Ca
2+ . 
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2.8 Elect rophys iologica l record ing  of '\ hole-ce l l  cu rren ts ( Patch c lamp 
tech n iq ue) 
2.8.1 Pipet tes 
The p ipettes for record i ng i n  entricu lar  myocytes were fabricated from 
fj lamented B F  1 50-86- 1 0  boro i l icate glass (00= 1 .5 mm.  1 0= 0.86 mm, Sutter 
I n struments Co .. CA, U ) us ing a horizontal pu l ler ( Sutter I nstruments Co. ,  CA, 
U ). I n  order to get a good contact between the e lectrode and the ce l l  membrane 
w ithout damaging the ce l l  membrane. the e lectrode t ips were fi re-po l i shed us ing a 
m icroforge (Ze iss I D03.  Germany) .  E lectrode res istance ranged between 2 .0 and 
4.0 MO as as essed in our standard p ipette and extrace l l u lar so lut ions using the 
pClamp 1 0  software .  
2.8.2 Seal Penetration 
Whole-ce l l  vers ion of the patch c l amp techn ique was used to measure ion 
currents ( see F igure 2 . 5 : for the arrangement of the patch c lamp setup). Cel ls  were 
mounted on the stage of an i nverted phase-contrast m icroscope (N i kon d iaphot, 
Tokyo, Japan ) .  The output s igna l s  were fi l tered at 5 KHz with an 8 pole fi lter, and 
stored on the hard d i sk of a computer for off- l ine analysis .  The p ipette, which had 
a sma l l  pos i t i ve i nternal pressure in order to keep the t ip  c lean ,  was pushed gent ly 
onto the ce l l  surface by us ing a three-ax is  m icroman ipu lator (ACCi  U I ,  
c ient ifica, U K ) . A t ight seal (g igasea l )  between the membrane and the t i p  o f  the 
p ipette ( 1 - 1 0  GO) was obtai ned by the appl icat ion of suct ion through the p ipette. 
Further suct ion d i srupted the membrane under the t ip  of the p ipette a l low ing the 
p ipette sol ut ion to d ia lyze the cel l ( F igure 2 .6) .  The experiments were carried out 
at room temperature (22-24 0c) in order to ensure a longer surv ival t ime of 
patched ce l l s  and a better t ime resol ut ion of the membrane currents. 
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Fig u re 2 .5  Patch c la m p  experimental set u p :  The patch pipette with i nternal 
recoring  e lectrode (A)  and reference e lectrode (B )  are connected to the headstage 
(C)  which is mounted on a m icromanipu lator (D). I so lated ce l l s  are v i sual ized 
with an i nverted l ight m icroscope ( E) .  The m icroscope, the m icroman ipu lator. and 
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head tage are p laced on an ant i - ibrat ion table (F )  to i o late these component 
from v ibrat ions that ma interfere with gigaseal format ion and placed i n  a Farada) 
cage (G) to h ie ld  the setup from ambient e lectrical noise .  The flow of the currents 
i nto the p ipette can be recorded us ing a h igh ly  ens i t i  e amp l ifier (H )  \ hich IS 
connected to an analog to d ig i ta l  con erter (d ig i t izer) ( I ) ,  where the s ignal IS 
d igit ized and sent to a computer for data analys is .  A computer creen ( J )  is used 
for mon itor ing experiments and for data d i sp lay .  
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Fig u re 2.6 Schematic p resen tation of w hole cel l con figu ration of patch c la m p  
tech n ique. 
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The membrane currents of card iac entricu lar m Oc)1es were recorded 
us ing an xopatch 2008 ampl i fier  (Mo lecu lar De ices, Down ington , P ,  A)  
I i nked t an AID interface ( Dig idata 1 322;  Mo lecular Dev ices) connected to an 
I B M  computer. 
Cel l that had stable currents from the th i rd to fifth m inutes after 
penetrat ion of the membrane were used in  the majority of our experiments. Drugs 
\ ere tested once the whole-ce l l  current had reached a stable level (usua l l y  1 0  
m inutes after obta in ing the whole-cel l configurat ion) .  A series of vol tage steps 
were appl ied to determ ine the current- oltage re lation h i p. D i fferent drugs were 
then added d i rect l y  to the bath solut ion and the change in the magni tude of current 
was mon itored cont inuously. I n  some cel ls  the bath so lut ion was changed to 
assess the recovery after washout of tested compound. 
The rate of so l ut ion flow to the record ing chamber was contro l led by two 
m icropumps (M icropump I nc . ,  WA,  U A) .  Changes of external so lut ions and 
appl icat ion of drugs were performed us ing a mu l t i - l ine perfusion system w ith a 
common outflow connected to record ing chamber. E lectrophys io logical data were 
analyzed us ing pC lamp 1 0 .2 (Mo lecu lar Dev ices, Un ion C ity, CA) and Orig in  7 .0 
(Orig i nLab Corp., orthampton, MA)  software. The ampl itudes of the currents 
were normal ized to ce l l  membrane capac i tance (nA/pF) .  
2 .8.3 Measu rement  of act ion potent ia ls 
2.8.3 . 1  P rotocol for measu r ing  action poten t ia ls 
APs  were measured us ing the current c lamp mode of the ", hole-ce l l  patch 
c lamp techn ique.  A fter g iga seal format ion, the membrane was ruptured with 
gent le suct ion to obta i n  whole ce l l  configurat ion.  The generation of A Ps was 
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e oked b 0 .9- 1 nA dep lar iz ing current pu lses of 4 ms duration app l ied at a 
frequenc f 0.2 Hz. During a typical experiment, the fol lowing protocol was 
employed : fi r t, \ hole- e l l  configurat ion was establ i shed and 4 to 5 minu tes 
d ia l }  i of the myoc)1es " i th p ipette so l ut ion was a l lowed to ensure the 
equ i l ibr ium cond it ions between the p ipette solut ion and in trace l l u lar m i l ieu .  
ubsequent to ach iev ing table record i ngs of base l ine e lectrical act i v i ty (V rest and 
P parameter ). myocyte were exposed to the tested drug for 1 0  to 1 5  m inutes 
and sub equent l )  it \va washed out .  
2 .8.3.2 Sol u t ions  
Bas ic  extrace l l u lar sol u t ions used for e lectrophysiological record ings 
contained ( i n  mM) : 1 44 NaC I ,  5 .4 KC I ,  1 . 8 CaC I 2, 1 .2 MgC I2 , I NaH2P04, 1 0  
H EPES.  1 0  gl ucose. and pH 7 .4 (adjusted with NaOH) .  Recording patch pipettes 
v" ere fi l led wi th i ntrace l l u lar so l ut ion conta in i ng  ( in mM) :  1 0  KCI ,  1 0  KOH, ] 05 
K -aspartate. 1 5  aCL 1 MgC b .  1 0  H EPES, 4 Mg-A TP, 5 Sucrose, and pH 7 .2 
(adjusted \\ i th  HC I ) . 
2.8A Meas u remen t of Na + cu rren ts 
2.804. 1 Protocol for measu ri n g  Na  + cu rrents 
For record ing of sod i um currents ( iNa), data were e l ic i ted from a hold ing 
poten t ia l  of -80 m Y  and depo larized wi th 50 ms pu lses to +60 mY in  1 0 m V 
increments every 1 0  seconds. Steady-state acti vat ion ( SSA) curves of INa before 
and after AEA appl icat ion were deri ved by fit t ing the respect ive current-vol tage 
re lat ionsh i p  ( i- V) with the product of Bol tzmann equation which describes 
vol tage-dependence of SSA.  This a l lowed us to determ i ne if the drug in fl uences 
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the parameter of iNa A,  the o l tage of ha lf-max imal  act i \  at ion (V 1 12 ) and the 
lope factor (k) .  
The conductance was calcu lated us ing the fol lowing equat ion .  G = J/(Vm -
VreJ, \ here I i the current ampl itude. V m i s  the test potent ia l  and Vre, is the 
re ersal potent ia l . The correspond ing steady-state act i vat ion curves were obtai ned 
by norma l i z i ng the conductance to the peak conductance. The norma l i zed 
conductances ( G/Gmax) were then p lotted agai nst the test potent ia l s  and fitted 
\V i th  the Boltzmann equation : 
G /Gmax= J /  l +exp[-(Vm-V I /2)1 k] 
\\ here V 1 11 i s  the vol tage at ha lf-max i mal  conductance and k i s  the slope factor. 
I n  order to determ i ne if the drug influences the propert ies of VGSCs 
i nact i  at ion. we compared steady-state i nact i vat ion (SS J )  dependencies of i a in 
the absence and presence of tested drug. SS I  curves were acqu i red US l llg a 
tandard o l tage protocol cons i st ing of a prolonged (400 ms) precondi t ion ing 
pu lse to various V m i n  the range of - J 00 m V to +70 m V which was immed iate ly 
fo l lowed by the constant iNa act i vat i ng test pu lse to V m= -20 m V. SS I -dependency 
\\ as p lotted as norma l i zed ampl i tude of INa at V m= -20 m V against the value of  
cond i t ion ing V m .  Current ampl i tude was normal ized to  the  peak CUlTent ( Il l  max). 
and p lotted against each cond i t ion ing potent ia l .  The steady-state inact ivation 
cur es were fi tted with the Bo l tzmann function 
I / lmax= J /  l +exp [ (Vm-V \I2)/ k] 
where V 1 12 i s  the voltage at which ha lf  the channels are ava i lable for open i ng, and 
k is the s lope factor. 
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2 .8.4.2.  o lu t ion 
xtrace l l u lar o l ut ion for record i ng of INa consi sted of ( in mM): ] 00 
TEA I, 40 NaC I ,  1 0  G lucose, I MgCb.  5 CsCI ,  0. 1 CaC I2 , I iCb ,  and 1 0  
H E P  (adjusted to p H  7 . 3  \ i th CsOH) .  I ntrace l l u lar solut ion conta i ned ( i n  m M )  
1 35 CsC I .  5 aC I ,  1 0  EGTA. ] 0  H EPES and I MgATP (adjusted to pH 7 .25  with 
CsOH) .  
2 .8.5 M easu remen t of L-type Ca2+ cu rrents 
2.8 .5 . 1  Protocol for measur ing  L-ty pe Ca2+ cu rrents 
For record ing of Ca2+ currents (h.ca). data were e l ic ited from a hold ing 
potent ia l  of -50 m V to membrane potent ia ls  ranging from -70 m V to +70 m V in 
1 0 m V increments for 300 ms. E l i m i nation of contam inat ing INa dur ing record ing 
of Ica was ach ieved by apply ing vol tage step-pu lses from re lat ively depolarized Vh 
of -50 m V .  which produced steady-state INa i nact ivat ion . 
The conductance a calcu lated using the fol lowing equation, G = J/( Vm -
Vrev) ,  ", here I is the current ampl i tude, V m i s  the test potent ia l  and Vrev i s  the 
reversal potent ia l .  The correspond ing steady-state act i vation curves were obta ined 
by norma l iz ing the conductance to the peak conductance. The normal ized 
conductances ( G/Gmax) were then p lotted agai nst the test potent ia ls  and fitted 
wi th  the Bo l tzmann equat ion : 
G /Gmax= l /  ] +exp [-(Vm-V Id! k] 
where V 1 /2 is the vo l tage at ha l f-max ima l  conductance and k i s  the s lope factor. 
The steady-state inact i vat ion curves were obta i ned us ing a standard 
vo l tage protocol ,  i n  wh ich I second precond i t ion ing pu lses from a hold ing 
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potent ia l  of -50 m "'" ere e l i c i ted in  the vol tage range of -70 mV to +70 mV i n  1 0  
m V  increment \\ h ich \: as immed iate ly  fol lo\ ed by the constant h.ca act ivat ing 
test pu l  e to Vm= + 1 0  mY. S I -dependency was p lotted as normal ized ampl itude 
of h.ca at Vm= + 1 0  mV agai nst the value of cond i t ion i ng Vm. Current ampl itude 
\ a normal ized to the peak current ( II I  max), and p lotted against each condi t ion ing 
potent ia l . The steady-state i nact i  at ion curves were a lso fitted \ i th the Boltzmann 
funct ion, 
I I lmax= 1 /  J +exp [ (Vm-V I /2)/ k ]  
where V I ·� i s  the  vo l tage at \: h ich ha lf  the channels are ava i l able for open ing. and 
k is the s lope factor. 
2.8 .5 .2 Solu t ions 
I n  order to prevent the ce l ls from contract ing dur ing patch i ng, the were 
fi rst patched i n  a Ca2+ free so l ut ion which cons isted of ( in mM) :  1 20 aC I .  1 
EGTA. ] 0  MgCh ,  1 0  G lucose, 1 0  H EPES,  I NaH2PO.j and 5 KC I .  Once the hole 
cel l configurat ion was obta i ned, the recod ing solut ion was appl ied .  The whole-cel l  
bath solut ion conta ined ( i n  mM) :  9 5  NaC I ,  5 0  TEAC I ,  2 MgCb ,  2 CaC\:!,  1 0  
HEPE and ] 0 G lucose (adjusted to  pH 7 .35  w i th  NaOH) .  The p ipette so l ut ion 
conta i ned ( i n  m M ) :  1 40 CsC I ,  1 0  TEACI ,  2 MgCb,  2 H EPE I MgATP and 1 0  
EGTA (adj usted to pH 7 .25  with CsOH) .  
2.8 .6 Meas u rement  of Na +/Ca2+ exch anger cu rren ts i n  card iomyocytes 
2 .8.6. 1 Protocol for measur ing  Na  
+/Ca2+ exchanger cu rren ts 
1 cx was recorded us ing a descending voltage ramp from + 1 00 m V to - 1 00 
m V from a hold i ng  potent ia l  of -40 m V for 2 seconds durat ion. As described 
prev ious ly ( H i nde, et a l .  1 999), INcx was measured as  current sens i t ive to n ickel 
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i2' ) .  Therefore i 2+ - i n  en i t i  e comp nents were subtracted from total currents 
to i o late I ex .  
2.8.6.2  Solu t ion 
The ce l l were first patched in  a Ca2+-free so l ut ion as described prev iously 
( ect ion 2 . 7 .5 .2) .  Extemal so l ut ion conta ined ( i n mM) :  1 50 NaC I ,  5 CsC l ,  2 
aC 12 , 2 MgCb .  1 0  HEPE , 1 0  G luco e (pH=7.4) .  N i fed ip ine ( 1 0  Il M) ,  Ouba in 
( l 00 Il M ). and N i n umic  ac id  (30 IlM) were used to block Ca2+ , Na+-K+ ATPase, 
and cr currents. respect i  e ly .  1 0  mM n ickel ch loride so lut ion was used to block 
J ex.  K+ currents were m in im ized by C + sub t itut ion for K+ in both p ipette and 
extemal sol ut ions.  The p ipette so l ut ion contai ned ( i n  mM) :  1 20 CsC I ,  20 NaCb,  
1 0  TEA C I .  2 MgCI 2 , 1 CaCb,  1 0  H EPES, 1 MgATP and 1 0  BA PTA ( pH= 7 .2  
w i th CsOH ).  The  combination of 1 0  mM BA PTA and 1 mM Ca2+ in  the p ipette 
so l ut ion gave a free [Ca2+] ,  of 20 nM (ca lcu lated with the "Maxchelator program" ; 
W EBMAX v 2 . 1 0, Stanford ,  CA.  USA.  wh ich was suppl ied by Dr. D. Bers) .  
2.9 Biochemica l assessment  of cel l v iab i l ity and mem b rane  i n tegrity of 
ventr icu l a r  card iomyocytes 
2.9. 1 MTT cel l  v iab i l ity assay 
The effect of A EA on cel l v iabi l ity was measured us ing MIT assay 'W h ich 
is based on the reduct ion of 3 -(4 ,5-d imethy l th iazol-2-y l )-2,5- d iphenyl tetrazo l i um 
( MTT) bromide into formazan crysta l s  by the m i tochondrial succi nate 
dehydrogenase of v iable ce l l s .  Cel ls  were p lated in 96-we l l  p lates at a dens i ty 
1 0,000 ce l l s/wel l  i n  a Ca2+-free so l ut ion ( See sect ion 2 .6 .4 .2  for so l ut ion 
composi t ion) .  Ce l l  count was est imated by m ix i ng 20 II I of ce l l s  with 1 80 II I  of 
trypan b lue and count i ng  the number of v iable cel ls us ing a hemocytometer. Cel l s  
were i ncubated for 40  m inutes w i th  or  w ithout tested drug a t  3 7  °c i n  a 5 % CO2 
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hum id i fied atmo phere. 2 � I  of Tri ton X- I 00 (9  % i n  water so l ut ion) per I 00 � I  
or ig ina l  vo l ume was used as  a po i t i  e control to produce ce l l  lysis .  After 
incubat ion.  25  �I of MIT (5  m g/m l )  were added to each we l l  and the p lates were 
incubated for a fU liher 3 h at 3 7 °C . Then the p lates were centri fuged at 1 500 rpm 
� r 5 m i nutes and the so lu t ions were carefu l ly decanted from a l l  the wel ls. The 
� rmazan crysta ls that fonned \ ere then so l ub i l ized i n  a 200 III of DMSO. The 
colored so l ut ion was quant i fied at 5 70 nm us ing Perk in  E lmer Victor-3 
pectrophotometer. The cytotox ic i ty was expressed as percentage over contro l .  
2 . 9 . 2  Homogenous mem brane  i n tegrity assay 
Membrane i ntegrity was assessed us ing the CytoTox-O E Assay 
( Promega, Mad ison. USA) .  Th is  is a rapid,  fluorescent measure of the re lease of 
lactate dehydrogenase ( L D H )  from ce l l s  with a damaged cel l membrane.  The test 
is based on the conversion of resazur in i nto resorufin as shown i n  figure 2 . 7 .  
Generat ion of the fl uorescent resorufin product i s  proport ional t o  the amount of  
L D H .  and therefore t he  number of l ysed ce l l s. Ce l l s  were p lated i n  96-we l l  plates 
at a densi t 1 0.000 ce l l s/we l l  i n  a Ca2+-free so l ut ion (See sect ion 2 .6 .4 .2 for 
solut ion compos i t ion) .  Ce l l  count was est imated us ing a hemocytometer (as 
ment ioned i n  the previous sect ion) .  Cel l s  were incubated for 40 m inutes w ith or 
w ithout tested drug. A volume of CytoTox-ONE Reagent equal to the volume of 
the solut ion conta in ing the cel ls was then added and i ncubated for 1 0  m inutes 
a fter wh ich  a stop sol ut ion was added to each wel l  and the fluorescent s ignal was 
measured. 2 III of Triton X - I 00 (9 % in water so l ut ion) per 1 00 �L 1 orig inal volume 
was used as a pos i t ive control to produce max imum LDH release (ce l l  lys is) .  A l l  
average fluorescence val ues were subtracted from background fluorescence. The 
fl uorescence was recorded with an exc i tat ion wavelength of 560 nm and an 
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Figu re 2 . 7  Release o f  LDH from damaged cel ls :  L D H  release i s  measured by 
supp ly ing  lactate, NAD+, and resazurin as substrates in the presence of 
d iaphorase. Generat ion of the fluorescent resorufin product is proport ional to the 
amount of LDH .  
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emi  s lon wa e length of 590 nm and the percent tox ic it of experimental drug was 
ca lcu lated a � 1 I0w : 
Percent to ic i t  J 00 X (experimental -background) I (max imum lDH re lease-
background) 
2 . 1 0  Prepa rat ion of d rugs and stock sol u t ions 
Experimental so l ut ions were prepared from stocks immed iate ly pr ior to 
each experiment .  Therefore, the cel ls  were perfused with the fresh ly made bath 
solut ions conta in i ng the des i red concentrat ions of the drugs. 
2 . 1 0. 1  A n a n d a m ide  a n d  methananda m ide  
A EA (MW 347 . 5 )  and  metA EA (MW 36 1 .56) were purchased from 
Ascent Sc ient i fi c ,  Cambridge, U K) .  A EA was a l ready d i sso lved in  ethano l ( 5  
mg/m l ) .  The  concentrat ion of A EA 'vvas 1 4 .4 m M .  From th is  stock so l ut ion, 7 il L  
o f  A EA w ere taken to obta i n  a fi nal test concentrat ion of 1 11 M .  S im i larly, 70 II I 
of A EA were taken to achie e a fina l  te t concentrat ion of 1 0  11 M .  Therefore ,  the 
ethanol concentrat ions in  the contro l  and in  presence of AEA were in  the range of 
0.007-0.07 % ( v/v ). MetAEA was a l so d i ssolved in ethanol (5 mg/m l )  and 
metA EA solut ion was prepared in the same way as A EA solut ion .  Stock sol ut ions 
were kept at -20 °C unt i l  the ir  use. 
2 . 1 0 .2  Can nab inoid receptor an tagon ists 
AM25 J ( M W  555 .24)  and A M630 ( M W  504.37) were purchased from 
Ascent Sc ient ific,  Cambridge, U K) .  AM25 1 was d i sso lved in  ethanol ( 8  mg/m l 
ethano l )  to make a fina l  stock concentrat ion of 1 4 .4 mM.  From th i s  stock sol ut ion, 
7 il L were taken to get a fi nal  test concentrat ion of 1 11M .  However, AM630 d id  
not  d i sso lve eas i l y  i n  ethanol and l arger vol umes of ethanol were requ i red to 
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complete l )  d i ssol e i t  (the h ighest concentrat ion of stock so lu t ion of AM630 that 
could be obta i ned \ a 2 mM) .  I n  th i s  case, the final concentrat ion of ethanol 
wou ld  be 0.05 %. Therefore, AM630 was d issolved in  d i methyl suphox ide 
( OM SO) (7 mg/m l )  to get a final stock concentrat ion of 1 4 .4 mM.  From th is  stock 
so l ut ion.  7 II I were taken to get a final  test concentrat ion of 1 11 M .  Stock solut ions 
of AM25 1 and M630 were kept at -20 °C unt i l  the ir  use. 
SR 1 4 1 7 1 6  ( M W  500.25) was purchased from S igma-A ldrich (St . louis, 
MO. U S  ) .  R I 44528  (MW 475 .2 )  was obta i ned through N I DA drug supply 
system ( Ba l t imore. U A). Both drugs were d isso lved in  DMSO. The final 
concentrat ion of  DMSO Ll sed in the experiments did not exceed 0.007 % (v/v) 
( Bonz. et a l . .  2003) .  
2 . 1 0.3 Pertussis tox i n  
PTX was purchased from S igma-Aldrich CSt .  lou is, MO, USA). PTX was 
d i ssolved i n  d i st i l led water and stock so l ut ion of 250 Ilg/500 m l  was kept in the 
refrigerator. Ce l l s  were incubated w ith PTX (2 Ilglm l )  for 3 hours at 37 °C 
(contro l  ce l l s  to th i s  group were incubated in  the same cond i t ions w ith d i st i l led 
water on ly) .  
2. 1 0.4  I n d omethac in  
I ndomethac in  ( M W  357 . 8 )  was purchased from Tocris ( Bal lw in ,  MO. 
USA)  and a stock so l ut ion of  i ndomethac in  was prepared in ethanol . Cel ls  were 
i ncubated w ith 30 11M i ndomethac i n  for 30 m inutes (contro l cel ls  to th is  group 
were incubated i n  the same cond i t ions w ith ethanol only) .  
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2 . 1 0.5  U RB S97 
The FA I I  inh ib i tor RB597 ( M W  338.4)  was purchased from Tocris 
( E l l i sv i l le .  MO. U A). U R B597 was d i ssolved in  ethanol to make a 20 mM stock 
o l ut ion .  e l l  \\ ere incubated with 1 11M U RB597 for 45 m inutes at  3 7 °C 
(contro l  cel ls  to th i  group were incubated in the same cond i t ions with ethanol 
onl ). 
2 . 1 0.6 N-ethy lmalei m ide  
N-ethy lmale im ide (NEM)  (MW 1 25 .3 )  was purchased from S igma-A ldrich 
( St .  Lou i . M O. A ). tock so l ut ion of EM (40 mM)  was prepared in  ethanol . 
Ce l l s  \ ere incubated \\ i th 50 11M EM for 30 m inutes a t  3 7 °C (contro l  cel l s  to 
th i s  group \\-ere incubated in the same cond i t ions w ith ethanol only) .  
2 . 1 0.7  Clen bu terol  
Clenbuterol ( M W  3 1 3 .65 )  was purchased from S igma-A ldr ich C St .  Lou i s. 
MO.  U A )  and \ a d i sso lved in  d i st i l led water. Cel l s  were perfused with 
c lenbutero l  at a concentrat ion of 30  11M .  
2. 1 0.8  B RL -37344 
B RL-37344 ( M W  385 .82)  was obta i ned from Tocris ( Bal lw in .  MO, USA) 
and was d i ssol ed  i n  d i st i l led water. Ce l l s  were perfused w ith B RL37,344 a t  a 
concentrat ion of  1 11 M .  
A l l  mater ia ls  mentioned e l sewhere were purchased from S igma-A ldr ich 
(St .  Lou is .  MO. U SA). 
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2 . 1 1 Data a nalys is  
Each e periment \ as  performed on  several myocytes from d i fferent 
heart . The resu lts of the experi ments were expressed as mean ± tandard error of 
the mean (S .E .M . ) .  tat ist ical s ign i ficance was eval uated us ing pa i red I-test 
(wi th i n  the same cel l analys is) or independent sample (-test and one way A OVA 
fol lO\ ed by Bonferron i Post-hoc analysis ( for ana lys i s  of data from d i fferent 
groups) .  tat i st ica l  ana lys is  of the data was performed us ing Origi n 7 .0 software 
(Or ig in Lab Corp . ,  Northampton. MA)  and IBM SPSS stat i st ics vers ion 20. On a l l  
graphs ( * ) denotes stat ist ical s ign i ficance w i th  P<0.05,  between spec i fied val ues. 
or i f  not spec i fied to the respect ive contro l .  
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3. R E  U LTS 
3. 1 A n a n d a m ide i n h i bi t  ventr icu lar  myocyte horten i n g  
I n  i n i t ia l  contro l  experiments and i n  l i ne with earl ier stud ies conducted 
under s im i lar cond i t ions ( Danziger et a I . ,  1 99 1 ; Delbridge, et a I . ,  2000; Bebarova, 
et a I . ,  20 \ 0), bath appl icat ion of contro l  so l ut ion (NT) conta in ing ethanol at the 
h i ghest concentrat ion used in contract i l i ty studies (0 .07 % v/v ' used as veh ic le  for 
\ 0 11 M AEA)  caused ) 8-20 % i nh i b i t ion of the shorten i ng (n=7- J 0; P<0.05 
compared to 0 t i me point )  in  experiments l ast ing up to 20-25 m inutes in  response 
to e lectrical s t imu lat ion ( I  Hz :  60 pu l ses del i vered every \ m inute). No further run 
do\ n of the shorten ing ampl itudes was observed . However, un less it was stated 
otherw i se. ethano l  wa inc l uded rout ine ly in control so l ut ions during shortening 
and Ca2+ transient experi ments. 
In the fi rst set of experiments, the effect of  AEA on the contract i l i ty of 
acute ly  i so lated rat ventr icu lar myocytes was tested . F igure 3 . 1 A  shows typical  
records of shorten ing i n  an e lectrica l l y  st imu lated ( I  Hz) myocyte superfused with 
e i ther T (conta i n i ng  0 .007 % ethanol  in al l experiments) or NT + \ !-1 M AEA.  
The  amp l i tude of shorten ing was s ign i ficant ly reduced up to  47 .3  ± 2 .6 % of  
contro l  ( n= 1 2- ]  4 ;  P<0 .05)  ( F igure 3 . ] B) ,  when the  concentrat ion of AEA was 
i ncreased in the range of ] 0 nM to 1 0  11M compared to NT. 
The negati ve inotropic effect (decrease of shorten ing ampl i tudes) by AEA 
cou l d  be due to degradat ion products of  AEA such as AA. For th i s  reason, we 
i nvest igated the effects of metA EA, a non hydrolyzable analog of AEA (Abadj i .  et 
a ! . .  1 994) and U R B597,  an i nh ib i tor of FAAH enzyme (Kathuria, et a I . ,  2003 ) .  
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Figu re 3. 1 Effects of AEA a n d  metAEA on ven tricu lar  myocyte horten ing :  
( A) Typica l  records  of  shorten ing i n  an  e lectrical l y  st imu lated ( I  Hz) ventricu lar 
myocyte superfused with e i ther NT or NT + I �l M AEA and dur ing \ ash out wi th 
T. ( B )  Bar graph showing the mean ampl itudes (AMP) of shortening expressed 
as a percentage of contro l a l ues, and i n  presence of AEA ( 1  nM to 1 0  !-1 M) .  Data 
are analyzed us ing ANOV A and are expressed as means ± S .E .M .. n = 1 2- 1 4  
cel l s .  * ind icates stat i st ica l l y  s ign i ficant d i fference at the level of P < 0.05 . (C)  
Bar graph show ing the mean amp l i tudes (AMP) of shorten ing expressed as a 
percentage of contro l  val ues, and i n  presence of metA EA ( J  nM to J 0 !-1M ) . Data 
are analyzed us ing ANOVA and are expressed as means ± S .E .M. ,  n = 7-8 cel ls .  * 
i nd icates stat i st ica l l y  s ign ificant d i fference at the level of P < 0.05 . 
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I n  card iom 0 ytes treated for 1 0  m inutes with 0. 1 - 1 0  flM metA EA ( F igure 
3 .  I ) the extent of inh ib i t ion was  not s ign i ficant ly d i fferent from that of AEA 
(n=7-8;  P>0.05) .  i m i lar ly, pretreatment with I flM U RB597 for 45 m inutes at  37 
DC ( Kathuria. et  a I . ,  2003 ; Amoros, et  aI . ,  20 1 0) d id  not alter the extent of AEA 
i nh ibi t ion ( F igure 3 .2A) .  I n  the absence and presence of URB597 treatment, AEA 
( 1  Il M )  i nh ib i ted m ocyte shorten ing b) 62 . 7  ± 8.4 % of contro l s  and 68.2 ± 4.8 % 
of contro l s, respect ive ly .  There were no stat ist ica l l y  s ign i ficant d i fferences in  the 
i nh ib i tory e ffect of A EA between cont ro l  (NT + 0 .007 % ethanol after 45  m inutes 
pretreatment) and U R B597 pretreated cel l s  ( n=9- 1 1 ;  P>0.05 ) .  We have a lso tested 
whether c c looxygenase products of A EA metabol i tes wou ld  med iate the 
ob e rved act ions of th i s  compound. The resu l ts ind icated that the extent of 
m ocyte shorten ing was not s ign i ficant ly d i fferent after incubat i ng the ce l l s w i th 
30 IlM indomethac in  a c c looxygellase inh ib i tor, for 30 m inutes ( n=8- 1 1 ;  
P>0.05 ) ( F i gure 3 . 2B) .  
Fu rthennore, t he  effect of synthet ic ca ll nabinoid W IN55 ,2 1 2-2 on 
myocytes shorten ing was a lso tested. When compared to AEA,  appl icat ion of 1 
f1M W IN55 ,2 1 2-2 d id  not cause a s ign i ficant a l terat ion in the ampl i tudes of 
myocyte shorten ing (n=7 : P>0.05) .  
A mong other contract ion parameters measured, rest ing cel l length ( RC L) 
was not s ign ificant l y  altered (n= 1 2- ] 4 ; P>0 .05)  by 1 0  m inutes superfusion with 
A EA (1 n M  to 1 Il M ) .  However. increas ing the concentrat ion of A EA to 1 0  IlM 
caused a sma l l  but stat is t ica l ly s ign i ficant reduct ion of RCL i n  about 60 % of cel l s  
tested ( n=  1 2- 1 4 ; P<0.05) .  S im i larly. t ime to  peak (TPK) shortening was 
s ign ificant ly  reduced (n= 1 2- 1 4 ; P<0.05) to 90.2 ± 4.2 /TIS by 1 0  IlM AEA 
compared to 1 04 . 7  ± 1 . 7 ms  in  NT.  
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Figu re 3.2 E ffects of pre i ncubat ion w ith  U RB597 or i ndomethac in  on AEA-
i n d u ced i n h ib i t ion of ventricu la r  myocyte shorten i n g :  (A)  Bar graph showing 
the effect of AEA on the mean amp l i tude ( A M P) of shorten ing expressed as 
percentage of control va l ues in  NT conta in ing 0.007 % ethanol or after 45 m inutes 
i ncubat ion with I 11M U RB597 at 3 7 °C . Data are analyzed us ing ANOV A and are 
expressed as means ± S .E .M . ,  n=9- J J ce l l s .  (B)  Bar graph showing the effect of 
A EA on the mean ampl i tudes ( A M P) of shorten ing expressed as percentage of 
contro l  va l ues in NT conta in ing 0.007 % ethanol or after 30 m inutes incubat ion 
'" i th 30  J-lM i ndomethac in  at 3 7 °C . Data are analyzed using i ndependent sample /-
test and are expressed as means ± S .E .M . , n=8- l l cel l s. 
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3.2 Ven tric u lar  m oc te ex pre s can nab i noid receptors 
I n  order to test for the i n  01 ement of cannabinoid receptor in  the effect 
of  AE on myocyte shorten ing. the express ion of these receptors in  the 
entricu lar  t i ssue \ as confi rmed b We tern blot ana lys is .  F igure 3 . 3  sho s that 
both C B I and CB�  receptors ( M W  about 63 kDa and 40 kDa. respect ively) are 
expressed in the ventricu lar t issue of W istar rats .  
3.3 Ca n nab i noid receptors a re not i n volved in the effect of anandamide on 
myocyte shorten i n g  
To test whether the inh ib i tory effect of AEA on myocyte shorten ing i s  
med iated by  t h e  acti vat ion of  cannabinoid receptors, the effects of  establ ished 
antagon ists of  C B I and C B2 receptors on AEA inh ib i t ion of shorten ing ampl i tudes 
were stud ied . Two structura l l y  d i fferent C B I  receptor antagon ists (AM2S 1 with a 
K I  of  7 . S  n M :  F igure 3 .4A and SR  1 4 1 7 1 6  w ith a K I  of 1 . 8 nM :  F i gure 3 .4B)  
( Pertwee, 2006: Sh i re. et a I . ,  1 999) and two C B2 receptor antagonists (AM630 
w i th a Ki  of  32 . 1 nM; F igure 3 .4C and SR 1 44S28 with Ki  of 0.6 nM: F igure 3 .4D)  
( Pertwee. 2006; Sh i re, et a I . ,  1 999) were tested . At 300 nM concentration. these 
antagonists were not able to reverse the i nh ib i tory effect of AEA on the shorten ing 
ampl i tudes of  card iomyocytes (n=8- ] 2 ;  P>O.OS) .  
S i nce the act ivat ion of both C B I  and C B2 receptors are med iated by G1/0 
sUbtypes of G-prote ins  ( Pertwee, 2006), the effect of inh ibitors of G1/0 prote ins 
such as PTX and N-ethy lma le im ide (NEM) on AEA- induced inh ib i t ion of 
card iomyocyte shorten ing were exami ned (F igures 3 . SA and 3 . SB) .  Pre incubat ion 
of card iomyocytes in e i ther PTX (2  Ilg/m l ,  3 hours at 3 7 °C) or NEM (SO 11M for 
30  m i nutes at 3 7 °C ; (Oz, et a l . ,  2007b» d id  not a lter the extent of AEA inh ib i t ion 
of card iomyocyte shorten i ng (n=9- 1 2 ; P>O.OS) .  
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Figu re 3.3 Expression o f  C B .  a n d  C B2 receptors i n  rat h ea rt :  Expression of 
CB1 and CB_ receptors in the heart of control W istar rats (n= 3 )  were ana Jyzed by 
Western blotting .  
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Figu re 3.4 E ffects of can nab ino id receptor a n tagon ists on AEA- ind uced 
i n h ib i t ion of ca rd iomyocyte shorten i ng :  Bar graphs showing the mean 
ampl itudes (AMP)  of shorten ing expressed as a percentage of contro l  va lues in  
presence of C B I  receptor antagon i st AM25 1 (A), CBI  receptor antagon i st 
SR  1 4 1 7 1 6  ( B) ,  C B2 receptor antagon i st AM630 (C),  and CB2 receptor antagonist 
R 1 44528 C D) .  Data are analyzed us ing ANOV A and are expressed as means ± 
S .E .M . ,  n= 8- 1 2  cel l s  for each group. * ind icates stat i st ica l l y  s ign i ficant d i fference 
at the level of P < 0.05 . 
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Figu re 3.5 E ffect of pertussis tox i n  and  N-ethy lma le imide on AEA-i n d u ced 
i n h i b it ion  of cardiomyocyte shorten ing :  (A)  Bar graph showing the effect of 
A EA on the mean ampl itudes (AMP)  of shorten ing expressed as a percentage of 
contro l  val ues and pertussis tox i n  pretreatment. ( B) Bar graph showing the effect 
of  A EA on the mean amp l i tudes (AMP)  of shorten ing expressed as a percentage 
of control va l ues and -ethy lmale im ide (N EM)  pretreatment. Data are analyzed 
using independent sample I-test and are expressed as means ± S .E .M. ,  n = 9- 1 2  
ce l ls .  
9 1  
I n  order to te t the effecti vene of the experimenta l protocols used to 
In e t igate the ro le of G-prote ins the efficacy of PTX or EM pretreatments on 
c l enbuterol  (B2 adrenergic receptor agon ist)- induced inh ib i t ion of card iomyocyte 
shorten ing a tested . I n  agreement with earl ier stud ies ( i ed lecka. et  a l . .  2008). 3 
hour pretreatment with 2 �g/m l PTX (F igure 3 .6A) or 30  m inutes pretreatment 
\ ith 50 � M  E M  (F igure 3 .6B)  effect ive ly b locked the inh ib i tory effect o f  the �2 
adrenoreceptor agon ist c l enbutero l  (30 � M )  on card iomyocyte shorten ing (n= 1 0-
1 2 ; P<0.05 ) .  
3 ..t  A n a n d a m ide  i n h i b i ts i n t race l l u la r  Ca2+ trans ients 
I n  these experiments, the effect of 1 0  m inutes bath appl ication of 1 fl M 
EA on the rest i ng intrace l l u l ar Ca2+  levels and on the ampl i tudes and k i netics of 
Ca2+ t rans ients e l ic i ted by e lectr ica l -fie ld  st imu lat ion were i nvest igated . Typical 
records of  Ca2+ trans ients in  a myocyte superfused with e i ther NT or NT + I fl M 
A EA and dur ing 'V ashout w ith NT are shown i n  F igure 3 . 7  A .  The effects of  I fl M 
A EA on rest ing fura-2 rat io, TPK Ca2+ transient, T HALF decay of Ca2+ transient, 
and A M P  of Ca2+ transients are shown in  F igure 3 . 7B-E, respect ive ly .  A l though, 
A EA has been shown to a l ter i ntrace l l u lar Ca2+ leve l s  i n  various types of cel l s  [ for 
rev iew. (Goodfe l l ow and G lass, 2009)] .  appl icat ion of 1 flM A EA for 1 0  m inutes 
d i d  not cause a s ign i ficant a l terat ion i n  resti ng  fura-2 rat io  and TPK Ca
2+ trans ient 
( n=2 1 -24 cel ls ;  P>0.05 ) ( F i gure 3 . 7B  and C). However, T HALF decay of the Ca
1+ 
trans ients and A M P  of the Ca2+ transients were s ign ificant l y  reduced by 1 �M 
A EA to  1 1 8 .9 ± 5 . 5  ms  and 0.243 ± 0.032 fura-2 rat io un its compared t o  1 29.3 ± 
5 .2 ms  ( 11=24 ce l ls; P<0.05 ) and 0 .326 ± 0.024 fura-2 rat io units (n =24 ce l l s: 
P<0.05)  in contro ls ,  respect ive ly ( F igure 3 . 70 and E) .  
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Fig u re 3.6 E ffect of p ret reatment  wi th  PTX or N E M  on G-protein med iated 
i n h ib i t ion of cardiomyocyte shorten i n g  by c len bu tero l :  Data are analyzed using 
independent sample  I-test and are expressed as means ± S .E.M . ,  n = 1 0- 1 2  ce l l s. 
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Figu re 3 .7  Effects of AEA on a m pl i tude and  t ime-cou rse of i n t racel l u lar  CaH 
i n  ven tricu la r  myocytes : ( A )  Typ ical records of Ca2+ transients i n  an electrica l ly  
st imu l ated ( 1  Hz)  ventricu lar myocyte superfused wi th  e i ther NT or  T + 1 �M 
AEA and dur ing washout with NT; scale bar ind icates 0 . 1 fura-2 rat io un i t  ( RU ). 
A l so shown rest ing fura-2 rat io (340/3 80 nm) ( B), t ime to peak CTPK) Ca2+ 
transient (C) ,  t ime to hal f (TI IALF) decay of the Ca2+ trans ient ( D )  and ampl itude 
(AMP)  of the Ca2+ transient (E ) .  Myocytes were mainta i ned at 3 5 -36 °C and 
superfused wi th  A EA for 1 0  m i nutes. Data are ana lyzed using pa i red I-test and are 
expressed as means ± S .E .M . ,  n==2 1 -24 ce l l s. * ind icates stat ist ica l l y  s ign i ficant 
d i fference at the level of P < 0.05 . 
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3 .5  A n a n d a m id e  ha no effect on  a rcoplasmic ret icu l u m  (SR) Ca2+ tra n  port 
The effect of I ).1 M EA on Ca2+ transport was in est igated in  myocytes 
e posed to 20 mM caffe ine .  F igure 3 . 8A shows a typical record ing i l l ustrat ing the 
protocol used in the e experiments. In i t ia l ly ,  the myocyte was e lectrica l l y  
t imu lated at Hz. E lectrical t imu lation was then turned off for 5 seconds and 
caffeine was appl i ed for 1 0  seconds us ing a rapi d  solut ion exchanger dev ice. 
E lectrica l  st imu lat ion was then restarted and the recovery of int race l l u lar Ca2+ was 
recorded dur ing a period of 60 seconds. arcoplasm ic ret icu lum Ca2+ content was 
asse sed by measur ing caffe i ne-evoked Ca2+ re lease (area under the caffeine­
e oked Ca2+ transient) ,  and fract ional re lease of Ca2+, by comparing the ampl itude 
of the e lectri ca l l y  evoked steady-state Ca�+ transients with that after caffe ine 
appl icat ion i n  the presence of ei ther NT or NT + 1 11 M AEA .  Fract ional re lease of 
R Ca2+ was not s ign i fi cant ly altered in  the presence of 1 11 M  AEA compared to 
T (0 .749 ± 0.024 in AEA versus 0 . 753 ± 0.028 in contro ls ;  n =23 ce l ls ;  P>0.05 ; 
F igure 3 . 8B) .  The area of caffe ine-evoked Ca2+ transient ( F igure 3 . 8C) and 
recovery of the Ca2+ transient during e lectrical st imu lation fol lowi ng app l i cation 
of caffe ine ( F igure 3 . 8D)  were a lso not s ign i ficant ly  a l tered in  myocytes exposed 
to I ).1M AEA compared to contro l  cel ls  (n = 2 1 -23  ce l l s ;  P>0.05) .  
3.6 A n a n d a m ide  has no  effect on myofi lament  sens i t iv ity to Ca
2+ 
The effects of AEA on myofi lament sens i t iv i ty to Ca
2+ were a lso 
i nvest igated .  These experiments invest igated whether A EA decreases the 
mechan ica l  responses by a l teri ng the affin i ty of  the contract i le mach inery of the 
ventricu lar myocytes to intrace l l u l ar Ca
2+ ( Spurgeon, et aL 1 992).  A typical  
record of myocyte shorten ing and fura-2 rat io and phase-plane d iagrams of fura-2 
rat io versus cel l length i n  myocytes exposed to NT are shown i n  F igure 3 .9A. 
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Figu re 3.8 E ffect  of AEA on sarcoplasmic ret icu l u m  Ca2+ t ra nsport: (A)  
Typica l  record i l lustrat i ng the effects of e lectrical st imu lat ion ( ES) and rapid 
appl ication of  caffe i ne on fura-2 rat io i n  a rat ventr icu lar myocyte. A lso shown are 
mean ampl i tude of SR  fract ional release of Ca2
+ ( B) ,  area under the caffe ine-
evoked Ca2+ trans ient (C )  and recovery of e lectrica l ly evoked i ntracel l u lar Ca
2+ 
after appl icat ion of caffe ine (D) .  Data are analyzed us ing pai red {-test and are 
expressed as means ± S .E .M .  n = 2 1 -23  cel l s . 
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Figu re 3.9 E ffect of A E A  on myofi lament  sens i t iv ity to Ca2+ : ( A) Typical  
records of  myocyte shorten i ng, fura-2 rat io and phase-plane d iagrams of fura-2 
rat io YS .  ce l l  l ength in a myocyte exposed to NT. The arrow ind icates the region 
where the grad ient  was measured . B-D show the effect of I 11M A EA on the mean 
grad ient of the fura-2-ce l l  length trajectory dur ing late re laxat ion of the twitch 
contract ion during the periods 500-600 ( B) ,  500-700 (C) and 500-800 ms (D )  
Data are analyzed us ing paired I-test and are expressed a s  means ± S .E .M . , n = 23 -
30  ce l ls. 
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The grad ient of  the trajector) reflect the re lat i e m ofi lament response to 
C 2+ a and hence. ha been u ed as a measure of myofi lament sens i t i  it to Ca2+ 
( purgeon. et a I . ,  1 992) .  The grad ients of the fura-2-ce l l  length trajectory dur ing 
late re laxat ion of the twitch contract ion , measured dur ing the periods 500-600 ms 
( F i gure 3 .98), 500-700 ms ( F igure 3 .9C), and 500-800 ms ( F igure 3 .9D),  were 
not s ign i ficant ly a l tered i n  the presence of I 11M AEA. suggest ing that 
myofi lament sens i t i  i ty to Ca2+ is not reduced by AEA (n = 23 -30 ce l l s ;  P>0.05). 
3.7 A n a n da m id e  su ppresses the act ion poten t ia ls in ventricu lar myocytes 
Generat ion of the card i ac A P  requ i res a spec i fic temporal act ivation 
pattern of severa l  ion channels .  Anandam ide has been shown to i n fl uence the 
funct ional  propert ies of  these channels e i ther d i rect ly  or ind i rect ly [ for rev iews, 
(Oz 2006; Goodfel low and G lass, 2009») .  Therefore, in th is  set of experiments. 
the effect of  A EA on card iac A Ps was invest igated . In agreement wi th ear l ier 
stud ies i n  rat card iomyocytes ( Danziger. et  a l .  1 99 1 ;  Delbr idge. et a l . .  2000; 
Bebarova. et a l . .  20 I 0). AP wa eforms remained unchanged in the presence of 
ethanol concentrat ions up to 0 .07 % (v/v) .  
Patch-c lamped card iomyocytes were exposed to AEA wh i le  cont i nuously 
mon i toring the i r  Y rest and A Ps in  the current clamp mode. The generation of APs 
was evoked by 0.9- 1 nA depo lariz ing current pu l ses of 4 ms durat ion app l ied at a 
frequency of 0 .2  Hz .  A typica l  exper imental protocol  inc luded : 1 )  the 
establ i shment of the whole-ce l l  configurat ion, 2 )  4 to 5 m inute d ia lysis of the 
myocytes with p ipette so lut ion to ensure equ i l ibr ium cond i t ions between the 
p ipette so l ut ion and intrace l l u lar m i l ieu .  3) record ing of the myocytes basel ine 
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e lectr ical  act i ity fo l lo� ing stab i l izat ion of Vrest and AP parameters, 4 )  expo ure 
of  the myocyte to E for 1 0  to 1 5  m inute and 5 )  \\ a hout of AEA. 
I n  i n i t ia l  e periment , effects of AEA were tested on the pass Ive 
membrane propel1 ie of  card iom ocytes. The passive propert ies of the entricu lar 
e l l s  from contro ls  were not s ign i ficant l  d i fferent from those of the AEA-treated 
ce l l  . Rest i ng membrane potent ia l s  (mean ± SEM) were -76.3 ± 1 . 7 ,  and -74.2 ± 
1 .6 m Y  i n  contro l  (n= 1 1 )  and A EA treated (n= 1 4 ) myocytes. respect ive ly .  The 
mean cel l capac i tance in the contro l  group of ce l l s  was 1 09.6 ± 1 2 . 8  pF, whereas 
in the A EA treated ce l ls was ] 04 . 7  ± 1 1 .6 pF. The input res i stance \ as 82 .3  ± 
1 3 .4 MD i n  contro l  cel l s  and 85 .6  ± 1 1 . 8 MD i n  AEA treated cel ls .  I n  control 
ce l ls. these pass i e membrane propert ies were not a l tered s ign i ficant l y  in  
experiments l ast ing up  to 25  to  30  m inutes. 
In agreement wi th  ear l ier  stud ies in rat ventricu lar myocytes [ for a rev iew. 
(AntzeJev i tch ,  et a I . ,  1 99 1  )] , two main types of waveforms were observed 
accord ing to the durat ion of the i r  APs; endocard ia l  (wi th long A P  durat ions, 
F i gure 3 . 1 0A ;  44.6 ± 2.9 ms: n=23 cel ls) and epicard ia l  (wi th short AP durat ions; 
F i gure 3. l OB ;  1 4 .9 ± 1 .6 ms; n=26 ce l ls) myocytes. Rest ing membrane potent ia ls  
were -77 .6 ± 1 .3 m Y  i n  endocard ia l  cel l s, and -78 .5  ± 1 .4 mV in  epicard ia l  cel l s  
( F i gure 3 . 1 1  A ) .  S im i lar to  ear l ier find ings (Antze lev itch, e t  a I . ,  1 99 1 ), the 
amp l i tudes of  A Ps ( 1 22 .6  ± 8.9 mY versus 1 1 0 .7  ± 7 . 1 mY) ( F igure 3 . 1 I B) and 
max ima l  rate of  r ise (dY/dtmax) va l ues ( 1 77 .3 ± 8 .4 Vis versus 1 4 1 .6 ± 7.2 Vis) 
( F i gure 3 . 1 1 C) i n  endocard ia l  cel l s  were h i gher than those of epicard ia l  ce l l s  
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F ig u re 3. 1 0  E ffect of A E A  on the excita b i l i ty of  ventri cu lar  myocytes: Representative recordings of A Ps in controls (dark grey area), in the 
presence of 1 11M AEA (l ight grey area) and after washout (striped area) in ventricular endocardial (A)  and epicard ial ( B) myocytes; the insets 
on panels A and B show the time course of the action potential durat ion (APD60) and resting potential (Vrest) changes in response to AEA 
application (indicated by horizontal bars) .  
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Figu re 3 . 1 1  S u m m a ry of the  effect of AEA on the a mpl i tude and  the shape of 
A Ps in ca rd iomyocytes : Quant ification of the changes in Vresl (A), AP ampl i tude 
( B) .  A P  max imal  rate of rise (C )  and AP durat ion ( D), characterized by A P D60 in  
contro ls  (dark grey bars) and i n  response to 0. 1 /-lM (cross hatched bars) or  1 !lM 
A EA ( l i ght  grey bars) .  Data are analyzed us ing ANOVA and are expressed as 
means ± . E . M . from 8 to 1 2  myocytes for each group. * ind icates stat i st ica l ly 
s ign i ficant d i fference at the level of P < 0.05 .  
1 0 1  
t concentrat ions of 0. 1 fl M  and I fl M ,  AEA consistent ly shortened the 
durat ion of P in both ce l l  type (measured at 60 % of repo larizat ion, A PD60; 
F i gure 3 . 1 1 D), wi th a hyperpolariz ing h i ft i n  V resl ( F igure 3 . 1 1 A) .  Changes in  AP 
horten ing i n  response to  AEA ( l  fl M )  appl icat ion were noticeable \ i t h i n  1 -2 
m inute ( insets to F igures 3 . 1 OA and 3 . 1  OB) .  Recoveries were usua l ly  part ia l  and 
requ i red longer t ime.  S i m i lar effect of AEA was observed in 5 ce l ls recorded at 
phys io logical temperatures ( 35 - 36 QC) .  APD60 decreased from 33 . 8  ± 4 .6 ms in  
contro ls  to 2 1 .4 ± 3 .2  ms  i n  the  presence of AEA ( n=5 ; P<0.05 ) .  
E ffects of  AEA on V rest (F igure 3 . I I A) ,  and APD60 (F igure 3 . 1 1 D) 
reached a stat ist ica l l y  s ign i ficant level at 1 flM A EA ( n=8- 1 2  cel l s  for each group; 
P<0.05) .  However, AP ampl itude (F igure 3 . 1 1 B) and d V/dtmax of AP (F igure 
3 . 1 1 C) were not a l tered s ign i ficant ly  in both types of ce l ls at 0. 1 fl M and 1 fl M 
A EA ( n= 1 0- 1 2  ce l l s  for each group: P>0.05) .  
At  h igher concentration ( 1 0  flM), A EA caused 5 - 1 0  m V depo larizat ion 
( F i gures 3 . 1 2A ,  3 . 1 2B and 3 . 1 3A)  in  endocard ia l  (n= 1 8 ce l l s; P<0.05) and 
epicard ia l  ce l l s  ( n=24 ce l l s ;  P<0.05)  and decreased s ign i ficant ly  the AP 
amp l i tudes and d V/dtma,\ in both types of  myocytes ( F igures 3 . 1 3 B and 3 . 1 3C ;  
n= 1 8-24 ce l l s ;  P<0.05) .  AEA ( 1 0  fl M )  a lso caused a s ign i ficant decrease i n  APD60 
( F i gure 3 . 1 3 D) .  However, i n  a subgroup of endocard ial ( 5  out of 1 8) and 
epicard ia l  (4 out of 24) cel ls, AEA,  a l though caused a s ign i ficant depolarization 
and a s igni ficant decrease in AP amp l itude and max imum rate of r ise of AP, it d id 
not a l ter A P D60 va lues s ign i ficant ly .  
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Fig u re 3. 1 2  E ffects of  high concentrat ion of  A E A  on the excita b i l ity of  ventricu l a r  myocytes: Representative recordings of  APs in controls 
(dark grey area), in the presence of 10 11M AEA ( l ight grey area) and after washout (striped area) in ventricular endocardial (A) and epicardial 
(B) myocytes; the insets on panels A and B show the time course of the action potential duration (APD6o) and resting potential (Vres1)  changes in 
response to AEA appl ication ( indicated by horizontal bars). 
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Fig u re 3 . 1 3  S u m m a ry of the  effect of h igh con cen trat ion of AEA on the 
a m pl i t ude  a nd the shape of A Ps i n  ca rd iomyocytes : Quant ification of the 
changes in Vrest ( A ), AP ampl i tude ( B) AP max imal rate of r ise (C)  and AP 
duration ( D), characterized by  A P D60 in  contro ls  (dark grey bars) and in  response 
to I 0 � AEA ( l ight grey bars). Data are analyzed using pai red I-test and are 
expressed as means ± S .E .M .  from 1 8  to 24 myocytes ( for A-C) and from 1 3  to 20 
( for D) .  * i nd icates stat ist ica l l y  s ign i ficant d i fference at the level of P < 0.05 . 
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3.8 Ca n n ab inoid receptor a re not i nvolved in  the effect of anandamide on 
the act ion poten t ials in ven t ricu l ar  myoc te 
In the e experiments, the effects of C B I  receptor antagon ist AM25 1 (0.3 
� M )  and CB2 receptor antagon i st AM630 (0.3 � M )  on A EA- induced changes in 
the AP durat ion of endocard ia l  and epicard ia l  myocytes were investigated. The 
effect of AE on PD60 remained unal tered in the presence of AM25 1 (n=5-7 
cel l s :  P>0.05 : F igure 3 . 1 4 A). S i m i lar ly, pretreatment w ith AM630 did not cause a 
s ign i ficant effect on A EA- induced changes in  APD60 in  both endocard ia l  and 
epicard ia l  myocy tes (n=5-7 ce l l s ;  P>0.05 :  F igure J 3 .4 B) .  S ince the act ions of 
cannabinoid receptor (CB I and CB2) are med iated by the act ivation of GLlo 
prote ins  sen i t i \ e to PTX treatment, we tested whether PTX pretreatment (2 
�g/m l ,  3 hours at 3 7 °C) a lters AEA- induced changes i n  AP durat ion In 
endocard ia l  and epicard ia l  myocytes. PTX d id  not cause a s ign i ficant a l terat ion in  
the  effects of AEA on both endocard ia l  and epicard ia l  myocytes (n=5 -7  ce l ls :  
P>0.05 :  F i gure 3 . 1 4C ) .  
3 . 9  A n a n d a m ide i n h i b its vol tage-dependent  Na  + channels I n  ventr icu la r  
myocytes 
Prev ious stud ies have i nd i cated that AEA has s ign i ficant antiarrhythmic  
effects ( U  gdyzhekova, e t  a I . ,  200 1 ;  L i .  e t  a I . ,  2009) .  S ince vol tage-act i vated 
inward a+ ( INa) and Ca2+ (h.ca) currents are the major ion currents shaping the 
act ion potent ia l  in ventr icu lar myocytes, we have conducted a series of 
experiments under cond i t ions that enab le re l iable iso lat ion of e i ther I a or h.ca i n  
vol tage-c lamp mode . I n  the fi rst set of experiments, INa was typica l ly  e l i c i ted by 
pu lses from -80 m V to +60 m V for 50 ms. F igure 3 .  I 5A shows record i ngs of INa 
i n  ventricu lar myocytes before and after appl icat ion of I 0 �M A EA.  
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3 . 1 4  E ffect of ca n nab inoid receptor an tagon ists and  PTX pret reatment  on 
AEA-i n d u ced change in myocyte exc i tab i l ity : (A) Effect of C B 1  receptor 
antagon i t AM25 1 (0 .3  Jl M)  on AEA- i nduced changes in APD60 in endocard ial 
and epicard ia l  m oc tes. APD60 wa presented in  control and i n  the presence of I 
Jl M AEA,  0 .3 Jl M  AM25 1 ,  and I Jl M A EA + 0 .3 Jl M  AM25 1 .  ( B) Effect of CB2 
receptor antagon ist AM630 (0.3 Jl M)  on A EA- induced changes i n  APD60 in  
endocard ia l  and epicard ia l  myocytes. APD60 was presented in  control and i n  the 
presence of 1 Jl M AEA,  0.3 Jl M AM630, and 1 JlM AEA + 0.3 JlM AM630. (C)  
Effect of PTX treatment on A EA- induced changes in  APD60 in  endocard ia l  and 
epicard ia l  myocytes. Changes are presented in contro l ,  in presence of 1 JlM AEA, 
in  contro l  + PTX , and in  presence of I JlM AEA + PTX . Data are analyzed using 
ANOYA and are expressed as means ± S .E .M . , from 5 to 7 myocytes of each 
type : * ind icate stat i st ica l l y  s ign i ficant d i fference at the level of P<0.05 . 
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Figu re 3 . 1 5  E ffect of A E A  on I a i n  ra t ventr icu lar  myocytes : (A)  AEA 
inh ib i ts lla recorded us ing whole ce l l  vol tage c lamp mode of patch c lamp 
techn ique . ! a was recorded dur ing 50 ms vol tage pulses to -20 mY from a hold ing 
potent ia l  of  -80 mY. Current traces were recorded before (contro l )  and after 1 0  
m i nutes appl icat ion of 1 0  j..lM AEA.  (B )  Maximal currents of YG Cs presented as 
a funct ion of t ime in the presence of veh ic le  (0 .07 % ethanol ) and 1 0  j..lM AEA 
(n=5-6 cel l s) .  (C) Representat ive record ings of INa i n  response to the depicted 
pu lse protocol under contro l cond i t ions and after app l i cation of 1 0  j..lM AEA.  ( D) 
ormal ized and averaged I- V re lat ionsh ips of contro l  INa ( fi l led c i rc les) and J a i n  
the  presence of 1 0  j..lM AEA (open c i rc les) determ ined by app ly ing a series of step 
depo lar iz ing pu l ses from -80 mY to +60 mY in 1 0 m Y increments for a durat ion 
of 50 ms. Data are analyzed us ing paired I-test and are expressed as means ± 
S .E .M .  from 5 to 7 cel l s. 
1 08 
The effect of A E  \\ as detectable \ i th i n  2-3 m inutes and reached a steady-state 
Ie el w i th in  1 0- I S  m inutes. The recovery was part ia l  during the experiments 
last i ng up to 2S t 30 m inutes (F igure 3 . 1 SB ) .  
W ith 40 mM a+ outside and Cs+ as  the major intrace l l u lar cat ion, inward 
I a i n  respon e to incremental step depolarizat ions (V  m, 1 0 m V i ncrement) app l ied 
from a hold ing potent ia l  Vh= - 80 mY,  INa started to activate at Vm= -60 mY, and 
reached max imal  ampl i tude at about Vm=-30 mY .  At  more posi t ive potent ia ls the 
i nward current decreased . re ers ing i ts d i rect ion at an apparent reversal potent ia l  
( Vre, ) of around +60 m V .  Traces of INa i n  the absence and presence of 1 0  IlM 
A EA were presented i n  F igure 3 . 1 SC .  A EA inh ib i ted INa without caus ing 
s ign i ficant change i n  the 1- V re lat ionsh ip .  The 1- V re lat ionsh ip for INa i s  
i l l ustrated in  F igure 3 . I S O. AEA inh ib ited INa without changing the threshold ,  
peak and re ersal potent ia ls .  
In  th i s  study. AEA was d i sso lved i n  ethanol ,  and therefore. we have tested 
the effect of ethanol  a a veh ic le .  I n  agreement with ear l ier studies ( Danziger, et 
a I . ,  1 99 1 ;  Bebarova, et a I . ,  20 1 0) ,  our resu l ts ind icate that max imal ampl i tudes of 
INa were a l tered after 1 0  m inutes veh ic le  appl ication in experiments last ing up to 
20 to 2S m inutes (F igure 3 . 1 6A) .  Due to the effect of veh ic le, we have tested each 
concentrat ion of AEA and veh ic le  separate ly and plotted the concen tration 
response curve after subtract ion of veh ic le effect . The effect of increasing AEA 
and correspond ing ethanol concentrat ions and corrected concentrat ion-response 
curve , ere presented in F igure 3 . 1 6B .  
I n  order to  exclude the poss ib i l ity of the invo lvement of degradat ion 
products of  A EA in the i nh ib i t ion of INa- the effect of 1 0  IlM metA EA was tested . 
1 09 
A 
60 
50 
.. 
...7-...... 40 o 
c o ·z 30 
� 
. -
"2 20 
� 
1 0  
o 
B 50 
40 
.. 
z 
-
t3 30 
c 0 . .0 
P- 20 
� 
� 1 0  
0 
• vehicle 
O AFA  
0. 1 0. 3 
EC25 = 4. 8 J.lM 
0. 1 
3 1 0  30 (IlM) 
I 1 0  30 
AEA (IlM) 
Fig u re 3 . 1 6  E ffect of i ncreasin g  AEA and vehicle concentrat ions on ] '3 
recorded i n  rat ven tric u la r  myocytes : (A)  Effects of AEA (0 . ] to 30 11M)  and 
correspond ing  veh i c le concentrat ions on the max imal  ampl itudes of I a currents. 
Data are ana lyzed using paired I-test and are expressed as means ± S .E .M.  from 5 
to 7 cel l s. ( B) Corrected concentrat ion response curve for the inh ib i tory effect of 
AEA on J a. The amount of i nh ib i t ion i nduced by the veh i c le was subtracted from 
the A EA- induced inh ib i t ion at correspond ing A EA concentrations. Data was fit 
wi th logist ic equat ion us ing Origi n data analysis software. 
1 ] 0 
1 0  m inute app l icat ion of metAEA caused a s ign ificant inh ib i t ion of iNa ( 36  ± 4 % 
of contro l s ;  n=5 ce l l s ;  P>0.05) .  
teady-state act ivat ion (SSA) curves of iNa, before and after AEA 
appl i cat ion, were derived by fitt i ng the respect i ve i- V re lat ionsh ips w ith the 
product of  Boltzmann equat ion (F igure 3 . 1 7  A) .  Th is  a l lowed us to determ ine i f  
AEA i n fl uences the parameters of  INa SSA : the voltage of ha lf-max imal  act i vat ion 
(Y II2) and s lope factor (k). In controls ,  Y I I2 and k val ues were -45 .2  mY and 7 . 1 
mY,  respect ive ly .  I n  the presence of 1 0  11M A EA,  Y 1 /2 and k values were -42 .3  
m Y, and 7 . 5  mY.  There were no stat ist ica l l y  s ign i ficant d i fferences between 
contro ls  and A EA-treated ce l l s  (n=8- 1 0 cel l s; P>0.05) .  
I n  order t o  detenn ine i f  AEA influences the propert ies of i nact i vation of  
YGSCs. SS I  dependenc ies of J a i n  the absence and presence of AEA were 
compared . Steady state i nact ivat ion curves were acqu i red us ing a standard vol tage 
protoco l  cons is t ing of prolonged (400 ms) cond i t ion ing pre-pu lse to various Ym, 
i n  the range of - 1 00 mY to +70 mY, which was immediate ly  fol lowed by a 
constant INa act i vat ing test pu lse to Ym= -20 mY.  Steady state i nact ivation­
dependency was p lotted as normal ized ampl itude of iNa at Ym= -20 mY aga inst the 
va lue of  cond i t ion ing Y m The fi t  of the obta ined data points using the Boltzmann 
equat ion ( F i gure 3 . 1 7B )  has ind icated that under control cond it ions, Y 1/2 and k 
values were -70.2 mY and - 5 . 8  mY, respect ively.  I n  the presence of 1 0  11M AEA, 
V 112 and K va lues were -8 1 .4 mY and -5 . 1  mY, respect ively.  Thus, AEA induced a 
s ign ificant hyperpo lar iz ing sh ift  i n  the vol tage-dependence of SS I  of card iac 
YGSCs (- 1 1 .4 mY ;  P<0.05) .  Comparison of I a currents, i n  the absence and 
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Figu re 3 . 1 7  E ffect of A E A  on steady state act ivat ion and  i nactivation of I'a i n  
rat ven tr icu lar  myocytes : ( A )  Steady-state act ivat ion ( SSA) and (B)  steady-state 
i nact i  at ion ( S  J )  cu rves of INa in the absence ( fi l led c i rc les) and presence of 1 
flM A EA (open c i rc les). (C )  Voltage-dependence of INa i nact ivat ion t ime constant 
(11) under contro l  condi t ions (fi l led c irc les) and in the presence of 1 flM AEA 
(open c irc les). Data are analyzed us ing paired I-test and are expressed as means ± 
S . E.M . ,  are from 7 cel l s .  * ind icates stat ist ica l l y  s ign i ficant d i fference at the level 
of P < 0 .05 .  
1 ]  2 
presence of A A, revea led not i ceable acceleration of the current's inact ivation 
k i net ics by A A .  Quant i fi cation of the t ime constant of I a i nactivat ion C rl), by 
fi tt ing the current I decay phase w i th exponent ia l  funct ions, showed that AEA ( J  0 
J.lM ) s ign i ficant ly reduced 11 i n  the range of Y m between -50 mY and +20 mY 
(F igu re 3 . 1 7C) .  Furthermore, the result  of th is  study show that the inh ib i tory 
effect  of AEA on the maximal  amp l i tudes of J a was not s igni ficant ly  affected by 
PT pretreatment (F igure 3 . 1 8) .  
3. 1 0  A n a n damide  i n h ib its voltage-dependent  Ca2+ cha n n els I n  ven t ricu lar  
myocytes 
The effect of A EA on the L-type Ca2+ currents (h.ca) was a lso tested. 
F i gure 3 . 1 9A shows a typical  record of h.ca e l i c i ted by app ly ing a s ingle 300 ms 
vol tage pu lse to + 1 0 m V from a hold ing potent ia l  of -50 m V i n  rat ventricu lar 
myocyte before and after 1 0  m i nutes superfusion with I /-lM AEA. Time course of 
the effect of  A EA on the density of h,ca was presented in  F igure 3 . 1 9B.  The 
e ffects of AEA were a l so invest igated on the b iophysica l  propert ies of h,ca in rat 
ventricu l ar myocytes. L-type Ca2+ current was recorded i n  the presence of 
intrace l l u lar Cs + and extrace l l u lar  TEA + to suppress K+ currents ,  wh i Ie reta i n i ng 
95 m M  a + i n  the extrace l l u lar so lu t ion .  E l im i nation o f  contaminat ing N a  + current 
dur ing record ing of h,ca was ach ieved by applying vol tage step-pu l ses from 
relat ive l y  depolarized Vh of -50 mY,  which produced steady-state INa i nact i  ation 
( Yo itychuk,  et a I . .  20 1 2 ) .  As ev ident from orig ina l  record ings and I- V 
re lat ionsh i ps (F igures 3 . 1 9C and D),  h.ca had a much slower k inet ics i n  response 
to step depolar izat ion,  and act ivated at more pos i t ive potent ia l s  than INa :  it started 
to appear at Vm= -30 mY,  reached max imum at around Vm= + 1 0  mY, and 
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Fig u re 3. 1 8  E ffect of PTX pretreatment  on AEA i n h ib it ion of the maximal  INa 
am pl i t udes. B lack bars i nd icate contro l s. Data are analyzed us ing independent 
sample {-test and are expressed as means ± S .E .M. ,  from 6 to 8 cel l s. 
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Fig u re 3 . 1 9  E ffect of AEA on h,ca i n  rat ven tricu lar  myocytes : ( A) AEA 
i nh ib i ts h.ca recorded us ing whole-ce l l  vol tage-c lamp mode of patch c l amp 
techn i que.  h,ca was recorded d ur ing 300 ms  vo ltage pu lses to  + 1 0 m V from a 
ho ld ing potent ia l  of  -50 m V .  Current traces recorded before (contro l )  and after 1 0  
m inutes app l icat ion of 1 11M AEA.  ( B) Max imal currents presented as a function 
of t ime in the presence of veh ic le  (0 .007 % ethanol )  and I 11M AEA (n=5 cel l s) .  
(C )  Representat ive record i ngs of h,ca i n  response to the depicted pulse protocol 
under control cond i t ions and after appl icat ion of I 11M AEA.  C D )  Norma l i zed and 
averaged J- V re lat ionsh ips of control h.ca (open ci rc les) and h.ca i n  the presence of 
1 11M A EA ( fi l led c i rc les) determ ined by app ly ing a series of step depo lariz ing 
pu lses from-70m V to +70 m V in  1 0 m V increments for a durat ion of 300 ms.  Data 
are analyzed us ing paired {-test and are expressed as means ± S .E .M .  from S to 7 
ce l l s .  
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decreased at h igher o l tages approach ing zero at about Y m= +60 mY (F igure 
3 . 1 90) .  
Current density of h.ca was a l so a l tered after 1 0  minutes appl ication of 
ethanol i n  exper iments l ast ing up to 20 to 25  m i n utes. Effects of increasing AEA 
and correspond ing ethanol concentrat ions  on h,ca and corrected concentrat ion­
response curve � ere presented i n  F i gure 3 .20.  
In order to exc lude the poss ib i l i ty of  involvement of degradation products 
of  AEA in  the i nh ib i t ion of h.ca, the effect of  1 11M metAEA was tested. MetAEA 
caused a s ign i ficant i nh ib i t ion of  Ca2+ currents (46 ± 4% inh ibit ion of contro ls ;  
n=5 ce l l s; P<0.05) .  ]n  add i t ion, the effect  of F AAH inh ib i t ion on AEA- induced 
i nh ib itory effect \ as tested. Pretreatment w ith 1 11 M URB597 for 45 m inutes at 37  
°C (contro ls  i ncubated wi th  0.007 % ethanol a lone) d id  not  a l ter the  extent of AEA 
i nh ib it ion of  L-type Ca2+ currents. I n  the absence and presence of U RB597, AEA 
( 1 11M )  inh ib i ted L-type Ca2+ currents to 32.7 ± 3 .6 % of and 35 .3 ± 4.2 % of 
contro ls ,  respect ive ly (n=5 -7 ;  P>0.05) .  
AEA produced a depolar iz ing sh i ft  of h.ca SSA by 1 2 .6 mY ( i .e . ,  V 1 12= -
9.4 ± 0 .3 mY .  i n  contro l ,  to V I 12= +3 .2  ± 0.2 mY,  i n  the presence of AEA) and 
hyperpolar iz ing sh i ft of h.ca SS I  by 4 .3 mV ( i .e . ,  from V II2= - 1 8 .9 ± 0. 1 mY, i n  
contro l ,  t o  V I /2= -23 .2  ± 0. 1 mY,  i n  the presence of AEA)  with l itt le influence on 
the s lopes of respect ive dependencies (k= 7 . 2 ± 0.4 mV and k= -5 .3  ± 0.3 mV for 
the contro l  act ivat ion and i nact ivat ion, respect ive ly,  vs.  k= 6 .9 ± 0.3 m V and k= -
5 . 1 ±0.2 m V  for the A EA-modified act ivat ion and i nact i vat ion respect ive ly), 
wh ich a l together resu lted in the notable reduct ion of I L.Ca "window current' · 
respons ib le for the stat ionary Ca
2+ entry in  the range of membrane 
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F igure 3.20 E ffects of i ncreasing  AEA and  veh icle concen trat ions on h, a 
recorded i n  rat ven tricu lar  myocytes : ( A) Effects of AEA (0 . 1 to 30 )..lM )  and 
correspond ing  veh i c l e  concentrat ions on the max imal  ampl itudes of h.ca. Data are 
analyzed us ing pa i red I-test and are expressed as means ± S .E .M .. from 5 to 7 
cel l s .  ( B) Corrected concentration response cur e for the inh ib i tory effect of AEA 
on h,ca' The amount of inh ib i t ion induced by the veh i c le was subtracted from 
A EA- induced inh ib i t ion at correspond ing A EA concentrations. Data was fit with 
logist ic equat ion us ing Orig in data analysis software. 
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potent ia l  from -40 mY to + 1 0  mY (F igure 3 .2 1 A  and 3 .2 1 B) .  Thus. the 
mechani m of EA act ion on card iac L-type YGCC most l i kely i nvolves 
i n fl uence on channel gat ing that reduces 'window current" as we l l  as part ia l  
b lockade of the  ion-conduct ing path\ ay that decreases current ampl  itude. 
In l i ne v ,  i th ear l ier reports ( o Jdatov, et a 1 . ,  J 998), k inet ic analysis of h.ca 
currents were fit to double-exponenti al funct ion with fast (If) and s low (l5) 
i nact ivat ion t ime constants. Comparison of lL,ca currents in the absence and 
presence of AE revealed not iceable acce lerat ion of the current's inactivation 
k i net ics by A A. Quanti ficat ion of the t ime constants of h.ca i nact ivat ion showed 
that AEA ( l �lM) s ign i ficant ly reduced I I  in the range of Ym -20 mY and + 1 0  mY 
(F i gure 3 .2 J C ) . 
I n  earl ier e lectrophysio logical stud ies, s idedness of AEA actions on 
various ion channe ls  has been reported (Oz, 2006). For th i s  reason, the effect of 
i ntrace l l u lar  appl icat ion of AEA by inc lud ing AEA ( 1 11 M )  i ns ide the patch 
e lectrode was tested ( F igure 3 .22) .  The extent of A EA inh ib i t ion (compared after 
1 5  m i nutes of A EA exposure) was not s ign ificant ly d i fferent between intrace l l u lar 
and extrace l l u lar AEA app l icat ions (n= 1 1 - 1 4  ce l l s ;  P>0.05). 
In order to test if the modulat ion of Ca
2+ binding s i te can med iate the 
effect  of A EA on the inact i vation k i net ics of L-type YGCCs, extrace l l u lar Ca
2+ 
was rep laced with 8a2+ and the effect of AEA on Ba
2+ currents (lsa) through L­
type VGCCs was tested . In l ine with earl ier stud ies (Soldatov, et a1 . , 1 998), 
i nact ivat ion of lBa fit to mono-exponent ia l  decay function (F igure 3 .23A) wi th 
s ign ificant vo l tage-dependency. I n  the presence of A EA,  inact ivat ion t ime 
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Figu re 3.2 1 E ffect of AEA on steady state activation and  inactivation of h.ca 
i n  rat ven tricu l ar  myocytes : (A) Steady-state act ivat ion (SSA) and (8)  steady-
state i nact i vat ion ( SS I )  curves of h.ca i n  the absence ( fi l led c i rc les) and presence 
of ) )lM A EA (open c i rc les). (C)  Vol tage-dependent fast (tr iangles) and slow 
(c i rc les) i nact ivat ion t ime constants (1:1) of h.ca under contro l  cond it ions ( fi l led 
c i rc les and tr iangles)  and in the presence of I )lM AEA (open c i rc les and 
tr iangles) .  Data are analyzed using pa i red {-test and are expressed as means ± 
E M .  from 5-6 cel ls . * ind icates stat ist ica l l y  s ign i ficant d i fference at the level of P 
< 0 .05 .  
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Figu re 3 . 2 2  Effect of  s ided ness of AEA appl ication on h,ca i n  rat ventricu lar  
myocytes : Comparison of the  i nt race l l u lar  and extracel l u lar app l i cat ion of  AEA 
on the maxima l  i nh ib i t ion of hca. Data are analyzed using independent sample 1-
test and are expressed as means ± S .E .M.  from 1 1 - 1 4  ce l l s. 
1 20 
constant ( F igure 3 .23  and 3 .23 B). and the  max imal  ampl itudes of 1B3 \>, ere 
ign i fi cant l )  i nh ib i ted compared to control va lues (n=7-8 ce l ls :  P<O.OS) .  
i nce the known cannabinoid receptors C B I  and CB2 [ for a reV le\\ , 
( Pertwee. et aL 20 1 0) ]  are coupled to PTX sens i t ive G1/0 type G-prote ins. we ha e 
tested w hether the i nh ib itory effects of  A EA on L-type VGCCs are mediated by 
the act ivat ion of cannab ino id  receptors . I n  the presence of 0.3 JlM AM2S 1 and 0.3 
Jl M AM630.  AEA ( 1  JlM )  i nh ib it ion of h,ca rema ined unal tered. Appl icat ion of 
AM2S 1 or AM630  alone d id  not have a s ign ificant effect  on the ampl i tudes of 
h.ca ( F igure 3 .24) (n=6-9 ce l l s; P>O.OS) .  Furthermore. the resu lts of th is  study 
sho\'. that the i nh ib i tory effect of A EA on the maximal  amp l i tudes of J l.Ca \" as not 
affected by PTX pretreatment (F igure 3 .2S ) .  
[ n  pos i t i ve contro l  experiments, PTX, as  i t  has  been reported earl ier 
(Zhang. et a l . ,  200S), effect ive ly attenuated the inh ib itory actions of BRL-37344,  a 
�3 adrenerg ic receptor agonist ,  on h,C3 recorded i n  ventricu lar myocytes (F igures 
3 .26A and 3 .26B) ind icat ing that G-prote ins are funct iona l l y  coupled to the ir  
target receptors. 
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Figu re 3 . 2 3  E ffect of A E A  o n  BaH c u rre n ts med iated by L-type VGCCs : (A) Traces of nonnal ized Ca2+ and Ba2+ CUlTents through L-type 
VGCCs. Normalized Ba2+ current in the presence 1 11M AEA is also presented in the figure. ( B) Effect of 1 11M AEA on the maximal ampli tudes 
and the inactivation kinetics of Ba2+ currents. Data are analyzed using paired [-test and are expressed as means ± S .E .M .  from 7-8  cel ls .*  
indicates statistical ly sign ificant difference at  the level of P <0.05 .  
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Figu re 3.24 E ffects of ca n nabinoid receptor a n tagon ists on AEA i n h ibit ion of 
L-type VGCCs : Effects of C B I  antagon i st AM25 1 (0 .3  �M)  and CB2 antagon ist 
A M630 (0 .3  � M )  on AEA ( 1  � M )  inh ib i t ion of hCa. Data are analyzed using 
A OVA and are expressed as means ± S .E .M .  from 6-9 ce l l s. * ind icates 
tat is t ica l 1y s ign ificant d i fference at the level of P <0.05 . 
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Figu re 3.25 Effects of PTX pretrea tment on AEA i n h ibit ion of L-type 
VGCCs : Percent i nh ib i t ion of hca after veh i c le (d ist i l led water) and PTX (2  
1lg/Il L 3hours). Data are analyzed us ing i ndependent sample {-test and are 
expressed as means ± S .E .M .  from 6-8 ce l l s .  
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F igu re 3.26 Effect of PTX pretreatment  o n  B R L -37344 i n h i bi t ion of h,ca 
recorded i n  ra t ven tricu l ar  myocytes : ( A) Records of currents present i ng the 
effect  of BRL-37344, on hca in  the absence and presence of PTX (2  Ilg/m l for 3 
hours i n  3 7  DC) pretreatment .  Records were obtai ned by apply ing a step 
depo l ar iz ing pu lse from -50 m V to + 1 0  m V for durat ion of 300 ms ( B) 
Presentat ion of resu l ts on the effect of PTX pretreatment on B RL-3 7344 inh ib i t ion 
of hCa. Data are analyzed us ing i ndependent sample t-test and are expressed as 
means ± S . E. M .  from 5-7 ce l l s .  * i nd icates stat ist ica l ly s ign ificant d i fference at the 
level of P<0.05 .  
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3. 1 1 Anandamide  i n h ib i t  a +/Ca2+ e. changer i n  ventricu lar  myocytes 
Currents mediated by CX ] were e l i c i ted by a descending vol tage ramp 
pu l es appl ied between + 1 00 mV and - 1 00 mV (dV/dt = 0. 1 Vis) from a holding 
potent ia l  of -40 m V for 2 seconds .  In order to verify that the currents recorded in  
our e per imental cond i t ions are mediated by the  NCX ] ,  ?'" ( 1 0  mM)  v as used 
rout ine ly at the end of each experiment to determ ine the N i 2+-sensit i ve CX ] 
current ( F i gure 3 .27  A and 3 .278) .  8ath app l i cat ion of N i 2+ for 5 m inutes 
re ers ib l  suppressed INCX l ,  ind icat ing that these CUITents are mediated by NCX I 
In  card iomyocytes ( F i gures 3 .27A and 3 .278) .  Command pu lses were appl ied 
every ] 5  seconds, and ampl i tudes of currents at + 1 00 m V and - 1 00 m V were 
p lotted as a funct ion of t ime ( F igure 3 .27  A) .  Anandam ide large ly attenuated both 
the outward and i nward components of N i2+ -sensit ive current .  The effect of AEA 
wa detectable at 2-3 m inutes and reached a steady-state level wi th in  5 m inutes. 
W ith in  the t ime period of our experiment, the recover was part ia l .  F igure 3 .278 
shows representat ive current traces i n  contro l  solut ion. in  the presence of AEA ( 1 0  
flM )  and i n  the presence of N i2+ ( 1 0  mM) .  I n  th i s  experiment, AEA was d i ssolved 
in ethano l .  The max ima l  amp l i tudes of INCX l  were not a l tered by 1 0  to I S  m inutes 
appl i cat ion of ethanol up to the concentrat ion of 0.07% ( VIV : n=6). 
F igure 3 .27C shows the mean 1- V re lat ionsh ips for i
2+ -sensit ive INCX l in  
control and i n  the  presence of 1 0  flM AEA.  INCX l was calcu lated by subtract ing 
the currents recorded in  N i 2+ from the current recorded without N i
2+ . Evaluation of 
the AEA i nh ibi t ion of INCX l  at d i fferent membrane potent ia ls  (F igure 3 .27D) 
i nd icated that AEA i nh ib its both outward and inward components of I 'CX I equa l ly .  
] 26 
A 
AEA ( 1 0  J..lM) Ni2� ( 1 0  mM) 
800 -1 _  �  <D 
600-1 o� �o 
400 
� 200 
� 0 
�� ;:: 
� 0 5 1 0  1 5  � 
U _ To"" (nun) � 
c 
200 0 -400�  t i 
_600 J t 
"� 6 '" 
c �  
-8 �  c <: 
5 54 
U 
J 
/e / " �O 
100 . 
. 
-o...-8...-@/-40 -20 
:/./6' -2 
• ..,-! 
I/ Y /' 
/. * 
• Q-Q�Q O� /0/ ___ control 
-0- AEA 
2i) 40 60 80 1 00  
Voltage (mY) 
1 27 
B 
...., 800 <: 
Co. 
'-" 
0 600 
� 
a 400 
Voltage (mV) 
- l�� -20 J -200 l -400 
-600 
D c: 1 00  0 
".;:)" 
:s :.a SO 
� 
-
� 60 +----''--1-' 40 J 
20 
- 1 00  -80 -60 ...4Q -20 0 
20 
Nil-> ( 1 O mM) 
+-,-!-! 
20 40 60 80 1 00  
Voltage (mV) 
Fig u re 3 .27 E ffect of AEA on J" X I  i n  rat ventricu lar myocyte : EA inh ib i ts 
! CXI recorded us ing \ hole ce l l  o l tage c lamp mode o f  patch c lamp techn ique. 
(A) Time course of the effects of AEA on the inward and outward i CXI  recorded 
i n  a card iomyocyte. iNCX I was e l i c i ted by 2 seconds vol tage ramps from + 1 00 mY 
to - 1 00 m Y  e\ ery 1 5  seconds. Ampl  i tudes of currents recorded at  + 1 00 mY and -
1 00 mY were presented as a function of t ime.  Horizonta l bars i nd icate drug 
appl icat ion t imes. A rrows correspond to the t ime poi nts for the currents shown in 
F igure 3 . 27B  ( B) Current traces were recorded in  contro l .  after 5 m inutes 
app l i cat ion of 1 0  ).lM AEA and fol lowing 1 0  mM N i2+ for 5 m inutes. (C)  Mean i­
V re lat ionsh ip  of CX 1 in the absence and presence of 1 0  flM AEA.  Data points 
(mean ± S .E .M . )  are from 7 cel ls .  ( D) Quanti ficat ion of the extent of AEA 
inh ib i t ion of iNC I at d i fferent membrane potent ia ls .  Data points (mean ± S .E .M . )  
are from 6 cel l s. Paired I-test was used to  compare the ampl i tude of current 
currents recorded at + 1 00 mY and - 1 00 mY.*  ind icates stat i st ica l l y  s ign i ficant 
d i fference at the level of  P<0.05 .  
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o l Ject ive ly. the e ob ervat ions ind icate that AEA ( I  0 �M)  exerts an inh ib i tol) 
effect on CX I in  ventricu lar myoc)'tes. 
The effect of increasi ng AEA concentrat ions on the outward (measured at 
+ 1 00 mY)  components of J 'CX I was demonstrated i n  F igure 3 .28 .  AEA inh ib ited 
J CX I i n  a concentrat ion-dependent manner with l Cso va l ues of 4 . 7  � M .  The effect 
of metAEA was a l  0 tested to avoid  the l ikely confounding effects of degradation 
products and oxygenated metabol i tes on NCX I .  At a concentration of 1 0  J-lM . 
metAEA a lso caused a s ign ificant i nh ib i t ion of  exchanger current (F igure 3 .29A). 
Furthennore the effect of AEA on NCX I in  the presence of the spec i fic FAAH 
inh ib i tor U RB597 was a l so tested. After incubat ion of card iomyocytes w ith I J.l M 
U RB597 for 1 hour, A EA cont inued to inh ibi t  the function of NCX I (F igure 
3 .29B) further suggest i ng  that the intact AEA molecule, but not the degredat ion 
products, mediates i ts e ffect on the exchanger. 
I n  the presence of I pM AM25 1 and I J.lM AM630, AEA ( 1  0 �M)  
i nh ib i t ion of INcx 1 remained unal tered (n=6-8,  F igure 3 .30) .  I n  add i t ion. the results 
of this study show that the i nh ib itory effect of AEA on the max imal amp l i tudes of 
J ex ! was not affected by PTX pretreatment ( F igure 3 . 3  I A). In pos i t ive contro l  
experi ments (sect ion 3 . 1 0) ,  PTX, as  i t  has been reported earl ier (Zhang, e t  a I . ,  
2005) ,  effect ive ly  attenuated the  inh ib itory actions of BRL-37344, a �3  adrenergic 
receptor agon ist ,  on L-type YGCCs recorded in ventr icular myocytes (F igure 
3 .26) .  GDP-�-S i s  a lso common ly used to inh ib i t  the responses mediated by the 
act i vat ion of  G-prote i n  receptors (Bondarenko, et a I . ,  20 1 3) .  For th i s  reason, the 
effect of A EA in the presence of GDP-�-S in  i ntracel lu lar so lut ion was tested. 
A fter the i nc l us ion of GDP-�-S ( I  mM) in p ipette so l ut ion, AEA cont inued to 
i nh ib i t NCX l ( F igure 3 . 3 1 8) .  
1 29 
1 00 
8 0  
� 
0 
• ?""""4 60 � 
. � 
� 
. � 
� 40 
� 
. � 
� 20 IC50 == 4 . 7  �M 
0 
0 . 1 1 1 0  1 00 
AEA (JIM) 
Fig u re 3 .28 E ffect of i ncreas ing AEA concen trat ion on I O J  i n  rat 
ven tr ic u l a r  myocytes : AEA inh ibi ts INcx l i n  a concentrat ion-dependent manner. 
i2+-sensi t ive current was measured at + )  00 mY.  Data po ints (mean ± S .E .M. )  are 
from 6 to 8 ce l ls .  
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Figu re 3.29 Effects of metAEA and  U RB597 on INcx 1 i n  rat ven tricu lar  
myocytes : (A)  Effect of 1 0 � M  metAEA on net lNcx l (after subtraction of current 
i n  1 0  m M  N i2+) .  Data points (mean ± S .E .M . )  are from 5 ce l l s .  ( B )  Effect of 1 0 �M 
AEA on INCX l  i n  card iomyocytes incubated with I �M U RBS97 for I hour. Data 
poi nts ( mean ± S .E .M .) are from 6 ce l ls .  Pai red I-test was used to compare the 
ampl itude of current currents recorded at + ]  00 m V and - \  00 m V .  * ind icates 
stat ist i ca l l y  s ign i ficant d i fference at the level of P<O.OS.  
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Figu re 3.30 Effect of can n a binoid receptor an tagon ists on AEA i nh ib i t ion of 
I" X I  recorded i n  ven tr icu l a r  ca rd iomyocytes : ( A )  Time course of the effects of 
C B l  antagon i t AM25 1 ( 1  f! M )  on AEA inh ibi t ion of INCX l .  ( B) Effect of I f!M 
AM25 1 on A E  i nh ib i t ion o f  net NCX J current at d i fferent membrane potent ia ls  
(after subtract ion of  current i n  1 0  mM i2+) .  (C)  Time course of the effects of  C B2 
antagon i st A M630 ( I  f! M )  on A EA inh ib i t ion of INCX l ( D) Time course of the 
effect of 1 f!M A M 630 on AEA inh ib i t ion of INCX l  at d i fferent membrane 
potent ia l s  (after subtract ion of current in 1 0  mM N i2+) .  Data points (mean ± 
S .E .M .) are from 6-8 ce l l s. Pa ired I-test was used to compare the ampl itude of 
current currents recorded at + 1 00 mY and - 1 00 mY .  * ind icates stat i st ica l ly  
s ign i ficant d i fference a t  the  level of P<0.05 . 
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Fig u re 3.3 1 Effects o f  PTX pretreatment  a n d  i n tracel l u la r  appl ication of 
G DP-fl-S on AEA i n h ibi t ion of I CX I in ven tric u lar  ca rd iomyocytes: (A)  
E ffect of  PTX pretreatment on  A EA inh ib i t ion of INcx l . Ampl i tudes of inward and 
outward components of INcx I were measured at + 1 00 m V and - J  00 m V, 
respect ive ly .  Data points (mean ± S .E .M . )  are from 6 ce l ls .  ( B) Effect of GDP-�-S 
inc l usion in  the patch ing p ipette on A EA inh ib i t ion of INcx I .  Ampl itudes of 
i nward and outward components of  INcx I were measured at + J 00 m V and - 1 00 
mY,  respect i  e ly. Data points (mean ± S .E .M . )  are from 7 ce l l s .  Data are analyzed 
us ing pai red I-test. * ind icates stat ist ica l l y  d i fferent from the contro l val ues at the 
level of P<0.05 . 
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3. 1 2  Anandamide h a  no effect  on cel l v iab i l ity i n  ent ricu lar  myoc te 
Cel l iab i l i ty was a sessed using the MTT assay. Cel l  death was induced 
by ) % Triton X - I OO (Abood, et a I . ,  200 1 ) . The effect of AEA ( 1 0  11M)  on ce l l  
v iab i l i ty of  \ entricu lar card iomyocytes was examined after 4 0  m inutes treatment. 
As shown in figure 3 .32A,  no change in ce l l  morphology \ as seen .  On assaying 
the effect of AEA on ce l l i ab i l i ty.  no s ign i ficant change in ce l l  v iab i l ity was 
observed ( F igure 3 .328) .  
3. 1 3  Ananda m ide has no effect on memb rane in tegrity I n  ven tricu lar  
myocytes 
Membrane i ntegrity was assessed us ing the lactate deh) drogenase (LDH)  
assay. LDH i s  a so luble enzyme located i n  the cytosol w h ich is  released into the 
surround ing cu l ture med ium upon ce l l  damage or lys is .  a process that common ly 
corre lates with both apoptosis and necrosis ( Bonfoco. et a l . .  1 995) .  The levels of 
LDH released i nto the surround ing med ia can. therefore.  serve as a re l iable 
measurement for cytotox ic i ty.  Cel l death was i nduced by ) % Tri ton X - l 00 
(Abood, et a I . ,  200 1 )  and was set to be tota l LDH act iv ity (1 00 %). Data from 
control and treated cel ls  were normal ized to total LDH re lease and calculated as 
percentage cytotoxi c i ty .  Resu l ts of the LDH assay are summarized in  F igure 3 . 33 .  
As depicted i n  the  figure no  s ign ificance d i fference i n  LDH act iv ity was observed 
between veh ic le  and A EA-treated ce l l s .  
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Figure 3.32 E ffect of AEA on morpho logica l characteristics and  cel l  v iab i l ity 
of ven tricu lar  card iomyocytes : (A)  Ventri cu lar card iomyocytes were treated 
ith e ither veh i c le or 1 0  11 M AEA for 40 m inutes. ( B) Effect of veh ic le, AEA or 
metAEA on ce l l  v iabi l ity as determ i ned by MTT assay. Data are anal yzed using 
ANOVA and are expressed as means ± S .E .M .  of five i ndependent experiments. * 
i nd icates stat istica l ly d i fferent from the control val ues at the level of P<0.05 . 
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Figure 3.33 Cytotox icity of AEA as assessed by LDH assay : Cel ls  are treated 
w i th veh ic le  or vehic le + AEA ( J  0 11M) for 40 m inutes. Va lues represent means ± 
. E.M  . .  expressed as a percentage of the total LDH act iv i ty induced by I % Triton 
X- 1 00 .  Data are analyzed us ing i ndependent sample I-test and are expressed as 
means ± S .E .M .  
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4. D I  CU I ON 
The resu lts of  th i s  study ind icate for the fi rst t ime that impa i red Ca2+ 
s igna l i ng  underl ies the negat ive inotropic act ions of A EA in rat ventricu lar 
myocytes, and that d i rect interact ion of AEA with ion channel(s) shaping A Ps. 
rather than the act ivat ion of known cannabinoid receptors. mediate, at lea t in 
part .  the effect of  A EA on myocyte contract i l i ty. These find ings a lso show that 
AEA- i nduced a l terat ions in A Ps of myocytes are due to d i rect i nh ib i t ion of 
vol tage-dependent Na+ and Ca2+ channe ls .  In add i t ion, the resu l ts of th is  study 
ind icate for the first t ime that under normal condi t ions, AEA can d i rect ly i nh ib i t  
the act i v i ty of CX I i n  ventricu lar myocytes. 
Systemic  adm in i strat ion of AEA causes complex hemodynam ic changes 
invol  i ng  phases of both i ncreased and decrea ed blood pressure as wel l  as 
changes in heart rate and contract i l i ty ( for rev iews, Randa l l ,  et a I . ,  2004; Batka i 
and Pacher, 2009). I t  has been suggested that these card iovascu lar actions of 
endocannabinoids i nvolve mu l t i p le sets of cel l u lar and molecular mechan isms 
( Randa l l ,  et a I . ,  2004 ; Ma l i nowska, et a I . ,  20 ] 2) .  In add i t ion to receptor-mediated 
and d i rect act ions of endocannabinoids on muscular structures, neuronal and 
endothe l ia l  ce l l s have a l so been shown to be i n fl uenced by AEA and its metabo l i c  
products (Oz, 2006). 
The lise of v ideo edge detect ion In ind iv idual  myocytes has several 
advantages over in vivo experiments and trad it ional In vitro systems such as 
Langendorff-perfused heart preparation, s i nce it a l lows measurement of 
contrac t i l i ty at s ing le-ce l l  level in a re lat ive ly iso lated env i ronment and exc l udes 
the i nfluence of autonom ic nerve end ings gap-j unctions, neurotransm i tter uptake 
system and coronary perfusion status (Oz et a I . ,  2006; Mal i nowska, et a I . ,  20 1 2) .  
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For example .  AE  ha  been reported to i nh ibit noradrena l i ne re lease from atr ium 
subjected to e lectr ical fie ld t imu lation (Goodfel low and Glass. 2009) and to 
enhance vaga l act i v ity ( for a rev iew, Mal inowska et a l . .  20 1 2) in in vivo and in in 
l'ifro m usc le preparations. im i larly, the modu lat ion of the functional propert ies of 
dopam i ne ( DA) .  eroton in .  and glycine transporters and gap junctions (Venance. 
et a l . .  1 995 )  b) AEA and AA has been reported in neurons, cu l tured neurons. g l ia .  
and s naptosomal preparations (Chen, et aI . ,  2003 ; Pearlman. et al . .  2003;  Steffens 
and Feuerste in .  2004; Oz. et a I . ,  20 1 0) .  However, i t  is un l i kely that these reuptake 
mechanisms are involved in our stud ies on ventr icu lar myocytes. Therefore. using 
acute ly  isolated ventricu lar myocytes, we have been able to bypass various 
potent ia l  target s i tes for A EA,  and focus on character iz ing its action on 
card iomyocytes. 
4 . 1  Myocyte shorten i n g  a n d  i n tracel l u la r  Ca2+ measuremen ts experiments 
I n  myoc te shorten ing experiments, bath appl ication of AEA caused a 
s ign i ficant reduction 111 the maximal  shorten i ng ampl itudes w ithout caus l l1g 
s ign i ficant a l terat ion 1 11 the t ime course of myocyte contract ion . Negat ive­
i notropic act ions of AEA m ight be attri buted to the impa i red re lease of Ca
2+ from 
the SR .  ]n fact, A EA and other various cannabi noid receptor agon i sts have been 
reported to modu late the ryanod i ne sensit ive i ntrace l l u lar Ca
2+ stores and Ca1+_ 
ATPase act i v ity i n  various ce l l types ( Epps, et a l . .  ] 982;  Mombou l i ,  et a I . ,  1 999: 
Zhuang. et a ! . .  2005 ; Rao and Kaminsk i ,  2006);  for recent rev iews, (Goodfel low 
and G l ass. 2009; De and Di ,  Y,  2009b) . However, i n  our recent study (A I  Kury. et 
aI . ,  20 1 4a), we have shown that b i nd ing of ryanodi ne to SR membranes was not 
a l tered by AEA .  S i m i lar ly, in the presence of AEA (0 . 1 and I flM), pass i ve Ca
2+ 
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re lease from R membrane vesic les remained unchanged . I n  l i ne ", i th these 
find ings, in the u rrent stud . the ampl itude and k i netics of caffe ine- i nduced Ca2+ 
release from intrace l l u lar Ca2+ store were not a l tered by AEA. Col lect i vely these 
resu l ts  ind icate that ryanod ine-sens i t i  e intrace l l u lar Ca2+ stores are not involved 
i n  the negat ive i notropic effects of AEA. 
On the other hand, the decrease in  TI IALF deca and AMP of the Ca2T 
trans ient by AEA during twitch responses may be due to increased uptake of 
cytoso l i c  Ca2+ to SR. I n  fact, our recent study (AI Kury. et a l . .  20 1 4a), ind icates 
that AEA,  (0 . 1 and I � M )  caused a ign i fi cant increase i n  Ca2+-ATPase act i v i ty in  
card i ac R membranes suggest ing that increased Ca2+ uptake by SR  m ight 
contribute to the observed changes in Ca2+ trans ients. I n terest ingly ,  NAEs with 
vary ing carbon chain lengths ( Epps. et a l . .  1 982) and fatty ac id-based compounds. 
such as AA .  ha e a l so been shown to modu late the act i v ity of Ca2+ -A TPase in 
card i ac and skeletal SR membranes. Potent iat ion of the Ca2+-ATPase act i v i ty 
w ithout alter ing Ca2+ re l ease and ryanod ine-bind ing to the Ca2+ re lease channel 
may account for the decrease in T HALF decay and ampl i tude of the Ca2+ transient 
caused by AEA ( 1  flM) .  Decreases in THALF decay and ampl itudes of the Ca2+ 
transients by low concentrat ion of A EA ( I  fl M )  dur i ng twitches, but not caffe ine-
induced Ca2+ transients, may suggest that compared to caffeine- induced responses 
2+ � . C 7+ 
. 
wh ich invo lve the release of large amounts of Ca from SR,  last a- transients 
dur ing e lectr ical  st imu lat ions are re lat ive ly more sensi t ive to alterat ions in Ca
2+_ 
ATPase act i v ity. 
Act ivat ion of cannabinoid receptors a lters the levels of second messengers 
such as cAMP, cGM P and protein k i nase C ( Demuth and Mol leman, 2006; 
Goodfel low and Glass, 2009) which are known to be involved in  tun ing the Ca
2+ 
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n i t iv i t}  of the contrac t i le prote ins .  Howe er. sens i t i  ity of contract i le prote ins 
to intrace l l u lar a2+ remains unchanged i n  the presence of AEA, suggest ing that 
pho phorylat ion and de-phosphorylat ion of the contrac t i l e  proteins do not play a 
s ign i ficant ro le i n  the negat ive i notropic act ions of AEA. An ear l ier study in  
i o lated rat atria demonstrated that AEA caused negat ive inotropic effects by 
decreas ing cAMP and increas ing n i tr ic ox ide (NO) levels (Steri n-Borda, et a I . ,  
2005 ) .  Ho'W e  er .  AEA st i l l  dec reased contrac t i le performance in  the  presence of 
L- AME,  a NOS inh ib i tor, exc lud ing a NO-med iated negative inotropic effect on 
human atr ia l  musc le ( Bonz. et a I . ,  2003) .  S im i larly, in another study in rat i solated 
heart. the negative inotropic act ions of synthet i c  cannabinoid H U -2 1 0  were not 
corre lated with the intrace l l u lar  concentrat ions of cAMP and cGM P (Maslov, et 
a I . ,  2004) .  Col lect ive ly ,  these fi nd ings, in agreement w ith the results of the current 
work. uggest that the effects of A EA on myocyte contract i l i ty are not related to 
changes in i ntrace l l u lar Ca2+ re lease mach inery or sens i t iv ity of myofi laments to 
Ca2� . Furthermore, in the presence of A EA ( 1  fl M),  intrace l l u lar Ca2+ leve ls  and 
rest ing cel l length of ventricu lar myocytes remain unaltered suggest ing that AEA 
does not s ign i ficant ly  affect Ca2+ homeostas i s  under rest ing cond it ions. 
]n several ear l ier invest igat ions, it has been reported that l!1 the 
concentrat ion range used in our study, AEA activates TRP channels  such as 
TRPV I receptors and causes increased levels of i ntrace l l u l ar Ca
2+ in various ce l l  
types ( De and D i ,  V ,  20 1 0 ; Bradshaw, et a l .  20 1 3) .  However, TRP channels are 
not l i ke ly to be involved i n  the observed act ions of AEA i n  card iomyocytes for the 
fol lowing reasons. F i rst, TRP channels are h igh l y  permeable to Ca
2+ and the ir  
act ivat ion causes increased intrace l l u lar Ca
2+ concentrat ions. However, 
app l icat ion of AEA (0 . 1 to 1 fl M )  does not cause any a l teration in intrace l l u lar 
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a2+ levels .  econd ly. an open ing of TRP channel s  wou ld  be assoc iated \\ i th 
decreased input res i stance of the cel l .  and e have not observed a detectable 
change in the i nput res i stance of myocytes during voltage clamp experiments. 
Th i rd l  . in earl ier stud ies, TRPY I channels. the main TRP channel subtype that is 
activated by AEA.  are not expressed in  adu l t card iomyocytes ( Dvorakova and 
Kummer. 200 I ) . 
AEA i s  metabol ized by F AAH and degradation products such as AA.  and 
AA deri atives have been shown to cause negat ive i notropic actions in 
card iomyocytes ( Hoffmann. et a I . ,  1 995 :  Mamas and Terrar. 200 1 :  L iu .  2007) .  
However, metAEA. the non-hydrolyzed analogue of A EA (Abadj i .  et  a I . ,  1 994) .  
a l so decreases the shorten ing of myocytes. I n  add i t ion . AEA conti nues to inh ibi t  
myocyte shorten ing after pretreatment of these ce l ls with URB597.  a spec i fic 
inh ib itor of F AAH ( P iomel l i ,  et  a l . ,  2006) .  Furthermore, the negat i ve inotropic 
effects of A EA are a l so i nsens i t ive to i ndomethac i n  app l i cation. ind icat ing that the 
effect was un l ike ly to involve the st imu lat ion of the re lease and metabo l i sm of 
endogenous AA. These fi nd i ngs prov ide ev idence that degradat ion products of 
A EA are not involved i n  the observed effects of th is  compound. Col lect i ve ly ,  
myocyte shorten ing experiments i nd icate that the negat i ve i notropic effect of AEA 
resu l ts from a d i rect i nteract ion of A EA with ventr icu lar myocytes, rather than i ts 
act ion on nerve end ings and neurotransm itter uptake systems that have been 
reported i n  various neuronal structures ( l shac, et a l . ,  1 996; Oz, et a l . .  20 ] 0). 
4.2 I nvolvemen t of ca n nab inoid receptors in the nega t ive i notropic effect  
I nvol ement of  cannabinoid receptors in  the negative inotropic actions of 
cannabinoids has been reported i n  several earl ier studies ( Ford, et a l . .  2002 ; Bonz, 
et a I . ,  2003 ;  Steri n-Borda, et a 1 . ,  2005 ;  Su, et a I . ,  20 1 1 ) .  However, the resu l ts of 
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the e i nve l igat ion have 110t been conclus ive ( for rev iews, 1 a l i n  wska, et a I . ,  
20 1 2 : Randa l l .  e t  a I . ,  2004 ; Mend izabal and Adler-Grasch insky, 2007) .  Both 
cannabinoid receptor-dependent and - i ndependent mechani sms have been 
uggested (Ma l i nov. ska, et a l . .  20 1 2 ). Wh i le Ford et ai. , showed that in rat card iac 
m u  c le, the i nh ib i tory effect of  AEA on contract i l i ty was not reversed i n  the 
presence of B I ( R 1 4 1 7 1 6A )  and CB2 (SR 1 44528) receptor antagon i sts ( Ford, et 
aI . ,  2002), Bonz ef ai. reported that AEA, metAEA, and HU-2 1 0  decreased 
contrac t i l e  performance in human atr ial muscle v i a  act i vation of CB I receptors 
(Bonz. et a I . ,  2003) .  I n  another study in rat atr ia, AEA was suggested to have 
negat ive  and pos i t ive i notropic effects mediated by the act ivat ion of C B I  and CB2 
receptors, respect i  e l y  ( ter in-Borda. et a I . ,  2005) .  Under our experimenta l  
cond i t ions.  two structura l l y  d i fferent C B I  antagon i sts AM25 1 (0 .3 IlM) and 
SR 1 4 1 7 1 6  ( 0 .3  IlM )  are not able to reverse the inh ib i tory effect of AEA on 
card iomyocyte shorten ing .  S i m i lar ly, two d i fferent C B2 antagon ists AM630 (0.3 
�) and SR I �4528 (0 .3 IlM) fai l  to antagon ize AEA-induced decrease of 
card iomyocyte shorten ing.  However, at h igher concentrat ions such as I IlM,  these 
antagon ists themse lves show inh ib i tory actions on card iomyocyte shorten ing 
(n=9- 1 2) .  To our knowledge, the negat ive i notropic act ions of relat ively h igh 
concentrat ions of AM25 1 and AM630 have not been reported prev iously. 
However negat ive i notropic act ions of SR 1 4 1 7 1 6  and SR 1 44528 on the 
contract i le funct ions of i so lated rat heart have a l so been attr i buted to the i r  d i rect 
effects on the contract i l i ty of card iomyocytes ( Krylatov, et aI . ,  2005) .  Earl ier 
stud ies on card i ac musc le and other preparat ions a lso ind icate that cannabinoid 
receptor antagon i sts w i th d i fferent chem ical structures can have off-target b ind ing 
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i tes on anou Ion channels and enzymes ( Ford, et a l . .  2002 : Batka i .  el a I . ,  
2004a :  Pal i l ,  el a l . .  20 I I ; BaLlr, e t  a I . ,  20 1 2) .  
4.3 Action poten t ia l  mea u rements 
During exci tat ion -contract ion coupl ing, a l terat ions I n the ampl i tudes and 
k inet ic  of card i ac A Ps are c lose ly assoc iated with corresponding changes in the 
contract i l i ty of  myocytes. In agreement with several earl ier electrophysiological 
tud ies on rat entricu lar myocytes, we have ident i fied two d i st inct ly d i fferent 
groups of ce l l s  d i sp lay ing e i ther epicard ia l  (short durat ion) or endocard ia l  ( long 
durat ion) A Ps ( for a re iew, Antze lev i tch .  et a I . ,  1 99 1 ) . In the current study. low 
A EA concentrat ion (0 . 1 fl M )  does not cause ign i ficant al terat ions in  ampl i tudes 
and k i net ics of A Ps in e i ther epicard ia l  or endocard ia l  myocytes (F igure 3 . 1 1 ) . 
However, there i s  a s l ight hyperpolarizat ion in  Vrest val ues. wh ich reaches a 
stat is t ica l l y  s ign ificant level at I fl M  AEA.  At th i s  concentrat ion, AEA decreases 
the durat ions of A Ps w ithout s ign i ficant ly affect ing the amp I i tudes and dV Idtmax of 
APs .  At  h i gher concentrat ion ( l O  fl M) ,  AEA i nduces changes in AP duration 
accompanied with depolar izat ion of the V rest and decreases of dV Idtma, in the 
endocard i a l  and epicard ia l  ventricu lar  myocytes. suggest i ng that AEA acts on 
m u l t ip le  ion channels w i th d i fferent potenc ies. I m portant ly .  no change in  APD60 
was observed i n  a subpopulat ion of cel l s  suggest ing that some of the act ions of 
AEA on these channe l s  are ce l l  spec ific .  
A l though, th i s  i s  the first patch c lamp study invest igat ing the effect of 
AEA on the card iac A Ps, an ear l ier report us ing intrace l l u lar record ing methods in 
rat papi l l ary musc l e  fibers reported that AEA, i n  the concentrat ion range of 1 - 1 00 
nM .  potent ly i nh ib i ted A P  durat ions i n  an AM25 1 sens i t ive manner ( L i ,  et a I . ,  
2009), suggest ing that act i vation of  C B  I receptor med iated the  negat ive i notropic 
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act ion of E .  How ever. under the experimental cond i t ions of th is  stud) . 
changes on nei ther ampl itudes nor k inetics of epicard ia l  and endocard ia l  APs are 
detectable unt i l J f..lM concentrat ion of AEA.  Important ly ,  the effects of AEA on 
the duration of both t) pes of A Ps are not reversed in  the presence of CB receptor 
antagon ists tested:  AM25 J and M630 ( F igure 3 . 1 3A and B) .  I n  add i t ion .  AEA 
cont i nues to affect P durat ion after PTX pretreatment (F igure 3. J 4C). It is l i ke ly 
that d i fferences in  methods ( patch c lamp versus i ntrace l lu lar  sharp e lectrode 
record ing) and preparat ions ( ventr icular myocytes versus i ntact musc le fibers wi th 
nerve end ings and gap junct ion connect ions) used i n  these stud ies may account for 
some of the d iscrepanc ie . 
I n  summary, based on the insens i t iv ity of the effect of AEA on myocyte 
shorten ing and act ion potent ia l  shorten ing to C B I  and CB2 antagon ists, as wel l as 
to the pretreatments with PTX and NEM, it is l i ke ly that AEA decreases myocyte 
shorten ing and shortens AP durat ion in a manner that is independent of CB I and 
C B2 cannabinoid receptors. 
4.4 E x per iments wi th  vol tage-dependent  Na + channels 
I n  card iac muscle, extrace l l u lar Ca2+ requ i red to tr igger Ca2
+ re lease from 
SR enters through L -type VGCCs which are opened dur ing the A P. The resu l ts 
using vol tage-c lamp mode of whole-cel l patch c lamp techn ique ind icate that i n  
agreement w i th the changes in  the ampl itudes, durat ion and dV/dtmax of  A Ps, AEA 
caused s ign i ficant i nh ib i t ion of voltage-dependent Na + and L-type Ca
2+ channels 
in card iomyocytes. Furthermore,  the resu l ts ind icate that the inh ib i t ion of these 
channels  by A EA is not sens i t ive to CB I or CB2 receptor antagoni sts. These 
find ings are in agreement w ith the d i rect inh ib i t ion of Na 
+ and L-type Ca2+ 
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channel  ob er ed in  earl ier stud ies. For example, AEA. at s im i lar or h igher 
concentrat ions. has been shown to inh ibit  d i rect ly the functions of vol tage-gated 
a + channels i n  neuronal structures (N icholson, et a I . ,  2003 ; K im ,  et a I . ,  2005 ;  
Duan,  e t  a l . .  2008), L-type Ca2+ channels (Oz, et a I . ,  2000; Oz, e t  a I . ,  2004b) and 
various t) pe of K+ channels  (Oz, et a I . ,  2007a; for a rev iew, Oz, 2006). 
In card iac musc les, VGSCs are a lmost exc l usively represented by the i r  
TTX-resistant Nav l . 5 isoform (Cattera l l  e t  a I . ,  2005a). Therefore. the changes in  
the  biophys ical  propert ies of INa by AEA,  namely  i nduction of the  hyperpolarizing 
h i ft  in the vol tage-dependence of i ts S S I  can be attri buted to the i r  effects on the 
gat ing of a 1 . 5 channe l .  A hyperpo larizing shift of the SSI ind icates that a 
h igher proport ion of  VG Cs wou ld  be inact i vated at rest ing membrane potent ia l  
and therefore, substant i a l l y  fewer channels  wou ld  be avai lable for act ivat ion, 
resu l t i ng in  a decreased ampl itude and rate of r ise during the upstroke of the AP .  
Our  prev IOus rad io l igand stud ies ind icated that the spec ific b inding of 
eH J BTX-B to ventr icu l ar muscle membranes was inh ib i ted by metAEA . I n  
add i t ion,  the resu l ts  wi th  C B I  and C B2 antagon ists suggested that the effect of 
metAEA on VGSCs was not mediated by the act i vation of C B I  or CB2 
cannabino id receptors (A I  K ury, et a I ,  20 1 4b, art ic le  In Press). Earl ier 
i nvestigat ions have shown that l ocal anesthet ics and c lass I ant iarrhythmics a lso 
i nteract wi th  the b ind ing s i te for eHJBTX-B on the card iac sod ium channel 
(She ldon, et a ! . ,  1 994). I t  i s  l i ke ly that AEA synthesized during ce l l  stress can bind 
to av 1 . 5 channel and modu late the act ions of local anesthetics and c lass I 
ant iarrhythm ics .  A l though, th i s  to our knowledge, is the first demonstrat ion of the 
d i rect i nh ibi tory act ion of A EA on a musc le type vol tage-dependent Na 
+ channel ,  
i n  several ear l ier  i nvestigat ions, AEA at s im i l ar o r  h igher concentrations, has 
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been sho\>\ n to i nh ib it  d i rect l the function of VG Cs in  neuronal structures 
icholson. et a I . ,  2003 ;  K im,  et a I . ,  2005 :  Duan, et a I . ,  2008).  [n agreement with 
our find ings, both A EA (The i l e  and Cumm ins, 20 [ 1 )  and its metabol ite AA 
( Bendahhou, et a I . ,  1 997) have been sho n to increase the inact ivation of Na + 
channe ls .  I nh ib it ion of VG Cs by A EA would  slow the conduct ion of 
depolarizat ion and modu late the automat ic i ty  in  the ventric les. 
In conc lus ion, the i nh ib i tory effect of AEA, on VGSC, which is  the major 
im ard current dur ing the upstroke (phase 0) of the AP i s  i n  agreement with the 
resu l ts  of the current-c lamp experiments (A I  Kury. et a I . ,  20 1 4a) ind icat ing that 
AEA decreases the ampl itude and in i t i a l  rate of r ise of the AP i n  ventr icu lar 
myocytes.  
4.5 E x perimen ts with voltage-dependent  Ca2+ channels 
I n  add i t ion to INa, AEA causes a s ign i ficant i nh ib i t ion of h,ca i n  
card iomyocytes .  T h i s  current contri butes t o  the p lateau o f  the card iac A P  (phase 
2) ,  therefore, i ts suppress ion causes both the decrease of p lateau ampl i tude and the 
shorten ing of the AP durat ion.  The resu l ts of th i s  work, in agreement with an 
ear l i er study ( L i ,  et aI . , 2009). show that A EA decreases the ampl i tude of the 
p lateau and causes shorten ing of AP durat ion. Resu l ts a lso show that AEA affects 
the act ivat ion and i nact i vat ion gat i ng of card iac L-type VGCCs producing a 
s ign i ficant reduction i n  I L.Ca "window current"' i n  the range of Y m between -40 
m V and + 1 0 m V, and induc ing pal1 ia l  b lockade of the ion-conduct ing pathway 
lead ing to decreased amp l i tude of I L.Ca· 
Dim in i shed stationary Ca2+ entry as a consequence of smal ler "window 
cUITent" may prevent Ca2+ overload and cause reduct ion of necrosis, whereas, 
i nh ib i t ion of h,ca may large l y  determ ine the decrease in the amp l i tude of AP 
1 47 
plateau and P horten ing obser ed in  the presence of AEA. o l lect i  e l ) , the 
resu l ts  of the ele troph s iological  experiments suggest that during exc itation-
contract ion coupl i ng, shorten ing of AP due to the inh ib i t ion of L-type Ca�+ 
channels decrea cs 2+ . d 2+ a - 1 11 uced Ca re lease from R and causes negat ive 
i notropic effect of AEA reported in  ear l ier  stud ies. In l i ne with this hypothesis, 
a l though caffe ine- induced Ca2+ transients and myofi lament sens i t iv ity to Ca2+ 
rema in  unchanged, e lectrica l ly- i nduced Ca2+ trans ients are s ign i ficantly depressed 
by AEA,  further suggest ing  that Ca2+- i nduced Ca2+ re lease is impaired in the 
presence of AEA.  Overa l l ,  A EA-med iated suppression of voltage-acti vated h.ca 
w ou ld  pro ide a mechanism for the negat ive i notropic effects observed in earl ier 
tudies .  
The mechan ism of the inh ib i tory effect of AEA does not  seem to involve 
the Ca2 - i nduced inact i at ion process. s i nce the ampl i tudes of 8a2+ currents 
through L-type VGCCs were effect ive ly i nh ib i ted by AEA. In add i t ion, A EA � as 
equa l l y  effecti e upon intrace l l u lar or extracel l u lar appl icat ion suggest i ng that 
there is no s idedness for A EA act ions on L-type VGCCs. Considering the h igh l  
l i poph i l ic nature of AEA;  i t  i s  not  surpris ing that A EA can access i t s  b ind ing site 
from both extra and intrace l l u lar s i tes effect ive ly .  
The resu lts of our rad io l i gand b ind ing stud ies a lso ind icated that AEA 
d i rect ly in teracts wi th and i nh ibi ts the function of L-type Ca2+ channels in  
ventricu lar  musc l e  membranes (A I  Kury, e t  a I . ,  20 I 4b, art ic le  In Press) .  Al though, 
to our knowledge, th i s  is the first demonstrat ion of the d i rect effects of AEA on 
the L -type VGCC in card iac muscle, s im i lar results demonstrat ing the effects 
AEA on skeletal muscle L-type VGCCs have a lso been described in biochem ical 
stud ies (Oz, et a I . ,  2000; Oz, et a I . ,  2004a) .  In rabbit ske leta l muscle, i t  has been 
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demonstrated that E i nh ibits the pec i fic b inding of e H ] l sradip ine to ske leta l 
T-tubule membrane . and d i rect l} inh ib i ts the function of ske leta l musc le L-type 
C 2+ a channels (Oz, et a I . ,  2000 : Oz, et a I . ,  2004a) in a manner that is i ndependent 
of known cannabinoid receptors. In fact. earl ier stud ies searching for endogenous 
modu lators of L-type Ca2+ channel have a lso iden t i fied AEA as a l igand for L-
C �+ type a  ( Johnson,  et a t . .  1 993 ) .  ubsequent ly ,  i nvest igations ind icated that the 
effects of A EA are not l im i ted to L-type VGCCs in musc les. D ifferent types of 
Ca2+ currents in neurons and other exc i table ce l l s  are a lso inh ib ited d irect ly by 
endocannabinoids such as A EA [ for a recent rev iew, ( Lozo aya, et a l . .  2009)] . 
I n  a recent study, it was found that the synthetic cannabinoid A-955840 
inh i bits the function of L-type CaH channels in  rabbit heart in  a manner 
i nsens i t ive to CB I and C B2 antagon ists (Su, et a I . ,  20 I I ) . In another recent study. 
A EA was reported to i nh ib i t  L-type Ca2+ channels by the act i vation of C B I  
receptors ( L i ,  e t  a I . ,  2009) .  I n  t h i s  study. A EA in the concentration range o f  1 0  nM 
to  1 )l M potent l y  i nh ib ited the  function of Ca2+ channels  and the effect of AEA 
was reversed by CB I  receptor antagon ists. I n  our experiments, AEA is  not 
effect ive at concentrat ions lower than 0. 1 )l M .  In add i t ion .  in  our study, the 
i nh i b i tory effect of AEA is not reversed by the antagonists of CB I and C B2 
receptors. The d i fferences between these two studies cou ld be due to d i fferent 
stra i ns of rats used (Sprague-Dawley in the i r  study versus Wistar rats in the 
present study). Our fi nd ings suggest that nei ther CB I nor C B2 receptors are 
invo lved i n  AEA inh ibi t ion of L-type Ca2+ channe ls  i n  rat card iomyocytes. 
A l though PTX-sensi t ive s ignal  transduction is we l l  documented for cannabinoid 
agon ists, cannabinoid coup l i ng to PTX- insensi t ive Gq has been reported in  several 
stud ies ( M c In tosh , et a I . ,  2007; Straiker, et a I . ,  2002 ; I sh i i  and Chun,  2002) .  
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Therefore. the effect of AE through a PTX- insensit i  e pathwa) cannot be 
exc l uded. Howe er. the resu l ts of our experiments with EM . which inactivate G­
prote ins  i nd i cate that act i at ion of G-prote ins is  not requ i red for AEA act ions i n  
card iom ) o  ytes. 
Degradat ion products of AEA, such as AA and fatty acids-based 
compounds.  have been shown to i nh ib i t  the funct ion of card iac L-type Ca2+ 
channels [ ( L i ,  et a I . ,  2009), for a rev iew; (Oz, 2006)) . However, metAEA a lso 
i nh ib i ted L-type Ca2+ cun'ent to the same extent with AEA. I n  add i t ion, AEA 
cont inued to i nh ib i t  L-type Ca2+ currents after pretreatment of these ce l l s  with the 
spec ific  i nh ib itor of FAA H ,  U RB597 ( Piomel l i ,  et a I . ,  2006). 
4.6 Exper iments w ith  ca rd iac Na+/Ca2+ exchanger 
The resul ts  of this study ind icate for the first t ime that under normal 
cond i t ions. A EA has a d i rect i nh ibitory effect  on both the forward and reverse 
mode of NCX I in ventr icular myocytes. U nder phys io logical cond i t ions. 
i nh ib i t ion of CX I operat ing  in reverse mode is expected to decrease Ca2+ 
entrance dur ing card iac act ion potent ia l ,  and induce negat i ve i notropic actions. 
Therefore. i t  i s  l ike l y  that the inh ib i t ion of NCX funct ion in the reverse mode can 
cause the suppression of AP p lateau and the decrease of the AP durat ion.  
The find ings of th is study suggest that neither CB I nor C B2 receptors are 
I n  o l ved i n  A EA inh ib i t ion of NCX in rat card iomyocytes. F i rst ly, AEA 
i nh ibi t ion IS a l tered by nei ther C B I  nor C B2 receptor antagon ists. Second ly, 
t reatment with PTX or i nc lus ion of GDP-p-S in  p ipette so lu t ion does not affect the 
act i v i ty of NCX I further suggest ing that G-prote ins are not involved in  AEA 
act ions.  Th i rd ly ,  i n  our recent study (A I  Kury et  a I . ,  20 1 4c) we have shown that 
A EA s ign i ficant l y  i nh ib i ted NCX I -med iated currents in H EK -293 ce l l s  which do 
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not conta i n  C B  1 or B2 receptors ( Oz, et a I . ,  20 1 0). Col lect ive ly these resu l ts 
suggest that E interacts d i rect ly  with CX I in ventricu lar  myocytes in a 
manner that i i ndependent of CB 1 and CB2 receptors. 
In rat odontobl asts, cannabinoid- i nduced Ca2+ influx through TRPY I was 
recent l y  shO\ n to be funct iona l l y  coupled to NCX-mediated Ca2+ extrusion 
( Tsumura, et a ! . .  20 1 2 ) .  However, i t  i s  un l i ke ly  that TRPV l act ivation is involved 
i n  the effect of AEA ob erved in th is  study s i nce adult  card iomyocytes do not 
express TRPV 1 channels ( Dvorakova and Kummer, 200 1 ) . In another recent 
study, it \ a reported that under i schem ic condi t ions, AEA inh ib i ts NCX I by 
act ivat i ng C B2 receptor v i a  PTX-sens i t ive G,/o prote ins ( L i ,  et a ! . .  20 1 3) .  
However. a recent study i n  endothe l ia l  cel l s  demonstrated that AEA,  i n  the 
concentrat ion range used in our study, s ign i ficant ly i nh ibits the act iv i ty of NCX I 
i n  a manner that i s  independent of G-prote in  receptors ( Bondarenko, et a I . ,  20 1 3 ) .  
Metabo l i c  degradat ion products of A EA, such as  AA and re l ated fatty 
ac ids  have a l so been shown to regul ate NCX l funct ion (X iao, et a l  . .  2004).  In the 
current study, the metabo l ica l l y  stab le analogue of AEA, metAEA (Abadj i et a I . , 
1 994),  a l so i nh ib i ts  INcx \ .  Furthermore, i n  the presence of U R B597, INcx l i s  
suppressed t o  the same extent by A EA,  suggest i ng that the degradat ion products 
of AEA are not invo lved in the inh ib i t ion of NCX 1 in card iac myocytes .  1n  our 
recent study in H EK -293 cel l s  (A I  K ury et a I . ,  20 1 4c)  ce l l  surface expression of 
NCX 1 ,  as determ i ned from the i ntensity of Y FP-NCX I express ion levels, was not 
a l tered after AEA appl i cation suggest ing  that A EA is not l ikely to a l ter NCX I 
traffick ing to the cel l surface. 
I n  add i t ion to the NCX,  SR Ca2+ -A TPase (SERCA2a) a l so plays an 
important role in card i ac contract ion and rhythm ic ity ( lnes i ,  et a l . ,  2008; E isner, et 
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a I . ,  20 1 3 ) . nder the experimental cond i t ions of th i s  work, \\ e cannot ru le out the 
contri but ion of ERCA2a to the observed act ions of A EA on the function of CX 
in card iomyocytes. I n  fact, our recent study ( A I  Kury, et a I . ,  20 1 4a) ind icates that 
A E  cause a s ign i ficant increase i n  SERCA2a act iv ity i n  card iac R membranes. 
A EA cont i nued to i nh ib i t  the CX 1 currents i n  HEK-293 ce l l s  \ h ich, a lthough 
express ERCA2 endogenously ( Vafladak i ,  et a I . ,  2009), is devo id of exc i tab i l i ty .  
F urthermore, bath appl icat ion of A EA does not a l ter intracel lu lar Ca2+ leve l s  in 
these cel l l i nes ( Oz, et a l . ,  20 1 0) .  
4.7 Mecha n is m  of act ion  of AEA 
Anandam ide belongs to long-cha in N A Es which are produced abundant ly 
i n  response to t i ssue necros is  and cel l u lar stress ( Hansen, et  a I . ,  2000; Berger. et 
a I . ,  2004) .  I n  fact, accumu lat ion of NAEs was first observed i n  exper imental 
myocard ia l  i nfarct ion i nduced by l igat ion of coronary arteries i n  can i ne heart 
[ (Epps et a l . .  1 979: Epps, et a I . ,  1 982). for a rev iew, ( Schmid and Berdyshev. 
2002)] . A l though the content of A Es i n  various mammal ian t i ssues ranges from 
about 0 . ] to 20 nmol/g ( H ansen, et a I . ,  2000), it was demonstrated that NAEs 
content increases up to 500 nmo l/g (approx imate ly  500 �) i n  i nfarcted areas of 
can ine  heart dur ing i schemia ( Epps, et a I . ,  1 979). AEA const itutes m i nor ( 1 -3 %) 
port ion of total N A E  leve ls  (Schmid and Berdyshev, 2002), however, the part i t ion 
coefficient  of AEA is in the same order with that of AA to bio logical  membranes 
(2-9 x l  04) ( Meves, 1 994). Thus, the membrane concentration of AEA wou ld  reach 
m uch h igher levels than those est imated for i ntrace l l u lar concentrat ions.  
I t  was prev ious ly reported that other NAE spec ies. such as 
stearoylethanol am i ne ( SEA) and N -oleoylethanolam i ne (OEA), are a lso produced 
dur ing i schem ia  and that they have s ign i ficant effects on the ampl i tudes and 
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k inet ics of P and accompanying ion ic currents .  The effects of SEA and OEA 
cou ld  account for the negati e inotropic act ions of these compounds on 
entricu lar myocytes ( Voi tychuk, et a I . ,  20 1 2) .  Sim i lar to AEA. other A Es.  
metabo l ic degradat ion products of NAEs. and structura l l  re lated compounds have 
been sho\ n to modu late the function of voltage-gated Ca2+ ( Voit, chuk, et a l . .  
20 1 2 : Oz.  e t  a l . . 2000; Oz. e t  a l . .  2005:  A l ptek in  e t  a 1 . .  20 1 0 ) and a+ (N icholson, 
et a l . .  2003 : K i m ,  et a I . ,  2005 ;  Duan, et a I . ,  2008) channels .  Furthermore, A EA has 
been shown to block T-type Ca2+ channe ls (Cay3 . 1  and Cav 3 .2 )  (Chem in .  et a l . .  
2007) and  card i ac K y 1 . 5 ( Barana, e t  a l . .  20 1 0) and  K v4 .3  (Amoros. e t  a I . ,  20 I 0) 
channels in a receptor- i ndependent manner. These effects may contribute to the 
overa l l  act ions of A EA on action potent ia l  and card iac mJ oC) te funct ion .  
Therefore, i n  the concentrat ions used in  th is  study, AEA i s  l i ke ly  to have 
i mportant imp  I icat ions regard i ng the contracti Ie and e lectrical responses of 
entr icu lar m yocytes to i schem ia  and cel l u lar stress ( Hansen.  et a l . .  2000; Berger. 
et a l . .  2004: Schm i d  and Berdyshey, 2002) .  I n  fact, shorten ing of AP durat ion by 
AEA can be benefic ia l  or hannfu l .  depending on the underly ing pathology. Thus. 
dur ing acute i schem ia,  in  wh ich the duration of the card iac AP i s  a l ready 
shortened, a further decrease shou ld  be proarrhythm ic ( Den Ru ij ter, et a I . ,  2007). 
However, shorten ing of AP durat ion shou ld  be benefic ia l  i n  prevent ing those 
arrhythm ias caused by tr iggered act i v i t ies observed in cond i t ions such as hea11 
fa i l ure ( Den Ru ij ter, et a I . ,  2007; Den Ru ij ter and Corone l ,  2009) .  
B ind ing s i te(s) of AEA and other endocannabinoids on their target proteins  
i s  current l y  unknown. A part from spec i fic b ind ing si tes on the ion channels and 
receptors ( F i gure 4 . 1 ) , AEA can accumulate and reach substant ia l ly  h igh 
concentrat ions i n  biological  membranes, thereby causing s ign ificant a l terat ions in  
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phy ico-chem ica l  propert ies of these membranes. As ment ioned earl ier, the 
membrane concentrat ion of AEA can reach much h igher Ie els than those 
esti mated for intracel lu lar  or extrace l l u l ar concentrat ions. It is l i kely that due to i ts 
h igh l i poph i l ic i ty, A E  can al ter the physico-chemical  character ist ics  o f  the l i p id 
env i ronment, or indeed, b ind to hydrophobic s ites on the ion channels and regulate 
the funct ional propert ies of these prote ins  [ (M avromoustakos, et a I . ,  200 1 ) ; for a 
rev ie\" , ( Oz, _006) ] .  Concentrat ions of AEA modulat ing the act i v i t ies of ion 
channels  and exchangers stud ied in  our invest igat ion appear to be wi th in  the range 
of 0 . 1 to 1 0  11 M .  I t  is not known whether these concentrat ions can be achieved 
under ph, s io logical  cond i t ions. The concentrat ions of AEA in the rat bra i n  have 
been reported to range from 2 .5  to 29 pmol/g (Schmid,  et a I . ,  2002) .  The 
concentrat ion of AEA in rat and human p lasma is  in the nM range of 0.7-8 nM 
and 4 -20 nM.  respect ive ly  (G iuffrida, e t  a l . .  2000; Bojesen and Bojesen, 1 994). 
However. as ment ioned earl ier, due to h igh part i t ion coefficients, A EA can 
effect ive ly accumulate in ce l l membranes and reach s igni ficantl y h igher 
concentrat ions.  Furthermore, dur ing ischem ia and ce l l  stress, t i ssue concentrat ions 
of AEA can increase further ( Epps. et a I . ,  1 979; Schmid and Berdyshev, 2002) 
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A EA 
F igu re 4 . 1  Proposed model for the  actions of AEA on  cel l u lar  excitab i l ity :  
Accord ing to the mode l ,  the effects o f  AEA are mediated by G-protein coupled 
cannabinoid receptors, l i gand-gated ion channe ls  and voltage-gated ion channels .  
C B-R,  cannabinoid receptor; LGIC, l igand-gated ion channe l ;  VGlC, voltage­
gated ion channe l .  Adapted from Oz, 2006. 
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I t  ha been more than a century s ince the Overton-Meyer ru le stated that 
membrane permeabi l i ty of any molecu le depend on its hydrophobic i ty .  A lthough 
the Overton-Meyer rule pred icts the access ib i l i ty of hydrophobic molecu les such 
as arious l i p id . fatt ac ids and endocannab inoids to the i r  membrane-de l i m i ted 
act ion and hence somewhat the potency of these molecu les on the i r  target 
prote i ns, it does not e luc idate the mechan ism(s) of action of these molec ules. One 
schoo l of thought focuses on the infl uence of latera l pressure profi les on i ntegra l 
membrane prote ins  to descr ibe how prote ins sense the effects of hydrophobic 
molecu l es in membrane b i l ayers (van den Bri nk-van der Laan, et a ! . ,  2004), and 
hyd rophobic  m i smatch between the lengths of the hydrophobic  membrane­
spann ing domains  and the b i layer th ickness ( Lundbaek. 2006). Changes in  the 
l atera l pressure profi le with a l tered l i p id composit ion (Cantor, 200 I ;  Van den 
Brink-van der Laan, et a ! . ,  2004) or by part i t ion ing of hydrophobic molecu les 
(Cantor, 200 1 )  have been shown to modu late the functions of ion channels and 
other i ntegral membrane prote ins .  It has been hypothes ized that if the hydrophobic 
length of the transmembrane domains of the ion channels does not match the 
hydrophobic  th ickness of the membrane phosphol i p id b i l ayer, such a m i smatch 
wou ld  create stress between the channel and the membrane (Andersen,  et a ! . , 
1 999) .  As  a resu l t ,  th i s  tens ion requ i res that the th ickness of the ce l l  membrane be 
decreased at i ts contact with the i nterface of the t ransmembrane regions of the ion 
channel  so that their hydrophob ic regions match and thus, affect  the 
conformational state and conductance of the ion channel (Jensen and Mouri tsen, 
2004) .  
In  an earl ier study, i t  was suggested that a l terations in  the  l ip id order of  
synapt i c  membranes caused by various cannabinoids m ight be  a necessary 
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property for the i r  pharmacological  act iv i t ies ( B loom. et a l . .  1 997).  Hov-. e  er. the 
in nuences of lateral membrane pressure and membrane th ickness are not observed 
un i  ersa l ly .  and other membrane propert ies can a lso play ro les in l i pid -prote in  
in teract ion ( Lee. et a l . .  2005) .  Another school of thought on the quest ion of ho\\ 
l i poph i l ic molecu le such as cannab inoids affect the function of ion channels 
focuse on the prote i n - l i p id i nterface. Recent i nvest igations suggest that l i pids 
such as fatty acids d isplace or interact with l i p ids and/or hydrophobic am ino ac ids 
located at the spec i fic l i p id-prote i n  i nterfaces of the ion channe l s. rather than 
altering bulk physico-chem ical propert ies of cel l  membranes ( M c l ntosh and 
S imon. 2006).  Thus. a l though hydrophobic ity is  an important factor determ in ing 
the b ioava i l ib i l ty of the drug at i ts  action s i te. h igh l y  hydrophobic molecu les such 
as cannabinoids may not need to change bu l k  membrane characterist ics to al ter the 
funct ion of ion channels ( BaITantes. 2004 ; Garc ia ,  2004) .  
A n  extens ive volume of work in  the l i terature ind icates that the b i layer is  
not s imply an i nert th in l ayer of l i p id  whose primary purpose is  to prov ide a 
barrier to ions ( M c I ntosh and S i mon, 2006). Fol lowing the i r  i nsert ion in to the 
fl u id membrane b i l ayer. ion channels assume an energet ica l ly  m in imal 
conformational state lead ing to a stable structure .  Important ly,  the binding of 
l igands.  such as AEA. leads to conformational changes assoc iated v i th the 
a l terat ions in the hydrophobic domains  of the ion channel s  ( Lee and MacK innon, 
2004; Lee, et a I . ,  2005 ;  Garc ia, 2004). The energet ic  requ i rements of these 
conformat ional  changes depend on the l ip id env ironment i n  which they are 
i mmersed (Sp ivak, et a I . ,  2007). A l though the exact mechan isms of action of AEA 
on ion channels and receptors are current ly  unknown, such i nteraction wi th 
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prote ins i s  l i ke ly  to med iate some of the pharmacological actions of AEA i n  the 
card iovascu l ar and ner ous sy terns .  
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5. CONCL U S I ON 
I n  conc lu  ion,  the re u l ts generated from the present study, ind icate for the 
fi rst t ime that EA inh ib i ts  myocyte contract i l i ty by acting on mul t i ple target 
prote i n . We have shown that A EA decreases the durat ion of APs and modulates 
the acti it) of a + and L-type Ca2+ channe ls  and inh ib its the function of NCX I in  
a C B )  and C B2 receptor- independent manner. Considering mass ive release of 
vanou A Es.  i nc lud ing AEA,  during ischemia  and hypox ic  cond i t ions, further 
under tand ing of the i r  act ion mechan isms and target prote ins  is  essent ia l  in the 
development of better treatment moda l it ies for these pathological cond i t ions. 
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6. L I M ITATI ONS A N D  FUTU R E  WORK 
• The main work l i m itat ions in  th i s  stud are :  
I .  Physio logical  temperature :  A l l  patch c lamp experiments were conducted at 
room temperature (22-23 0c) in order to ensure longer surv i va l  t ime of patched 
cel l s  and a better t ime reso lut ion of the membrane currents. G iga-ohm sea ls  i n  
patch-c lamp experiments are known to be unstable a t  ra ised temperatures. For th is  
reason ,  we chose to work at  room temperature. A s im i lar approach was taken in  
earl ier stud ie i n  various cel l types (Voi tychuk et a I . ,  20 J 2 ;  L i  e t  aI . ,  20 J 3 ;  
Bondarenko e t  a I . ,  20 1 3 ) .  
2 .  The i nfluence of solvent :  AEA was d i ssolved in  ethanol .  As w i th  earl ier stud ies, 
ethano l  a lone caused a decrease in the contract i l i ty of ventricu lar myocytes and 
the ampl itudes of INa and h,ca Therefore, for each set of experiments, i t  was 
necessary to test the effect  of  the so l vent separately. 
• I n  order to extend our find ings 111 th i s  thes is .  the fo l lowing experiments 
can be done i n  the future : 
1 .  Our study showed that AEA can decrease the AP ampl i tude and shorten A P  
durat ion i n  rat ventr icu lar myocytes wh ich m ight be one o f  the mechan isms for 
ant i -arrhythmic  effect of  AEA.  However the mechan i sm of act ion of AEA is not 
complete ly understood and the effect of A EA on the card i ac conduction system 
remains unknown. Therefore, invest i gat ing the effect of A EA on s inoatr ial and 
atrioventr icu lar nodes wou ld  be very i nformat ive .  
2 .  In  add i t ion to the endocannabino id AEA, l eve ls  of 2-AG have been shown to be 
increased in a range of card iovascu lar d isorders. Therefore, understand i ng the 
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e lectrophysiological  and pharmacological effect of th is  endogenous cannabinoid 
i n  the heart ma) a id  i n  further understanding of any potent ia l  ro le of 2-AG i n  
card iovascu lar pathologies. 
3. Card iac K+ channels p lay an important ro le in determ i n ing the rest ing 
membrane potent ia l  and the shape and durat ion of the card iac AP .  A l though the 
effect of AEA on outward K+ currents ( Ito) and ATP-sensi t ive K+ currents ( IATP) 
has been shown prev iously,  the contribut ion of other K+ conductances such as the 
rap id (hr) and slow ( If..s) components of  the delayed rect ifier and the inward 
rec t i fier (hJ) remains unknown. Therefore, studying the effect A EA on these 
conductances wou ld  help in better understand ing the mechan i sm of action of AEA 
on card iac cel l s. 
4 .  S ince the k i net ics  and voltage dependence of channel gat ing are mod ified by 
aux i l iary subun its of vol tage gated Na + and Ca2+ channels, studying the d i rect 
effect  of A EA on d i fferent subun its of voltage-gated ion channels, US I ng 
express ion systems  such as Ch inese Hamster Ovary (CHO) or Human Embryonic 
K idney ( H E K )  293 cel l s, wou ld  give a more deta i led p icture on the mechan ism of 
the d i rect effect  of AEA on these channels .  
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